Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


COVID-19: Daily Top 10 Papers


  Inflammatory Bowel Diseases

  Free Subscription


Articles published in Inflamm Bowel Dis

Retrieve available abstracts of 1221 articles:
HTML format



Single Articles


    July 2021
  1. CHIBA M, Ishii H, Sageshima M, Iwabuchi A, et al
    Appendiceal Orifice Inflammation in Severe Ulcerative Colitis and Its Resolution With Infliximab and Plant-based Diet as First-line Therapy.
    Inflamm Bowel Dis. 2021 Jul 22. pii: 6325475. doi: 10.1093.
    PubMed    


  2. SYAL G, Serrano M, Jain A, Cohen BL, et al
    Health Maintenance Consensus for Adults With Inflammatory Bowel Disease.
    Inflamm Bowel Dis. 2021 Jul 19. pii: 6323888. doi: 10.1093.
    PubMed     Abstract available


  3. DAI C, Jiang M, Huang YH
    Anti-TNF Therapy and the Risk of Herpes Zoster Among Patients With Inflammatory Bowel Disease.
    Inflamm Bowel Dis. 2021 Jul 14. pii: 6321215. doi: 10.1093.
    PubMed    


  4. COATES MD, Ba DM, Liu G, Dalessio S, et al
    Revisiting the Association Between Inflammatory Bowel Disease and Parkinson's Disease.
    Inflamm Bowel Dis. 2021 Jul 14. pii: 6321214. doi: 10.1093.
    PubMed     Abstract available


  5. SHIBUYA T, Nomura O, Nagahara A
    Safety and Efficacy of Ustekinumab for Ulcerative Colitis in a Liver Transplant Patient.
    Inflamm Bowel Dis. 2021 Jul 13. pii: 6320083. doi: 10.1093.
    PubMed    


  6. OJO BA, VanDussen KL, Rosen MJ
    The Promise of Patient-Derived Colon Organoids to Model Ulcerative Colitis.
    Inflamm Bowel Dis. 2021 Jul 12. pii: 6319488. doi: 10.1093.
    PubMed     Abstract available


  7. WEISSMAN S, Systrom HK, Aziz M, El-Dallal M, et al
    Colorectal Cancer Prevention in Inflammatory Bowel Disease: A Systematic Analysis of the Overall Quality of Guideline Recommendations.
    Inflamm Bowel Dis. 2021 Jul 10. pii: 6318812. doi: 10.1093.
    PubMed     Abstract available


  8. KHAN N, Pernes T, Weiss A, Trivedi C, et al
    Efficacy of Vedolizumab in a Nationwide Cohort of Elderly Inflammatory Bowel Disease Patients.
    Inflamm Bowel Dis. 2021 Jul 10. pii: 6318811. doi: 10.1093.
    PubMed     Abstract available


  9. TSE CS, Singh S, Sandborn WJ
    A Framework for Clinical Trials of Neurobiological Interventions That Target the Gut-Brain Axis in Inflammatory Bowel Disease.
    Inflamm Bowel Dis. 2021 Jul 9. pii: 6318240. doi: 10.1093.
    PubMed     Abstract available


    June 2021
  10. WALLDORF J, von Arnim U, Schmelz R, Riesner-Wehner A, et al
    SARS-CoV-2 Vaccination in Patients With Inflammatory Bowel Disease-Fear and Desire.
    Inflamm Bowel Dis. 2021 Jun 28. pii: 6310707. doi: 10.1093.
    PubMed    


  11. CHOSHEN S, Turner D, Pratt LT, Precel R, et al
    Development and Validation of a Pediatric MRI-Based Perianal Crohn Disease (PEMPAC) Index-A Report from the ImageKids Study.
    Inflamm Bowel Dis. 2021 Jun 21. pii: 6307118. doi: 10.1093.
    PubMed     Abstract available


  12. TAFT TH, Quinton S, Jedel S, Simons M, et al
    Posttraumatic Stress in Patients With Inflammatory Bowel Disease: Prevalence and Relationships to Patient-Reported Outcomes.
    Inflamm Bowel Dis. 2021 Jun 17. pii: 6301664. doi: 10.1093.
    PubMed     Abstract available


  13. HANZEL J, Dreesen E, Vermeire S, Lowenberg M, et al
    Pharmacokinetic-Pharmacodynamic Model of Vedolizumab for Targeting Endoscopic Remission in Patients With Crohn Disease: Posthoc Analysis of the LOVE-CD Study.
    Inflamm Bowel Dis. 2021 Jun 17. pii: 6301858. doi: 10.1093.
    PubMed     Abstract available


  14. QIN X
    High Fecal Proteolytic Activity That Precedes Ulcerative Colitis Likely Results From Impaired Inactivation of Pancreatic Proteases Rather Than Bacteria.
    Inflamm Bowel Dis. 2021 Jun 14. pii: 6298410. doi: 10.1093.
    PubMed    


  15. GALIPEAU HJ, Caminero A, Verdu EF
    Increased Bacterial Proteolytic Activity Detected Before Diagnosis of Ulcerative Colitis.
    Inflamm Bowel Dis. 2021 Jun 14. pii: 6298409. doi: 10.1093.
    PubMed    


  16. LAMAZZA A, Fiori E, Carati MV, Pronio AM, et al
    Self-Expandable Metal Stents for Refractory Complete Rectal Obstruction in Patients With Crohn Disease.
    Inflamm Bowel Dis. 2021 Jun 10. pii: 6295865. doi: 10.1093.
    PubMed    


  17. GONG L, Xiao J, Yi J, Xiao J, et al
    Immunomodulatory Effect of Serum Exosomes From Crohn Disease on Macrophages via Let-7b-5p/TLR4 Signaling.
    Inflamm Bowel Dis. 2021 Jun 9. pii: 6295437. doi: 10.1093.
    PubMed     Abstract available


  18. VANDE CASTEELE N, Leighton JA, Pasha SF, Cusimano F, et al
    Utilizing Deep Learning to Analyze Whole Slide Images of Colonic Biopsies for Associations Between Eosinophil Density and Clinicopathologic Features in Active Ulcerative Colitis.
    Inflamm Bowel Dis. 2021 Jun 9. pii: 6295436. doi: 10.1093.
    PubMed     Abstract available


  19. DAVID JG, Chute D, Reed B, Saeed S, et al
    Assessing the Prevalence of and Risk Factors for Disordered Eating Attitudes and Behaviors in Adolescents With Inflammatory Bowel Disease.
    Inflamm Bowel Dis. 2021 Jun 9. pii: 6295433. doi: 10.1093.
    PubMed    


  20. JORDI SBU, Lang BM, Auschra B, von Kanel R, et al
    Depressive Symptoms Predict Clinical Recurrence of Inflammatory Bowel Disease.
    Inflamm Bowel Dis. 2021 Jun 7. pii: 6294150. doi: 10.1093.
    PubMed     Abstract available


  21. DANESE S, Peyrin-Biroulet L
    Selective Tyrosine Kinase 2 Inhibition for Treatment of Inflammatory Bowel Disease: New Hope on the Rise.
    Inflamm Bowel Dis. 2021 Jun 5. pii: 6293782. doi: 10.1093.
    PubMed     Abstract available


  22. MIKAIL M, Wilson A
    Low Serum Tumor Necrosis Factor-alpha Antagonist Concentrations in Patients With Inflammatory Bowel Disease Who Achieve Healing From Pyoderma Gangrenosum.
    Inflamm Bowel Dis. 2021 Jun 5. pii: 6293784. doi: 10.1093.
    PubMed    


    May 2021
  23. LUI J, Ramos GP, Codipilly DC, Katzka D, et al
    The Use of Biologics for the Treatment of Esophageal Crohn Disease.
    Inflamm Bowel Dis. 2021 May 29. pii: 6288092. doi: 10.1093.
    PubMed    


  24. LI H, Shu H, Tian F
    Distinct Entity of Inflammatory Bowel Disease in Autoimmune Sclerosing Cholangitis.
    Inflamm Bowel Dis. 2021 May 27. pii: 6285983. doi: 10.1093.
    PubMed    


  25. GAZOULI M, Dovrolis N, Bourdakou MM, Gizis M, et al
    Response to Anti-alpha4beta7 Blockade in Patients With Ulcerative Colitis Is Associated With Distinct Mucosal Gene Expression Profiles at Baseline.
    Inflamm Bowel Dis. 2021 May 27. pii: 6285911. doi: 10.1093.
    PubMed     Abstract available


  26. LIU JJ
    Disparity in the Care of black Inflammatory Bowel Disease Patients.
    Inflamm Bowel Dis. 2021 May 25. pii: 6284055. doi: 10.1093.
    PubMed    


  27. SHAFFER SR, Erondu AI, Traboulsi C, Rai V, et al
    Achieving Histologic Normalization in Ulcerative Colitis Is Associated With a Reduced Risk of Subsequent Dysplasia.
    Inflamm Bowel Dis. 2021 May 25. pii: 6284061. doi: 10.1093.
    PubMed     Abstract available


  28. PENA-SANCHEZ JN, Osei JA, Marques Santos JD, Jennings D, et al
    Increasing Prevalence and Stable Incidence Rates of Inflammatory Bowel Disease Among First Nations: Population-Based Evidence From a Western Canadian Province.
    Inflamm Bowel Dis. 2021 May 25. pii: 6284047. doi: 10.1093.
    PubMed     Abstract available


  29. MORRIS GA, McNicol M, Boyle B, Donegan A, et al
    Increasing Biosimilar Utilization at a Pediatric Inflammatory Bowel Disease Center and Associated Cost Savings: Show Me the Money.
    Inflamm Bowel Dis. 2021 May 25. pii: 6284046. doi: 10.1093.
    PubMed     Abstract available


  30. OLIVER BJ, Kennedy AM, van Deen WK, Weaver SA, et al
    Development of Balanced Whole System Value Measures for Inflammatory Bowel Disease Care in the IBD Qorus Collaborative Using a Modified Delphi Process.
    Inflamm Bowel Dis. 2021 May 25. pii: 6284056. doi: 10.1093.
    PubMed     Abstract available


  31. IACUCCI M, Jeffery L, Acharjee A, Nardone OM, et al
    Ultra-high Magnification Endocytoscopy and Molecular Markers for Defining Endoscopic and Histologic Remission in Ulcerative Colitis-An Exploratory Study to Define Deep Remission.
    Inflamm Bowel Dis. 2021 May 21. pii: 6279651. doi: 10.1093.
    PubMed     Abstract available


  32. SACHAN A, Srivastava S, Shah J, Singh AK, et al
    Strongyloides Stercoralis in Acute Severe Ulcerative Colitis-A Triggering Nuisance or An Opportunistic Bystander?
    Inflamm Bowel Dis. 2021 May 21. pii: 6279668. doi: 10.1093.
    PubMed    


  33. HUSSAMEDDIN A, Sedano R, Ramsewak D, Driman D, et al
    Vedolizumab-Induced Endoscopic and Histologic Improvement in Gastric Menetrier's Disease in a Patient With Ulcerative Colitis.
    Inflamm Bowel Dis. 2021 May 21. pii: 6279703. doi: 10.1093.
    PubMed    


  34. HANZEL J, Jansen JM, Ter Steege RWF, Gecse KB, et al
    Multiple Switches From the Originator Infliximab to Biosimilars Is Effective and Safe in Inflammatory Bowel Disease: A Prospective Multicenter Cohort Study.
    Inflamm Bowel Dis. 2021 May 20. pii: 6278840. doi: 10.1093.
    PubMed     Abstract available


  35. VAN WASSENAER EA, Benninga MA, van Limbergen JL, D'Haens GR, et al
    Intestinal Ultrasound in Pediatric Inflammatory Bowel Disease: Promising, but Work in Progress.
    Inflamm Bowel Dis. 2021 May 20. pii: 6278841. doi: 10.1093.
    PubMed     Abstract available


  36. MCCURDY J, Siw KCK, Kandel R, Larrigan S, et al
    The Effectiveness and Safety of Hyperbaric Oxygen Therapy in Various Phenotypes of Inflammatory Bowel Disease: Systematic Review With Meta-analysis.
    Inflamm Bowel Dis. 2021 May 18. pii: 6277724. doi: 10.1093.
    PubMed     Abstract available


  37. CHEAH M, Wilson A, Solh Z, Khanna R, et al
    IgA-Mediated Warm Autoimmune Hemolytic Anemia as an Extraintestinal Manifestation in a Patient With Crohn Disease on Vedolizumab.
    Inflamm Bowel Dis. 2021 May 18. pii: 6277765. doi: 10.1093.
    PubMed    


  38. VERDE A, Grammegna A, Petrone E, Mastrominico A, et al
    Crohn-Like Colitis in a Young Boy With Hirschsprung Disease.
    Inflamm Bowel Dis. 2021 May 18. pii: 6277720. doi: 10.1093.
    PubMed    


  39. DOS SANTOS CHM, Koga GA
    Response to the Letter to the Editor: "Pyoderma Gangrenosum in An Ulcerative Colitis Pediatric Patient During Vedolizumab Therapy Successfully Treated With Oral Cyclosporine".
    Inflamm Bowel Dis. 2021 May 18. pii: 6277711. doi: 10.1093.
    PubMed    


  40. GRAZIANO F, Macaluso FS, Cassata N, Citrano M, et al
    Pyoderma Gangrenosum in An Ulcerative Colitis Pediatric Patient During Vedolizumab Therapy Successfully Treated With Oral Cyclosporine.
    Inflamm Bowel Dis. 2021 May 18. pii: 6277715. doi: 10.1093.
    PubMed    


  41. SQUIRE JD, Gonzalez-Estrada A, Caldera F, Farraye FA, et al
    COVID-19 Vaccination in Patients With Inflammatory Bowel Disease and History of Reaction to Injectable Therapies.
    Inflamm Bowel Dis. 2021 May 17. pii: 6276957. doi: 10.1093.
    PubMed    


  42. DE FRIAS GOMES CG, de Almeida ASR, Mendes CCL, Ellul P, et al
    Histological Inflammation in the Endoscopically Uninflamed Mucosa is Associated With Worse Outcomes in Limited Ulcerative Colitis.
    Inflamm Bowel Dis. 2021 May 17. pii: 6276940. doi: 10.1093.
    PubMed     Abstract available


  43. HILLEY P, Gilmore R, Srinivasan A, Choy M, et al
    Combined Targeted Treatment Using Biologic-Tofacitinib Co-Therapy in Chronic Active Ulcerative Colitis.
    Inflamm Bowel Dis. 2021 May 17. pii: 6276958. doi: 10.1093.
    PubMed    


  44. FASOULAS K, Stergiou E, Soufleris K
    Ustekinumab for Crohn Disease With Severe Gastroduodenal Involvement.
    Inflamm Bowel Dis. 2021 May 17. pii: 6276944. doi: 10.1093.
    PubMed    


  45. SANTELLA C, Bitton A, Filliter C, Bessissow T, et al
    Anti-TNF Therapy and the Risk of Herpes Zoster Among Patients With Inflammatory Bowel Disease.
    Inflamm Bowel Dis. 2021 May 17. pii: 6276941. doi: 10.1093.
    PubMed     Abstract available



  46. Corrigendum to: Gastrointestinal Surgery for Inflammatory Bowel Disease Persistently Lowers Microbiome and Metabolome Diversity.
    Inflamm Bowel Dis. 2021 May 17. pii: 6276866. doi: 10.1093.
    PubMed    



  47. Erratum to: Timely Monitoring of Inflammation by Fecal Lactoferrin Rapidly Predicts Therapeutic Response in Inflammatory Bowel Disease.
    Inflamm Bowel Dis. 2021 May 17. pii: 6276685. doi: 10.1093.
    PubMed    


  48. TAXONERA C, Alba C, Olivares D, Martin M, et al
    Innovation in IBD Care During the COVID-19 Pandemic: Results of a Cross-Sectional Survey on Patient-Reported Experience Measures.
    Inflamm Bowel Dis. 2021;27:864-869.
    PubMed     Abstract available


  49. TAXONERA C, Olivares D, Alba C
    Tofacitinib in Acute Severe Ulcerative Colitis: Case Series and a Systematic Review-Authors' Reply.
    Inflamm Bowel Dis. 2021 May 14. pii: 6275622. doi: 10.1093.
    PubMed    


  50. JAIRATH V, Guizzetti L, Baker KA, Williamson LA, et al
    Impact of COVID-19 on Inflammatory Bowel Disease Clinical Trial Recruitment: A Global Survey of Principal Investigators.
    Inflamm Bowel Dis. 2021 May 14. pii: 6275617. doi: 10.1093.
    PubMed    


  51. HOWALDT S, Domenech E, Martinez N, Schmidt C, et al
    Long-Term Effectiveness of Oral Ferric Maltol vs Intravenous Ferric Carboxymaltose for the Treatment of Iron-Deficiency Anemia in Patients With Inflammatory Bowel Disease: A Randomized Controlled Noninferiority Trial.
    Inflamm Bowel Dis. 2021 May 14. pii: 6275616. doi: 10.1093.
    PubMed     Abstract available


  52. DALAL RS, Mitri J, Goodrick H, Allegretti JR, et al
    Real-World Comparison of Tofacitinib vs Ustekinumab Among Bio-Exposed Patients With Ulcerative Colitis: A Propensity Score Analysis.
    Inflamm Bowel Dis. 2021 May 14. pii: 6275620. doi: 10.1093.
    PubMed    


  53. CLICK B, Merchea A, Colibaseanu DT, Regueiro M, et al
    Ileocolic Resection for Crohn Disease: The Influence of Different Surgical Techniques on Perioperative Outcomes, Recurrence Rates, and Endoscopic Surveillance.
    Inflamm Bowel Dis. 2021 May 14. pii: 6275618. doi: 10.1093.
    PubMed     Abstract available


  54. JENA A, Mishra S, Sachan A, Singh H, et al
    Tofacitinib in Acute Severe Ulcerative Colitis: Case Series and a Systematic Review.
    Inflamm Bowel Dis. 2021 May 14. pii: 6275623. doi: 10.1093.
    PubMed    


  55. MCCURDY JD, Reid J, Yanofsky R, Sinnathamby V, et al
    Fecal Diversion for Perianal Crohn Disease in the Era of Biologic Therapies: A Multicenter Study.
    Inflamm Bowel Dis. 2021 May 14. pii: 6275627. doi: 10.1093.
    PubMed     Abstract available


  56. ALKHAYYAT M, Abureesh M, Almomani A, Abou Saleh M, et al
    Patients With Inflammatory Bowel Disease on Treatment Have Lower Rates of Celiac Disease.
    Inflamm Bowel Dis. 2021 May 14. pii: 6277368. doi: 10.1093.
    PubMed     Abstract available


    April 2021
  57. XU F, Carlson SA, Wheaton AG, Greenlund KJ, et al
    COVID-19 Hospitalizations Among U.S. Medicare Beneficiaries With Inflammatory Bowel Disease, April 1 to July 31, 2020.
    Inflamm Bowel Dis. 2021 Apr 27. pii: 6255240. doi: 10.1093.
    PubMed    


  58. HYAMS JS, Brimacombe M, Haberman Y, Walters T, et al
    Clinical and Host Biological Factors Predict Colectomy Risk in Children Newly Diagnosed With Ulcerative Colitis.
    Inflamm Bowel Dis. 2021 Apr 27. pii: 6255234. doi: 10.1093.
    PubMed     Abstract available


  59. RODRIGUEZ-LAGO I, Barreiro-de Acosta M
    Risk of Depression During the Natural History of Inflammatory Bowel Disease: The Phantom Menace.
    Inflamm Bowel Dis. 2021 Apr 26. pii: 6179794. doi: 10.1093.
    PubMed    



  60. Corrigendum to: Hepatitis-B Vaccine Response in Inflammatory Bowel Disease Patients: A Systematic Review and Meta-analysis.
    Inflamm Bowel Dis. 2021 Apr 20. pii: 6240061. doi: 10.1093.
    PubMed    


  61. ELTABBAKH M, Abd Alaty W, Sakr MA, Sherief AF, et al
    Commenting on the Letter (Completing the Picture in Egypt: Response to "Inflammatory Bowel Diseases in Egypt During the COVID-19 Pandemic").
    Inflamm Bowel Dis. 2021;27:e66.
    PubMed    


  62. GOREN G, Schwartz D, Friger M, Banai H, et al
    Randomized Controlled Trial of Cognitive-Behavioral and Mindfulness-Based Stress Reduction on the Quality of Life of Patients With Crohn Disease.
    Inflamm Bowel Dis. 2021 Apr 13. pii: 6224593. doi: 10.1093.
    PubMed     Abstract available


  63. ASONUMA K, Kobayashi T, Nakano M, Sagami S, et al
    Residual Short-Segment Distal Inflammation Has No Significant Impact on the Major Relapse of Extensive Ulcerative Colitis.
    Inflamm Bowel Dis. 2021 Apr 13. pii: 6224886. doi: 10.1093.
    PubMed     Abstract available


  64. SCARALLO L, Bolasco G, Barp J, Bianconi M, et al
    Anti-Tumor Necrosis Factor-Alpha Withdrawal in Children With Inflammatory Bowel Disease in Endoscopic and Histologic Remission.
    Inflamm Bowel Dis. 2021 Apr 9. pii: 6218764. doi: 10.1093.
    PubMed     Abstract available


    March 2021
  65. HERNANDEZ J, Rouille E, Chocteau F, Allard M, et al
    Nonhypoalbuminemic Inflammatory Bowel Disease in Dogs as Disease Model.
    Inflamm Bowel Dis. 2021 Mar 30. pii: 6203397. doi: 10.1093.
    PubMed     Abstract available


  66. FANG J, Wang H, Xue Z, Cheng Y, et al
    PPARgamma: The Central Mucus Barrier Coordinator in Ulcerative Colitis.
    Inflamm Bowel Dis. 2021 Mar 27. pii: 6192824. doi: 10.1093.
    PubMed     Abstract available


  67. SHAH KP, Triana AJ, Gusdorf RE, McCoy AB, et al
    Demographic Factors Associated With Successful Telehealth Visits in Inflammatory Bowel Disease Patients.
    Inflamm Bowel Dis. 2021 Mar 26. pii: 6188947. doi: 10.1093.
    PubMed     Abstract available


  68. KLUSMANN B, Fleer J, Tovote KA, Weersma RK, et al
    Trajectories of Fatigue in Inflammatory Bowel Disease.
    Inflamm Bowel Dis. 2021 Mar 26. pii: 6188945. doi: 10.1093.
    PubMed     Abstract available


  69. STIDHAM RW, Liu Y, Enchakalody B, Van T, et al
    The Use of Readily Available Longitudinal Data to Predict the Likelihood of Surgery in Crohn Disease.
    Inflamm Bowel Dis. 2021 Mar 26. pii: 6188946. doi: 10.1093.
    PubMed     Abstract available


  70. ZHANG T, Xu Y, Yao Y, Jin L, et al
    Randomized Controlled Trial: Perioperative Dexamethasone Reduces Excessive Postoperative Inflammatory Response and Ileus After Surgery for Inflammatory Bowel Disease.
    Inflamm Bowel Dis. 2021 Mar 22. pii: 6179795. doi: 10.1093.
    PubMed     Abstract available


  71. SANDS BE, Long MD, Reinisch W, Panes J, et al
    Tofacitinib for the Treatment of Ulcerative Colitis: Analysis of Nonmelanoma Skin Cancer Rates From the Ulcerative Colitis Clinical Program.
    Inflamm Bowel Dis. 2021 Mar 20. pii: 6179119. doi: 10.1093.
    PubMed     Abstract available


  72. GARRIDO I, Lopes S, Macedo G
    Hit the Road JAK! The Role of New Oral Treatment in Inflammatory Bowel Disease.
    Inflamm Bowel Dis. 2021 Mar 20. pii: 6179114. doi: 10.1093.
    PubMed     Abstract available


  73. KHORSHID M, AbdAllah M
    Completing the Picture in Egypt: Response to "Inflammatory Bowel Diseases in Egypt During the COVID-19 Pandemic".
    Inflamm Bowel Dis. 2021;27:e39.
    PubMed    


  74. WINTER RW, Ananthakrishnan A, Burke KE, Kochar B, et al
    Time to Negative SARS-CoV-2 PCR Should Not Delay Care Among Patients With Inflammatory Bowel Diseases.
    Inflamm Bowel Dis. 2021;27:590-592.
    PubMed    


  75. AGRAWAL M, Brenner EJ, Zhang X, Modesto I, et al
    Characteristics and Outcomes of IBD Patients with COVID-19 on Tofacitinib Therapy in the SECURE-IBD Registry.
    Inflamm Bowel Dis. 2021;27:585-589.
    PubMed    


  76. SANTANA GO, de Santana AC, Pfeilsticker VB
    Ileum Perforation in Crohn's Disease Patient During SARS-Cov-2 Infection.
    Inflamm Bowel Dis. 2021;27:e42.
    PubMed    


  77. PAUWELS RWM, Proietti E, van der Woude CJ, Oudijk L, et al
    Vedolizumab Tissue Concentration Correlates to Mucosal Inflammation and Objective Treatment Response in Inflammatory Bowel Disease.
    Inflamm Bowel Dis. 2021 Mar 11. pii: 6168345. doi: 10.1093.
    PubMed     Abstract available


  78. BHAT S, Caldera F, Farraye FA
    Barriers to Administering Vaccines in Inflammatory Bowel Disease Centers.
    Inflamm Bowel Dis. 2021 Mar 11. pii: 6168341. doi: 10.1093.
    PubMed    


  79. ZAIATZ BITTENCOURT V, Jones F, Doherty G, Ryan EJ, et al
    Targeting Immune Cell Metabolism in the Treatment of Inflammatory Bowel Disease.
    Inflamm Bowel Dis. 2021 Mar 10. pii: 6166277. doi: 10.1093.
    PubMed     Abstract available


  80. XIANG BJ, Huang YH, Dai C
    A Rare Autoinflammatory Syndrome Involving Acute Severe Ulcerative Colitis Combined With Iritis.
    Inflamm Bowel Dis. 2021 Mar 9. pii: 6163199. doi: 10.1093.
    PubMed    


  81. SCHMOYER CJ, Saidman J, Bohl JL, Bierly CL, et al
    The Pathogenesis and Clinical Management of Stricturing Crohn Disease.
    Inflamm Bowel Dis. 2021 Mar 9. pii: 6163204. doi: 10.1093.
    PubMed     Abstract available


  82. ANDERSON A, Cherfane C, Click B, Ramos-Rivers C, et al
    Monocytosis Is a Biomarker of Severity in Inflammatory Bowel Disease: Analysis of a 6-Year Prospective Natural History Registry.
    Inflamm Bowel Dis. 2021 Mar 9. pii: 6163208. doi: 10.1093.
    PubMed     Abstract available


  83. TAKAHASHI H, Ogawa M, Hoshina T, Kusuhara K, et al
    Multiple Nodules in the Kidney and Spleen Presenting as the Initial Manifestation of Crohn Disease.
    Inflamm Bowel Dis. 2021 Mar 9. pii: 6163180. doi: 10.1093.
    PubMed    


    February 2021
  84. VERSTOCKT S, Verstockt B, Machiels K, Vancamelbeke M, et al
    Oncostatin M Is a Biomarker of Diagnosis, Worse Disease Prognosis, and Therapeutic Nonresponse in Inflammatory Bowel Disease.
    Inflamm Bowel Dis. 2021 Feb 24. pii: 6148910. doi: 10.1093.
    PubMed     Abstract available


  85. NASSANI N, Sweiss N, Berry JT, Calhoun C, et al
    Leukocytoclastic Vasculitis in Cutaneous Crohn Disease in the Setting of COVID-19.
    Inflamm Bowel Dis. 2021 Feb 22. pii: 6146239. doi: 10.1093.
    PubMed    


  86. IMPERATORE N, Bennato R, D'Avino A, Lombardi G, et al
    SARS-CoV-2 as a Trigger for De Novo Ulcerative Colitis.
    Inflamm Bowel Dis. 2021 Feb 22. pii: 6146240. doi: 10.1093.
    PubMed    


  87. BORGHINI R, Vescovo M, Giordano C, Donato G, et al
    Onset of Suspected Ulcerative Colitis After Treatment With Tocilizumab in Patient With Celiac Disease and Juvenile Idiopathic Arthritis.
    Inflamm Bowel Dis. 2021 Feb 22. pii: 6146241. doi: 10.1093.
    PubMed    


  88. MORILLA I, Uzzan M, Cazals-Hatem D, Colnot N, et al
    Computational Learning of microRNA-Based Prediction of Pouchitis Outcome After Restorative Proctocolectomy in Patients With Ulcerative Colitis.
    Inflamm Bowel Dis. 2021 Feb 20. pii: 6145454. doi: 10.1093.
    PubMed     Abstract available


  89. CHIARELLA-REDFERN H, Lee S, Jubran B, Sharifi N, et al
    Suboptimal Vaccination Administration in Mothers With Inflammatory Bowel Disease and Their Biologic-Exposed Infants.
    Inflamm Bowel Dis. 2021 Feb 20. pii: 6145400. doi: 10.1093.
    PubMed     Abstract available


  90. MIRANDA-BAUTISTA J, Rodriguez-Feo JA, Puerto M, Lopez-Cauce B, et al
    Liver X Receptor Exerts Anti-Inflammatory Effects in Colonic Epithelial Cells via ABCA1 and Its Expression Is Decreased in Human and Experimental Inflammatory Bowel Disease.
    Inflamm Bowel Dis. 2021 Feb 20. pii: 6145399. doi: 10.1093.
    PubMed     Abstract available


  91. TAXONERA C, Olivares D, Alba C
    Real-World Effectiveness and Safety of Tofacitinib in Patients With Ulcerative Colitis: Systematic Review With Meta-Analysis.
    Inflamm Bowel Dis. 2021 Feb 15. pii: 6136180. doi: 10.1093.
    PubMed     Abstract available


  92. PANES J, Lindsay JO, Teich N, Lindgren S, et al
    Colectomy Incidence Rates in Five-Year Data From the Observational Postmarketing Ulcerative Colitis Study of Originator Infliximab.
    Inflamm Bowel Dis. 2021 Feb 12. pii: 6134175. doi: 10.1093.
    PubMed     Abstract available


  93. DHARMASIRI S, Garrido-Martin EM, Harris RJ, Bateman AC, et al
    Human Intestinal Macrophages Are Involved in the Pathology of Both Ulcerative Colitis and Crohn Disease.
    Inflamm Bowel Dis. 2021 Feb 11. pii: 6133075. doi: 10.1093.
    PubMed     Abstract available


  94. DALAL RS, Allegretti JR
    Ustekinumab Dose Optimization in Crohn Disease: One Size Does Not Fit All.
    Inflamm Bowel Dis. 2021 Feb 11. pii: 6133071. doi: 10.1093.
    PubMed    


  95. JUDGE C, Saeidi R, Sugrue K, Rabbitt L, et al
    Combining Therapies in Inflammatory Bowel Disease: End of the Line or a New Era?
    Inflamm Bowel Dis. 2021 Feb 5. pii: 6129139. doi: 10.1093.
    PubMed    


  96. MAHMMOD S, Schultheiss JPD, van Bodegraven AA, Dijkstra G, et al
    Outcome of Reverse Switching From CT-P13 to Originator Infliximab in Patients With Inflammatory Bowel Disease.
    Inflamm Bowel Dis. 2021 Feb 4. pii: 6128461. doi: 10.1093.
    PubMed     Abstract available


  97. BHURWAL A, Minacapelli CD, Patel A, Mutneja H, et al
    Evaluation of a U.S. National Cohort to Determine Utilization in Colectomy Rates for Ulcerative Colitis Among Ethnicities.
    Inflamm Bowel Dis. 2021 Feb 3. pii: 6127293. doi: 10.1093.
    PubMed     Abstract available


  98. DUBINSKY MC, Watanabe K, Molander P, Peyrin-Biroulet L, et al
    Ulcerative Colitis Narrative Global Survey Findings: The Impact of Living With Ulcerative Colitis-Patients' and Physicians' View.
    Inflamm Bowel Dis. 2021 Feb 2. pii: 6126719. doi: 10.1093.
    PubMed     Abstract available


  99. BALDAN-MARTIN M, Chaparro M, Gisbert JP
    Tissue Proteomic Approaches to Understand the Pathogenesis of Inflammatory Bowel Disease.
    Inflamm Bowel Dis. 2021 Feb 2. pii: 6126723. doi: 10.1093.
    PubMed     Abstract available


  100. GARG R, Mohammed A, Singh A, Regueiro M, et al
    Trends and Outcomes of Acute Diverticulitis in Inflammatory Bowel Disease: A Propensity-matched National Study.
    Inflamm Bowel Dis. 2021 Feb 2. pii: 6126191. doi: 10.1093.
    PubMed     Abstract available


    January 2021
  101. RUBIN DT, Sninsky C, Siegmund B, Sans M, et al
    International Perspectives on Management of Inflammatory Bowel Disease: Opinion Differences and Similarities Between Patients and Physicians From the IBD GAPPS Survey.
    Inflamm Bowel Dis. 2021 Jan 29. pii: 6123676. doi: 10.1093.
    PubMed     Abstract available


  102. ROBERTSON AR, Arnott ID
    How Can We Predict Who Would Benefit From a Small-Bowel Capsule Endoscopy When Staging Crohn Disease?
    Inflamm Bowel Dis. 2021 Jan 29. pii: 6123688. doi: 10.1093.
    PubMed    



  103. Corrigendum to: Safety of Ustekinumab in Inflammatory Bowel Disease: Pooled Safety Analysis of Results from Phase 2/3 Studies.
    Inflamm Bowel Dis. 2021 Jan 29. pii: 6123652. doi: 10.1093.
    PubMed    


  104. SHAH J, Shah A, Hassman L, Gutierrez A, et al
    Ocular Manifestations of Inflammatory Bowel Disease.
    Inflamm Bowel Dis. 2021 Jan 27. pii: 6121235. doi: 10.1093.
    PubMed     Abstract available


  105. CHUGH R, Kroner PT, Farraye FA, Ginsburg PM, et al
    Small-Bowel Lymphoma Mimicking Crohn Disease: A Case Series.
    Inflamm Bowel Dis. 2021 Jan 27. pii: 6121236. doi: 10.1093.
    PubMed    


  106. DE SIRE R, Castiglione F, Picardi M, Mascolo M, et al
    Chemotherapy-Induced Remission of Steroid-Dependent Ulcerative Colitis Associated With Rectal Hodgkin Lymphoma.
    Inflamm Bowel Dis. 2021 Jan 27. pii: 6121229. doi: 10.1093.
    PubMed    


  107. SORRENTINO D, Gray JM
    Timely Monitoring of Inflammation by Fecal Lactoferrin Rapidly Predicts Therapeutic Response in Inflammatory Bowel Disease.
    Inflamm Bowel Dis. 2021 Jan 27. pii: 6121238. doi: 10.1093.
    PubMed     Abstract available


  108. SUZUKI K, Kakuta Y, Naito T, Takagawa T, et al
    Genetic Background of Mesalamine-induced Fever and Diarrhea in Japanese Patients with Inflammatory Bowel Disease.
    Inflamm Bowel Dis. 2021 Jan 27. pii: 6121230. doi: 10.1093.
    PubMed     Abstract available


  109. SEDANO R, Jairath V
    Tofacitinib for the Treatment of Three Immune-mediated Conditions in One Patient: Ulcerative Colitis, Pyoderma Gangrenosum, and Alopecia Areata.
    Inflamm Bowel Dis. 2021 Jan 23. pii: 6114619. doi: 10.1093.
    PubMed    


  110. SEDANO R, Jairath V
    High-Dose Rescue Tofacitinib Prevented Inpatient Colectomy in Acute Severe Ulcerative Colitis Refractory to Anti-TNF.
    Inflamm Bowel Dis. 2021 Jan 23. pii: 6114620. doi: 10.1093.
    PubMed    


  111. BURKE KE, Kochar B, Allegretti JR, Winter RW, et al
    Immunosuppressive Therapy and Risk of COVID-19 Infection in Patients With Inflammatory Bowel Diseases.
    Inflamm Bowel Dis. 2021;27:155-161.
    PubMed     Abstract available


  112. HASHASH JG, Jabak S, Francis FF, Regueiro M, et al
    Should We Be Screening for SARS-CoV-2 in IBD Patients Before Initiation of Biologic Therapy?
    Inflamm Bowel Dis. 2021;27:291-294.
    PubMed    


  113. BRAMUZZO M, Lionetti P, Miele E, Romano C, et al
    Phenotype and Natural History of Children With Coexistent Inflammatory Bowel Disease and Celiac Disease.
    Inflamm Bowel Dis. 2021 Jan 16. pii: 6102415. doi: 10.1093.
    PubMed     Abstract available


  114. DI NARDO G, Quitadamo P, Quatrini M, Malfona F, et al
    Autoimmune Hemolitic Anemia in a Boy With Inactive Ulcerative Colitis.
    Inflamm Bowel Dis. 2021 Jan 16. pii: 6102424. doi: 10.1093.
    PubMed    


  115. TA AD, Ollberding NJ, Karns R, Haberman Y, et al
    Association of Baseline Luminal Narrowing With Ileal Microbial Shifts and Gene Expression Programs and Subsequent Transmural Healing in Pediatric Crohn Disease.
    Inflamm Bowel Dis. 2021 Jan 16. pii: 6102412. doi: 10.1093.
    PubMed     Abstract available


  116. ROY PALADHI U, Harb AH, Daniel SG, Dawwas GK, et al
    The Impact of Introducing Patient-Reported Inflammatory Bowel Disease Symptoms via Electronic Survey on Clinic Visit Length, Patient and Provider Satisfaction, and the Environment Microbiome.
    Inflamm Bowel Dis. 2021 Jan 16. pii: 6102417. doi: 10.1093.
    PubMed    


  117. CHANDE N, Singh S, Narula N, Gordon M, et al
    Medical Management Following Surgical Therapy in Inflammatory Bowel Disease: Evidence from Cochrane Reviews.
    Inflamm Bowel Dis. 2021 Jan 16. pii: 6102409. doi: 10.1093.
    PubMed    


  118. WEIMERS P, Ankersen DV, Lokkegaard ECL, Burisch J, et al
    Occurrence of Colorectal Cancer and the Influence of Medical Treatment in Patients With Inflammatory Bowel Disease: A Danish Nationwide Cohort Study, 1997 to 2015.
    Inflamm Bowel Dis. 2021 Jan 7. pii: 6067198. doi: 10.1093.
    PubMed     Abstract available


  119. LI N, Zhan S, Tian Z, Liu C, et al
    Alterations in Bile Acid Metabolism Associated With Inflammatory Bowel Disease.
    Inflamm Bowel Dis. 2021 Jan 5. pii: 6063290. doi: 10.1093.
    PubMed     Abstract available


  120. REGENSBURGER D, Tenkerian C, Purzer V, Schmid B, et al
    Matricellular Protein SPARCL1 Regulates Blood Vessel Integrity and Antagonizes Inflammatory Bowel Disease.
    Inflamm Bowel Dis. 2021 Jan 4. pii: 6061405. doi: 10.1093.
    PubMed     Abstract available


  121. FOULON A, Pichois R, Sabbagh C, Fumery M, et al
    Bowel Endometriosis Mimicking Crohn Disease.
    Inflamm Bowel Dis. 2021 Jan 4. pii: 6061378. doi: 10.1093.
    PubMed    


  122. PUGLIESE D, Schepis T, Bove V, Privitera G, et al
    Morbidly Obese Patient With Ulcerative Colitis Treated With Endoscopic Gastroplasty: A Case Report.
    Inflamm Bowel Dis. 2021 Jan 4. pii: 6061374. doi: 10.1093.
    PubMed    


  123. KOCHHAR GS, Mohan BP, Khan SR, Chandan S, et al
    Hepatitis-B Vaccine Response in Inflammatory Bowel Disease Patients: A Systematic Review and Meta-analysis.
    Inflamm Bowel Dis. 2021 Jan 4. pii: 6061413. doi: 10.1093.
    PubMed     Abstract available


  124. HONG S, Zaki TA, Main M, Hine AM, et al
    Comparative Evaluation of Conventional Stool Testing and Multiplex Molecular Panel in Outpatients With Relapse of Inflammatory Bowel Disease.
    Inflamm Bowel Dis. 2021 Jan 2. pii: 6058972. doi: 10.1093.
    PubMed     Abstract available


  125. SCHARRER S, Primas C, Eichinger S, Tonko S, et al
    Inflammatory Bowel Disease and Risk of Major Bleeding During Anticoagulation for Venous Thromboembolism.
    Inflamm Bowel Dis. 2021 Jan 2. pii: 6058971. doi: 10.1093.
    PubMed     Abstract available


  126. BAR-GIL SHITRIT A, Ben-Horin S, Mishael T, Hoyda A, et al
    Detection of Ustekinumab in Breast Milk of Nursing Mothers With Crohn Disease.
    Inflamm Bowel Dis. 2021 Jan 2. pii: 6058989. doi: 10.1093.
    PubMed    


  127. JEON Y, Limketkai BN
    Implications of Dietary Impact on Hepatic Steatosis and IBD.
    Inflamm Bowel Dis. 2021;27:10-11.
    PubMed    


    December 2020
  128. HIRTEN RP, Danieletto M, Scheel R, Shervey M, et al
    Longitudinal Autonomic Nervous System Measures Correlate With Stress and Ulcerative Colitis Disease Activity and Predict Flare.
    Inflamm Bowel Dis. 2020 Dec 31. pii: 6056323. doi: 10.1093.
    PubMed     Abstract available


  129. HASOSAH M, Alqahtani A, Almehaidib A, Qurashi M, et al
    Congenital Chloride Diarrhea and Childhood Inflammatory Bowel Disease: A Multicenter Case Series.
    Inflamm Bowel Dis. 2020 Dec 30. pii: 6055672. doi: 10.1093.
    PubMed    


  130. BORREN NZ, Long MD, Sandler RS, Ananthakrishnan AN, et al
    Longitudinal Trajectory of Fatigue in Patients With Inflammatory Bowel Disease: A Prospective Study.
    Inflamm Bowel Dis. 2020 Dec 25. pii: 6047698. doi: 10.1093.
    PubMed     Abstract available


  131. QIN X
    More Epidemiological Studies Warranted to Determine the Cause of Inflammatory Bowel Disease.
    Inflamm Bowel Dis. 2020 Dec 17. pii: 6040645. doi: 10.1093.
    PubMed    


  132. CURTIS JR, Regueiro M, Yun H, Su C, et al
    Tofacitinib Treatment Safety in Moderate to Severe Ulcerative Colitis: Comparison of Observational Population Cohort Data From the IBM MarketScan(R) Administrative Claims Database With Tofacitinib Trial Data.
    Inflamm Bowel Dis. 2020 Dec 16. pii: 6039005. doi: 10.1093.
    PubMed     Abstract available


  133. DWADASI S, Zafer M, Goens D, Paknikar R, et al
    Inpatient Therapy With Calcineurin Inhibitors in Severe Ulcerative Colitis.
    Inflamm Bowel Dis. 2020 Dec 15. pii: 6034840. doi: 10.1093.
    PubMed     Abstract available


  134. PARIAN AM, Limketkai BN, Chowdhury R, Brewer GG, et al
    Serrated Epithelial Change Is Associated With High Rates of Neoplasia in Ulcerative Colitis Patients: A Case-controlled Study and Systematic Review With Meta-analysis.
    Inflamm Bowel Dis. 2020 Dec 9. pii: 6028664. doi: 10.1093.
    PubMed     Abstract available


  135. MELO FJ, Pinto-Lopes P, Estevinho MM, Magro F, et al
    The Role of Dipeptidyl Peptidase 4 as a Therapeutic Target and Serum Biomarker in Inflammatory Bowel Disease: A Systematic Review.
    Inflamm Bowel Dis. 2020 Dec 9. pii: 6028655. doi: 10.1093.
    PubMed     Abstract available


  136. LEE C, Hong SN, Kim ER, Chang DK, et al
    Depletion of Intestinal Stem Cell Niche Factors Contributes to the Alteration of Epithelial Differentiation in SAMP1/YitFcsJ Mice With Crohn Disease-Like Ileitis.
    Inflamm Bowel Dis. 2020 Dec 4. pii: 6020062. doi: 10.1093.
    PubMed     Abstract available


  137. BERNSTEIN CN, Hitchon CA, Walld R, Bolton JM, et al
    The Impact of Psychiatric Comorbidity on Health Care Utilization in Inflammatory Bowel Disease: A Population-based Study.
    Inflamm Bowel Dis. 2020 Dec 4. pii: 6020061. doi: 10.1093.
    PubMed     Abstract available


  138. LEE SH, Walshe M, Oh EH, Hwang SW, et al
    Early Changes in Serum Albumin Predict Clinical and Endoscopic Outcomes in Patients With Ulcerative Colitis Starting Anti-TNF Treatment.
    Inflamm Bowel Dis. 2020 Dec 3. pii: 6017554. doi: 10.1093.
    PubMed     Abstract available


    November 2020
  139. BATTAT R, Lukin D, Scherl EJ, Pola S, et al
    Immunogenicity of Tumor Necrosis Factor Antagonists and Effect of Dose Escalation on Anti-Drug Antibodies and Serum Drug Concentrations in Inflammatory Bowel Disease.
    Inflamm Bowel Dis. 2020 Nov 30. pii: 6012174. doi: 10.1093.
    PubMed     Abstract available


  140. BAMBA S, Inatomi O, Takahashi K, Morita Y, et al
    Assessment of Body Composition From CT Images at the Level of the Third Lumbar Vertebra in Inflammatory Bowel Disease.
    Inflamm Bowel Dis. 2020 Nov 25. pii: 6000807. doi: 10.1093.
    PubMed     Abstract available


  141. YOON H, Jangi S, Dulai PS, Boland BS, et al
    Histologic Remission Is Associated With Lower Risk of Treatment Failure in Patients With Crohn Disease in Endoscopic Remission.
    Inflamm Bowel Dis. 2020 Nov 25. pii: 6000793. doi: 10.1093.
    PubMed     Abstract available


  142. DIMOPOULOS C, Al-Bawardy B
    SARS-CoV-2 Infection and Dual-Biologic Therapy for Crohn's Disease.
    Inflamm Bowel Dis. 2020;26:e153-e154.
    PubMed    


  143. UR RAHMAN A, Hussain I, Hasan B, Ur Rashid M, et al
    Association of Complicated Diverticulitis With Development of De Novo Inflammatory Bowel Disease.
    Inflamm Bowel Dis. 2020 Nov 18. pii: 5987626. doi: 10.1093.
    PubMed     Abstract available


  144. BROMS G, Friedman S, Kim SC, Wood ME, et al
    The Patterns of Use of Medications for Inflammatory Bowel Disease During Pregnancy in the US and Sweden Are Changing.
    Inflamm Bowel Dis. 2020 Nov 18. pii: 5987622. doi: 10.1093.
    PubMed     Abstract available


  145. GEEM D, Kugathasan S
    It Takes Two to Make It Right: Dual Biologic and Small Molecule Therapy for Treatment-Refractory Pediatric Inflammatory Bowel Disease.
    Inflamm Bowel Dis. 2020 Nov 17. pii: 5984956. doi: 10.1093.
    PubMed    


  146. SEDANO R, Jairath V
    Tofacitinib Induced Long-term Clinical, Endoscopic, and Histological Remission as a 6th Line Agent in Medically Refractory Ulcerative Colitis.
    Inflamm Bowel Dis. 2020 Nov 17. pii: 5985000. doi: 10.1093.
    PubMed    


  147. ATTAUABI M, Burisch J, Seidelin JB
    Efficacy of Ustekinumab for Active Perianal Fistulizing Crohn Disease: A Double-Center Cohort Study.
    Inflamm Bowel Dis. 2020 Nov 17. pii: 5985019. doi: 10.1093.
    PubMed    


  148. GONZALEZ-BERNARDO O, Riestra S, Vivas S, de Francisco R, et al
    Chromoendoscopy With Indigo Carmine vs Virtual Chromoendoscopy (iSCAN 1) for Neoplasia Screening in Patients With Inflammatory Bowel Disease: A Prospective Randomized Study.
    Inflamm Bowel Dis. 2020 Nov 10. pii: 5970332. doi: 10.1093.
    PubMed     Abstract available


  149. BRETON J, Witmer CM, Zhang Y, Downing M, et al
    Utilization of an Electronic Medical Record-integrated Dashboard Improves Identification and Treatment of Anemia and Iron Deficiency in Pediatric Inflammatory Bowel Disease.
    Inflamm Bowel Dis. 2020 Nov 9. pii: 5962204. doi: 10.1093.
    PubMed     Abstract available


  150. SHIRWAIKAR THOMAS A, Criss ZK, Shroyer NF, Abraham BP, et al
    Vitamin D Receptor Gene Single Nucleotide Polymorphisms and Association With Vitamin D Levels and Endoscopic Disease Activity in Inflammatory Bowel Disease Patients: A Pilot Study.
    Inflamm Bowel Dis. 2020 Nov 9. pii: 5962201. doi: 10.1093.
    PubMed     Abstract available


  151. RAMOS GP, Dimopoulos C, McDonald NM, Janssens LP, et al
    The Impact of Vedolizumab on Pre-Existing Extraintestinal Manifestations of Inflammatory Bowel Disease: A Multicenter Study.
    Inflamm Bowel Dis. 2020 Nov 9. pii: 5962203. doi: 10.1093.
    PubMed     Abstract available


  152. SIVASAILAM B, Manski S, Wentz A, Cross RK, et al
    Presence of Obstructive Symptoms and Absence of Perianal Crohn Disease Is Predictive of Surgery After Endoscopic Balloon Dilation.
    Inflamm Bowel Dis. 2020 Nov 9. pii: 5962193. doi: 10.1093.
    PubMed     Abstract available


  153. CORDES F, Lenker E, Weinhage T, Spille LJ, et al
    Impaired IFN-gamma-dependent STAT3 Activation Is Associated With Dysregulation of Regulatory and Inflammatory Signaling in Monocytes of Ulcerative Colitis Patients.
    Inflamm Bowel Dis. 2020 Nov 9. pii: 5962195. doi: 10.1093.
    PubMed     Abstract available


  154. SLEUTJES JAM, de Vries AC, van der Woude CJ, Roeters van Lennep JE, et al
    Lipid Profiles in Patients With Ulcerative Colitis Receiving Tofacitinib-Implications for Cardiovascular Risk and Patient Management.
    Inflamm Bowel Dis. 2020 Nov 6. pii: 5957728. doi: 10.1093.
    PubMed    


  155. HALLORAN BP, Jamil LH, Lo SK, Reeson M, et al
    Double-Balloon Endoscopy in Crohn Disease: A Tertiary Referral Center Experience.
    Inflamm Bowel Dis. 2020 Nov 6. pii: 5957726. doi: 10.1093.
    PubMed     Abstract available


  156. ALLEGRETTI JR, Kelly CR, Grinspan A, Mullish BH, et al
    Inflammatory Bowel Disease Outcomes Following Fecal Microbiota Transplantation for Recurrent C. difficile Infection.
    Inflamm Bowel Dis. 2020 Nov 6. pii: 5957723. doi: 10.1093.
    PubMed     Abstract available


  157. BRUCKNER RS, Spalinger MR, Barnhoorn MC, Feakins R, et al
    Contribution of CD3+CD8- and CD3+CD8+ T Cells to TNF-alpha Overexpression in Crohn Disease-Associated Perianal Fistulas and Induction of Epithelial-Mesenchymal Transition in HT-29 Cells.
    Inflamm Bowel Dis. 2020 Nov 4. pii: 5955654. doi: 10.1093.
    PubMed     Abstract available


  158. BLOOMFELD RS, Bickston SJ
    Financial Toxicity in People With Inflammatory Bowel Disease.
    Inflamm Bowel Dis. 2020 Nov 4. pii: 5955755. doi: 10.1093.
    PubMed     Abstract available


    October 2020
  159. DOLINGER MT, Spencer EA, Lai J, Dunkin D, et al
    Dual Biologic and Small Molecule Therapy for the Treatment of Refractory Pediatric Inflammatory Bowel Disease.
    Inflamm Bowel Dis. 2020 Oct 30. pii: 5944028. doi: 10.1093.
    PubMed     Abstract available


  160. RUBIN DT, Griffith J, Zhang Q, Hepp Z, et al
    The Impact of Intestinal Complications on Health Care Costs Among Patients With Inflammatory Bowel Disease Treated With Anti-Tumor Necrosis Factor Therapies.
    Inflamm Bowel Dis. 2020 Oct 27. pii: 5940811. doi: 10.1093.
    PubMed     Abstract available


  161. BEHZAD C, Taheri H, Kashifard M
    Establishing Safe Out-of-Hospital Infusion Centers May Improve the Quality of Care in Patients With IBD During the COVID-19 Pandemic.
    Inflamm Bowel Dis. 2020;26:e140.
    PubMed    


  162. HORRIGAN JM, Siegel CA, Tadros M
    Management of IBD Patients Who Are Unwilling or Unable to Receive Infusion Therapy During the COVID-19 Pandemic.
    Inflamm Bowel Dis. 2020;26:e137.
    PubMed    


  163. ELTABBAKH MM, Shamkh MAA, Bassuny AN, Abd Alaty WH, et al
    Inflammatory Bowel Diseases in Egypt During the COVID-19 Pandemic.
    Inflamm Bowel Dis. 2020;26:1771-1778.
    PubMed    


  164. MATSUMOTO K, Urabe Y, Oka S, Inagaki K, et al
    Genomic Landscape of Early-stage Colorectal Neoplasia Developing From the Ulcerative Colitis Mucosa in the Japanese Population.
    Inflamm Bowel Dis. 2020 Oct 22. pii: 5934978. doi: 10.1093.
    PubMed     Abstract available


  165. FERREIRA-DUARTE M, Estevinho MM, Duarte-Araujo M, Magro F, et al
    Unraveling the Role of ACE2, the Binding Receptor for SARS-CoV-2, in Inflammatory Bowel Disease.
    Inflamm Bowel Dis. 2020 Oct 16. pii: 5925264. doi: 10.1093.
    PubMed     Abstract available


  166. RUBIN DT, Hart A, Panaccione R, Armuzzi A, et al
    Ulcerative Colitis Narrative Global Survey Findings: Communication Gaps and Agreements Between Patients and Physicians.
    Inflamm Bowel Dis. 2020 Oct 15. pii: 5924202. doi: 10.1093.
    PubMed     Abstract available


  167. KE J, He R, Hou X
    Reply to the Letter: Gut Microbiota-mediated Pleiotropic Effects of Fucose Can Improve Inflammatory Bowel Disease by Modulating Bile Acid Metabolism and Enhancing Propionate Production.
    Inflamm Bowel Dis. 2020 Oct 14. pii: 5923156. doi: 10.1093.
    PubMed    


  168. ALKHAYYAT M, Abureesh M, Gill A, Khoudari G, et al
    Lower Rates of Colorectal Cancer in Patients With Inflammatory Bowel Disease Using Anti-TNF Therapy.
    Inflamm Bowel Dis. 2020 Oct 14. pii: 5923165. doi: 10.1093.
    PubMed     Abstract available


  169. VANDE CASTEELE N, Feagan BG, Wolf DC, Pop A, et al
    Therapeutic Drug Monitoring of Tumor Necrosis Factor Antagonists in Crohn Disease: A Theoretical Construct to Apply Pharmacokinetics and Guidelines to Clinical Practice.
    Inflamm Bowel Dis. 2020 Oct 14. pii: 5923164. doi: 10.1093.
    PubMed     Abstract available


  170. DE FREITAS LF, Feitosa MR, Feres O, Parra RS, et al
    Cutaneous Vasculitis Associated With Vedolizumab in Ulcerative Colitis.
    Inflamm Bowel Dis. 2020 Oct 13. pii: 5922392. doi: 10.1093.
    PubMed    


  171. CHEN G, Lissoos T, Dieyi C, Null KD, et al
    Development and Validation of an Inflammatory Bowel Disease Severity Index Using US Administrative Claims Data: A Retrospective Cohort Study.
    Inflamm Bowel Dis. 2020 Oct 12. pii: 5920980. doi: 10.1093.
    PubMed     Abstract available


  172. DOS SANTOS CHM, Koga GA
    The Challenge of Treating Pyoderma Gangrenosum in a Patient With Crohn Disease Based on Poor Scientific Evidence.
    Inflamm Bowel Dis. 2020 Oct 12. pii: 5920985. doi: 10.1093.
    PubMed    


  173. TRINDADE IA, Ferreira NB
    COVID-19 Pandemic's Effects on Disease and Psychological Outcomes of People With Inflammatory Bowel Disease in Portugal: A Preliminary Research.
    Inflamm Bowel Dis. 2020 Oct 12. pii: 5920974. doi: 10.1093.
    PubMed     Abstract available


  174. MARKOVIC S, Ivanovski TK, Zogovic B, Cvetkovic M, et al
    Biological Therapy for Inflammatory Bowel Disease During the COVID-19 Pandemic: Experiences From a Tertiary IBD Service.
    Inflamm Bowel Dis. 2020 Oct 12. pii: 5920986. doi: 10.1093.
    PubMed    


  175. FANTINI MC, Biancone L, Dragoni G, Bezzio C, et al
    Telemedicine and Remote Screening for COVID-19 in Inflammatory Bowel Disease Patients: Results From the SoCOVID-19 Survey.
    Inflamm Bowel Dis. 2020 Oct 8. pii: 5919368. doi: 10.1093.
    PubMed    


  176. FANG X, Vazquez-Baeza Y, Elijah E, Vargas F, et al
    Gastrointestinal Surgery for Inflammatory Bowel Disease Persistently Lowers Microbiome and Metabolome Diversity.
    Inflamm Bowel Dis. 2020 Oct 7. pii: 5918916. doi: 10.1093.
    PubMed     Abstract available


    September 2020
  177. YU Q
    Slc26a3 (DRA) in the Gut: Expression, Function, Regulation, Role in Infectious Diarrhea and Inflammatory Bowel Disease.
    Inflamm Bowel Dis. 2020 Sep 29. pii: 5912727. doi: 10.1093.
    PubMed     Abstract available


  178. PEMMASANI G, Elgendy I, Mamas MA, Leighton JA, et al
    Epidemiology and Clinical Outcomes of Patients With Inflammatory Bowel Disease Presenting With Acute Coronary Syndrome.
    Inflamm Bowel Dis. 2020 Sep 26. pii: 5911943. doi: 10.1093.
    PubMed     Abstract available


  179. KUROWSKI JA, Achkar JP, Gupta R, Barbur I, et al
    Adipokine Resistin Levels at Time of Pediatric Crohn Disease Diagnosis Predict Escalation to Biologic Therapy.
    Inflamm Bowel Dis. 2020 Sep 26. pii: 5911945. doi: 10.1093.
    PubMed     Abstract available


  180. SINH P, Cross R
    Cardiovascular Risk Assessment and Impact of Medications on Cardiovascular Disease in Inflammatory Bowel Disease.
    Inflamm Bowel Dis. 2020 Sep 26. pii: 5911946. doi: 10.1093.
    PubMed     Abstract available


  181. SANDBORN WJ, Feagan BG, Danese S, O'Brien CD, et al
    Safety of Ustekinumab in Inflammatory Bowel Disease: Pooled Safety Analysis of Results from Phase 2/3 Studies.
    Inflamm Bowel Dis. 2020 Sep 23. pii: 5910238. doi: 10.1093.
    PubMed     Abstract available


  182. VIGANO C, Massironi S, Pirola L, Cristoferi L, et al
    COVID-19 in Patients With Inflammatory Bowel Disease: A Single-center Observational Study in Northern Italy.
    Inflamm Bowel Dis. 2020 Sep 19. pii: 5908896. doi: 10.1093.
    PubMed    


  183. HONAP S, Cookson H, Sharma E, Samaan MA, et al
    Tofacitinib for the Treatment of Ulcerative Colitis, Alopecia Universalis, and Atopic Dermatitis: One Drug, Three Diseases.
    Inflamm Bowel Dis. 2020 Sep 18. pii: 5908061. doi: 10.1093.
    PubMed    


  184. CASTELLINI G, Savarese M, Leone S, Previtali E, et al
    Italian IBD Patients Coping With Covid-19 Emergency: The Mitigating Role of Psychological Readiness to Engage in Self-care.
    Inflamm Bowel Dis. 2020;26:e130-e131.
    PubMed    


  185. OCCHIPINTI V, Sociale OR, Pastorelli L
    Response to "Italian IBD Patients Coping With COVID-19 Emergency: The Mitigating Role of Psychological Readiness to Engage in Self-Care".
    Inflamm Bowel Dis. 2020;26:e123.
    PubMed    


  186. RIMONDI A, Tontini GE, Mazza S, Caprioli F, et al
    Fogging IBD Management: An Unusual Case of IBD Flare-up During the COVID-19 Outbreak.
    Inflamm Bowel Dis. 2020;26:e128-e129.
    PubMed    


  187. BURGUENO JF, Abreu MT
    Reply to the Letter to the Editor: The Incidence and Outcomes of COVID-19 in Patients With IBD: A Rapid Review and Meta-Analysis.
    Inflamm Bowel Dis. 2020;26:e127.
    PubMed    


  188. AZIZ M, Fatima R, Haghbin H, Lee-Smith W, et al
    The Incidence and Outcomes of COVID-19 in IBD Patients: A Rapid Review and Meta-analysis.
    Inflamm Bowel Dis. 2020;26:e132-e133.
    PubMed    


  189. CLOUGH JN, Hill KL, Duff A, Sharma E, et al
    Managing an IBD Infusion Unit During the COVID-19 Pandemic: Service Modifications and the Patient Perspective.
    Inflamm Bowel Dis. 2020;26:e125-e126.
    PubMed    


  190. NAVANEETHAN U, LehnerNoguera V
    Prolonged Duration of SARS-CoV-2 Viral Positivity in a Crohn's Disease Patient.
    Inflamm Bowel Dis. 2020;26:e124.
    PubMed    


  191. KORNBLUTH A, Kissous-Hunt M, George J, Legnani P, et al
    Management of Inflammatory Bowel Disease and COVID-19 in New York City 2020: The Epicenter of IBD in the First Epicenter of the Global Pandemic.
    Inflamm Bowel Dis. 2020 Sep 3. pii: 5900880. doi: 10.1093.
    PubMed    


  192. KOUTROUMPAKIS F, Phillips AE, Yadav D, Machicado JD, et al
    Serum IgG4 Subclass Deficiency Defines a Distinct, Commonly Encountered, Severe Inflammatory Bowel Disease Subtype.
    Inflamm Bowel Dis. 2020 Sep 3. pii: 5900865. doi: 10.1093.
    PubMed     Abstract available


  193. SITKIN S, Vakhitov T, Kononova S, Skalinskaya M, et al
    Gut Microbiota-Mediated Pleiotropic Effects of Fucose Can Improve Inflammatory Bowel Disease by Modulating Bile Acid Metabolism and Enhancing Propionate Production.
    Inflamm Bowel Dis. 2020 Sep 3. pii: 5900883. doi: 10.1093.
    PubMed    


  194. SANDS BE, Colombel JF, Ha C, Farnier M, et al
    Lipid Profiles in Patients With Ulcerative Colitis Receiving Tofacitinib-Implications for Cardiovascular Risk and Patient Management.
    Inflamm Bowel Dis. 2020 Sep 1. pii: 5900074. doi: 10.1093.
    PubMed     Abstract available


  195. SYED S, Stidham RW
    Potential for Standardization and Automation for Pathology and Endoscopy in Inflammatory Bowel Disease.
    Inflamm Bowel Dis. 2020 Sep 1. pii: 5900066. doi: 10.1093.
    PubMed     Abstract available


  196. BEZZIO C, Pellegrini L, Manes G, Arena I, et al
    Biologic Therapies May Reduce the Risk of COVID-19 in Patients With Inflammatory Bowel Disease.
    Inflamm Bowel Dis. 2020 Sep 1. pii: 5900070. doi: 10.1093.
    PubMed    


    August 2020
  197. ALBSHESH A, Ungar B, Ben-Horin S, Eliakim R, et al
    Terminal Ileum Thickness During Maintenance Therapy Is a Predictive Marker of the Outcome of Infliximab Therapy in Crohn Disease.
    Inflamm Bowel Dis. 2020 Aug 29. pii: 5898844. doi: 10.1093.
    PubMed     Abstract available


  198. GUERRA I, Algaba A, Jimenez L, Mar Aller M, et al
    Incidence, Clinical Characteristics, and Evolution of SARS-CoV-2 Infection in Patients With Inflammatory Bowel Disease: A Single-Center Study in Madrid, Spain.
    Inflamm Bowel Dis. 2020 Aug 24. pii: 5896213. doi: 10.1093.
    PubMed     Abstract available


  199. COHEN BL, Gallinger ZR, Ha C, Holubar SD, et al
    Development of Entrustable Professional Activities for Advanced Inflammatory Bowel Disease Fellowship Training in the United States.
    Inflamm Bowel Dis. 2020;26:1291-1305.
    PubMed     Abstract available


  200. ZHANG Q, Chen D, Yang Y
    Incidence and Prevalence of Human Papilloma Virus-associated Cancers in IBD.
    Inflamm Bowel Dis. 2020;26:e101.
    PubMed    


  201. HU AB, Burke KE, Kochar B, Ananthakrishnan AN, et al
    Yield of Random Biopsies During Colonoscopies in Inflammatory Bowel Disease Patients Undergoing Dysplasia Surveillance.
    Inflamm Bowel Dis. 2020 Aug 19. pii: 5894187. doi: 10.1093.
    PubMed     Abstract available


  202. PALACIOS ARGUETA P, Salazar M, Attar B, Simons-Linares R, et al
    90-Day Specific Readmission for Clostridium difficile Infection After Hospitalization With an Inflammatory Bowel Disease Flare: Outcomes and Risk Factors.
    Inflamm Bowel Dis. 2020 Aug 19. pii: 5894152. doi: 10.1093.
    PubMed     Abstract available


  203. MAVRAGANI CP, Nezos A, Dovrolis N, Andreou NP, et al
    Type I and II Interferon Signatures Can Predict the Response to Anti-TNF Agents in Inflammatory Bowel Disease Patients: Involvement of the Microbiota.
    Inflamm Bowel Dis. 2020 Aug 19. pii: 5894175. doi: 10.1093.
    PubMed     Abstract available


  204. TOWNSEND T, Fiske J, Collins P, Bond A, et al
    Ambulatory Management of Acute Severe Ulcerative Colitis: A Pandemic-driven Initiative.
    Inflamm Bowel Dis. 2020 Aug 19. pii: 5894170. doi: 10.1093.
    PubMed    


  205. SUGIMOTO K, Fujita S, Miyazu T, Ishida N, et al
    Improvement in Ulcerative Colitis by Administration of Benralizumab for Comorbid Refractory Bronchial Asthma: A Novel Clinical Observation.
    Inflamm Bowel Dis. 2020 Aug 19. pii: 5894173. doi: 10.1093.
    PubMed    


  206. JOSE DA SILVA R, da Rocha Ribeiro TC, Chebli LA, Chebli JMF, et al
    An Unexpected Cause of Headache and Splenic Lesions During Anti-TNF Therapy in Crohn Disease.
    Inflamm Bowel Dis. 2020 Aug 19. pii: 5894171. doi: 10.1093.
    PubMed    


  207. DUBINSKY MC, DiBonaventura M, Fan H, Bushmakin AG, et al
    Tofacitinib in Patients with Ulcerative Colitis: Inflammatory Bowel Disease Questionnaire Items in Phase 3 Randomized Controlled Induction Studies.
    Inflamm Bowel Dis. 2020 Aug 14. pii: 5892619. doi: 10.1093.
    PubMed     Abstract available


  208. HOKAMA A, Omija H, Kishimoto K, Kinjo T, et al
    Response to "Histopathological Mimics of Inflammatory Bowel Disease".
    Inflamm Bowel Dis. 2020 Aug 14. pii: 5892558. doi: 10.1093.
    PubMed    


  209. BATRA SK, Heier CR, Diaz-Calderon L, Tully CB, et al
    Serum miRNAs Are Pharmacodynamic Biomarkers Associated With Therapeutic Response in Pediatric Inflammatory Bowel Disease.
    Inflamm Bowel Dis. 2020 Aug 14. pii: 5892560. doi: 10.1093.
    PubMed     Abstract available


  210. BERNSTEIN CN, Ng SC, Banerjee R, Steinwurz F, et al
    Worldwide Management of Inflammatory Bowel Disease During the COVID-19 Pandemic: An International Survey.
    Inflamm Bowel Dis. 2020 Aug 14. pii: 5892568. doi: 10.1093.
    PubMed     Abstract available


  211. LIU C, Yuan ZY, Yuan H, Wu KX, et al
    Status of Gene Methylation and Polymorphism in Different Courses of Ulcerative Colitis and Their Comparison with Sporadic Colorectal Cancer.
    Inflamm Bowel Dis. 2020 Aug 14. pii: 5892563. doi: 10.1093.
    PubMed     Abstract available


  212. LIN A, Roth H, Anyane-Yeboa A, Rubin DT, et al
    Prevalence of Nonalcoholic Fatty Liver Disease in Patients With Inflammatory Bowel Disease: A Systematic Review and Meta-analysis.
    Inflamm Bowel Dis. 2020 Aug 11. pii: 5891018. doi: 10.1093.
    PubMed     Abstract available


  213. BORREN NZ, Plichta D, Joshi AD, Bonilla G, et al
    Multi-"-Omics" Profiling in Patients With Quiescent Inflammatory Bowel Disease Identifies Biomarkers Predicting Relapse.
    Inflamm Bowel Dis. 2020 Aug 7. pii: 5885066. doi: 10.1093.
    PubMed     Abstract available


  214. LICHTENSTEIN GR, Rogler G, Ciorba MA, Su C, et al
    Tofacitinib, an Oral Janus Kinase Inhibitor: Analysis of Malignancy (Excluding Nonmelanoma Skin Cancer) Events Across the Ulcerative Colitis Clinical Program.
    Inflamm Bowel Dis. 2020 Aug 7. pii: 5885008. doi: 10.1093.
    PubMed     Abstract available


  215. LO SASSO G, Khachatryan L, Kondylis A, Battey JND, et al
    Inflammatory Bowel Disease-Associated Changes in the Gut: Focus on Kazan Patients.
    Inflamm Bowel Dis. 2020 Aug 7. pii: 5885057. doi: 10.1093.
    PubMed     Abstract available


  216. GARRIDO I, Lopes S, Macedo G
    Inflammatory Bowel Disease Management in a Major Referral Center During COVID-19 Pandemic.
    Inflamm Bowel Dis. 2020 Aug 1. pii: 5879647. doi: 10.1093.
    PubMed    


    July 2020
  217. MAJSTER M, Lira-Junior R, Hoog CM, Almer S, et al
    Salivary and Serum Inflammatory Profiles Reflect Different Aspects of Inflammatory Bowel Disease Activity.
    Inflamm Bowel Dis. 2020 Jul 29. pii: 5877759. doi: 10.1093.
    PubMed     Abstract available


  218. JAGANNATH B, Lin KC, Pali M, Sankhala D, et al
    A Sweat-based Wearable Enabling Technology for Real-time Monitoring of IL-1beta and CRP as Potential Markers for Inflammatory Bowel Disease.
    Inflamm Bowel Dis. 2020 Jul 28. pii: 5877396. doi: 10.1093.
    PubMed     Abstract available


  219. SEHGAL P, Ungaro RC, Foltz C, Iacoviello B, et al
    High Levels of Psychological Resilience Associated With Less Disease Activity, Better Quality of Life, and Fewer Surgeries in Inflammatory Bowel Disease.
    Inflamm Bowel Dis. 2020 Jul 22. pii: 5874745. doi: 10.1093.
    PubMed     Abstract available


  220. TIAN WN, Huang YH, Dai C
    The Effect of the COVID-19 Pandemic on the Medical Mode of Patients With Inflammatory Bowel Disease in China.
    Inflamm Bowel Dis. 2020 Jul 22. pii: 5874746. doi: 10.1093.
    PubMed    


  221. GREEN ME, Brahmbhatt B, Baumgarten D, Krishna M, et al
    Meckel's Diverticulum Masquerading as Crohn Disease.
    Inflamm Bowel Dis. 2020 Jul 21. pii: 5874417. doi: 10.1093.
    PubMed    


  222. VERDON C, Reinglas J, Coulombe J, Gonczi L, et al
    No Change in Surgical and Hospitalization Trends Despite Higher Exposure to Anti-Tumor Necrosis Factor in Inflammatory Bowel Disease in the Quebec Provincial Database From 1996 to 2015.
    Inflamm Bowel Dis. 2020 Jul 17. pii: 5872809. doi: 10.1093.
    PubMed     Abstract available


  223. NAVANEETHAN U, Lourdusamy D, LehnerNoguera V, Shen B, et al
    Safety of Endoscopy in Patients With Inflammatory Bowel Disease During the COVID-19 Pandemic.
    Inflamm Bowel Dis. 2020 Jul 17. pii: 5872834. doi: 10.1093.
    PubMed    


  224. CRISTOBAL I, Madoz-Gurpide J, Rojo F, Garcia-Foncillas J, et al
    The Molecular Mechanisms Involved in the miR-29a-5p/STAT3 Signaling Loop in Ulcerative Colitis-Associated Colorectal Cancer Still Remain Unclear.
    Inflamm Bowel Dis. 2020;26:e87.
    PubMed    


  225. BERINSTEIN JA, Cohen-Mekelburg SA, Steiner CA, McLeod M, et al
    Variations in Health Care Utilization Patterns Among Inflammatory Bowel Disease Patients at Risk for High Medical Service Utilization Enrolled in High Deductible Health Plans.
    Inflamm Bowel Dis. 2020 Jul 17. pii: 5872817. doi: 10.1093.
    PubMed     Abstract available


  226. HERNANDEZ BENABE S, Langshaw AH
    IBD in the Times of COVID-19.
    Inflamm Bowel Dis. 2020;26:e92.
    PubMed    


  227. BAMIAS G, Lagou S, Gizis M, Karampekos G, et al
    The Greek Response to COVID-19: A True Success Story from an IBD Perspective.
    Inflamm Bowel Dis. 2020;26:1144-1148.
    PubMed     Abstract available


  228. GOYAL A
    Clostridium Difficile and Increased Risk of Surgery in Crohn's Disease. Can Early Microbial Signatures Forecast Risk of Disease Progression?
    Inflamm Bowel Dis. 2020;26:1222-1224.
    PubMed    


  229. AYOUB A, Jairath V, Aldraiweesh S, Khanna R, et al
    Safety of Biologic Therapy in Octogenarians and Nonagenarians With Inflammatory Bowel Disease in Ontario: A Case Series.
    Inflamm Bowel Dis. 2020 Jul 11. pii: 5870254. doi: 10.1093.
    PubMed    


  230. GEORGIOU AN, Ntritsos G, Papadimitriou N, Dimou N, et al
    Cigarette Smoking, Coffee Consumption, Alcohol Intake, and Risk of Crohn's Disease and Ulcerative Colitis: A Mendelian Randomization Study.
    Inflamm Bowel Dis. 2020 Jul 6. pii: 5867966. doi: 10.1093.
    PubMed     Abstract available


  231. DI RUSCIO M, Variola A, Angheben A, Resimini S, et al
    A Challenging Colectomy for Acute Severe Ulcerative Colitis Complicated by COVID-19.
    Inflamm Bowel Dis. 2020 Jul 6. pii: 5867642. doi: 10.1093.
    PubMed    


  232. GROSSBERG LB, Pellish RS, Cheifetz AS, Feuerstein JD, et al
    Review of Societal Recommendations Regarding Management of Patients With Inflammatory Bowel Disease During the SARS-CoV-2 Pandemic.
    Inflamm Bowel Dis. 2020 Jul 3. pii: 5866902. doi: 10.1093.
    PubMed    


  233. CARD TR, Zittan E, Nguyen GC, Grainge MJ, et al
    Disease Activity in Inflammatory Bowel Disease Is Associated With Arterial Vascular Disease.
    Inflamm Bowel Dis. 2020 Jul 3. pii: 5866856. doi: 10.1093.
    PubMed     Abstract available


  234. SAHU P, Kedia S, Padhan R, Ahuja V, et al
    Pregnancy-Onset Inflammatory Bowel Disease (PO-IBD): A Riddle Inside an Enigma.
    Inflamm Bowel Dis. 2020 Jul 3. pii: 5866857. doi: 10.1093.
    PubMed    


    June 2020
  235. SEGAL JP, Askari A, Clark SK, Hart AL, et al
    HPV-related Cancers in Inflammatory Bowel Disease: Association Not Yet Causation.
    Inflamm Bowel Dis. 2020 Jun 29. pii: 5864595. doi: 10.1093.
    PubMed    


  236. DULAI PS, Jairath V, Zou G, Stitt LW, et al
    Early Combined Immunosuppression May Be More Effective for Reducing Complications in Isolated Colonic- vs Ileal-Dominant Crohn Disease.
    Inflamm Bowel Dis. 2020 Jun 27. pii: 5863990. doi: 10.1093.
    PubMed     Abstract available


  237. PEPE M, Carulli E, Forleo C, Moscarelli M, et al
    Inflammatory Bowel Disease and Acute Coronary Syndromes: From Pathogenesis to the Fine Line Between Bleeding and Ischemic Risk.
    Inflamm Bowel Dis. 2020 Jun 27. pii: 5863988. doi: 10.1093.
    PubMed     Abstract available


  238. LEE JA, Magavi PR, Konijeti GG
    Treatment of Ulcerative Colitis and Seronegative Inflammatory Spondyloarthritis With Vedolizumab and Tofacitinib.
    Inflamm Bowel Dis. 2020 Jun 27. pii: 5863987. doi: 10.1093.
    PubMed    


  239. AXELRAD JE, Malter L, Hong S, Chang S, et al
    From the American Epicenter: Coronavirus Disease 2019 in Patients with Inflammatory Bowel Disease in the New York City Metropolitan Area.
    Inflamm Bowel Dis. 2020 Jun 24. pii: 5861860. doi: 10.1093.
    PubMed     Abstract available


  240. GRANT RK, Jones GR, Plevris N, Lynch RW, et al
    The ACE (Albumin, CRP and Endoscopy) Index in Acute Colitis: A Simple Clinical Index on Admission that Predicts Outcome in Patients With Acute Ulcerative Colitis.
    Inflamm Bowel Dis. 2020 Jun 23. pii: 5861142. doi: 10.1093.
    PubMed     Abstract available


  241. NAKASEKO H, Nishida D, Abe N, Tanaka K, et al
    Effect of Exclusive Enteral Nutrition on Renal Function for Granulomatous Interstitial Nephritis Associated With Crohn Disease.
    Inflamm Bowel Dis. 2020 Jun 22. pii: 5860630. doi: 10.1093.
    PubMed    


  242. HONAP S, Pavlidis P, Ray S, Sharma E, et al
    Tofacitinib in Acute Severe Ulcerative Colitis-A Real-World Tertiary Center Experience.
    Inflamm Bowel Dis. 2020 Jun 22. pii: 5860628. doi: 10.1093.
    PubMed    


  243. SCHAFER E, Shyu I, Walker C, Smallfield G, et al
    New Presentation of Hepatic Inflammatory Pseudotumor and Crohn Disease.
    Inflamm Bowel Dis. 2020 Jun 20. pii: 5860196. doi: 10.1093.
    PubMed    


  244. KELSEN JR, Dawany N, Conrad MA, Karakasheva TA, et al
    Colonoids From Patients With Pediatric Inflammatory Bowel Disease Exhibit Decreased Growth Associated With Inflammation Severity and Durable Upregulation of Antigen Presentation Genes.
    Inflamm Bowel Dis. 2020 Jun 19. pii: 5859746. doi: 10.1093.
    PubMed     Abstract available


  245. TSURUTA Y, Furuta Y, Naoe H, Tanaka M, et al
    Multiple Gastric Polyps Improved After Treatment for Ulcerative Colitis.
    Inflamm Bowel Dis. 2020 Jun 18. pii: 5859375. doi: 10.1093.
    PubMed    


  246. GUO L, Rohde J, Farraye FA
    Stigma and Disclosure in Patients With Inflammatory Bowel Disease.
    Inflamm Bowel Dis. 2020;26:1010-1016.
    PubMed     Abstract available


  247. GRASSIA R, Soro S, Conti CB
    Inflammatory Bowel Diseases and Biological Treatment in SARS-CoV-2 Era. Why Not?
    Inflamm Bowel Dis. 2020;26:e71.
    PubMed    


  248. FLESHNER P
    Editorial on Hirten et al.
    Inflamm Bowel Dis. 2020;26:1059.
    PubMed    


  249. LIGHTNER AL
    Inflammation of the Ileal Anal Pouch: Do Biologics Really Change the Trajectory?
    Inflamm Bowel Dis. 2020;26:1087-1088.
    PubMed    


  250. ORTEGA MORENO L, Fernandez-Tome S, Chaparro M, Marin AC, et al
    Profiling of Human Circulating Dendritic Cells and Monocyte Subsets Discriminates Between Type and Mucosal Status in Patients With Inflammatory Bowel Disease.
    Inflamm Bowel Dis. 2020 Jun 17. pii: 5858322. doi: 10.1093.
    PubMed     Abstract available


  251. JEROME R, Sebastien H, Delphine WV, Jean-Francois E, et al
    Refractory Inflammatory Bowel Disease Associated With Sclerosing Cholangitis, Diabetes Insipidus, and Myeloid Neoplasm: Langerhans Cell Histiocytosis Was Hiding Since the Beginning.
    Inflamm Bowel Dis. 2020 Jun 12. pii: 5856440. doi: 10.1093.
    PubMed    


  252. SCHLABITZ F, Teich N, Michl P, Walldorf J, et al
    Inflammatory Bowel Disease and COVID-19-"Preventive" Sick Certificates as a Frequent Coping Strategy in the Face of the Pandemic.
    Inflamm Bowel Dis. 2020 Jun 12. pii: 5856424. doi: 10.1093.
    PubMed    


  253. JOHN RA, Gearry RB
    Smoking Cessation for Patients With Crohn Disease: Not Just for the Patient?
    Inflamm Bowel Dis. 2020 Jun 12. pii: 5856324. doi: 10.1093.
    PubMed    


  254. COELHO-PRABHU N, Bruining DH, Faubion WA, Kane SV, et al
    A 1-Year Cross-sectional Inflammatory Bowel Disease Surveillance Colonoscopy Cohort Comparing High-definition White Light Endoscopy and Chromoendoscopy.
    Inflamm Bowel Dis. 2020 Jun 12. pii: 5856329. doi: 10.1093.
    PubMed     Abstract available


  255. DUZENLI T, Koseoglu H, Akyol T
    NLR and PLR as Novel Prognostic Biomarkers of Mucosal Healing in Ulcerative Colitis Patients Treated with Anti-TNF.
    Inflamm Bowel Dis. 2020 Jun 9. pii: 5854914. doi: 10.1093.
    PubMed    


  256. BERTANI L, Costa F, Barberio B, Savarino E, et al
    Reply to Letter to the Editor: NLR and PLR as Novel Prognostic Biomarkers of Mucosal Healing in Ulcerative Colitis Patients Treated With Anti-TNF.
    Inflamm Bowel Dis. 2020 Jun 9. pii: 5854915. doi: 10.1093.
    PubMed    


  257. LIU B, Yang MQ, Yu TY, Yin YY, et al
    Mast Cell Tryptase Promotes Inflammatory Bowel Disease-Induced Intestinal Fibrosis.
    Inflamm Bowel Dis. 2020 Jun 8. pii: 5854445. doi: 10.1093.
    PubMed     Abstract available


  258. KOBAYASHI Y, Ohfuji S, Kondo K, Fukushima W, et al
    Association of Dietary Fatty Acid Intake With the Development of Ulcerative Colitis: A Multicenter Case-Control Study in Japan.
    Inflamm Bowel Dis. 2020 Jun 8. pii: 5854441. doi: 10.1093.
    PubMed     Abstract available


  259. QIAN XX
    Temporal, Sexual, and Geographic Distributions of the Coexistence of Ulcerative Colitis and Graves Disease.
    Inflamm Bowel Dis. 2020 Jun 8. pii: 5854442. doi: 10.1093.
    PubMed    


  260. MARTIN ARRANZ E, Suarez Ferrer C, Garcia Ramirez L, Rueda Garcia JL, et al
    Management of COVID-19 Pandemic in Spanish Inflammatory Bowel Disease Units: Results From a National Survey.
    Inflamm Bowel Dis. 2020 Jun 4. pii: 5851307. doi: 10.1093.
    PubMed     Abstract available


  261. CHUDY-ONWUGAJE K, Mamunes AP, Schwartz DA, Horst S, et al
    Predictors of High Health Care Utilization in Patients With Inflammatory Bowel Disease Within 1 Year of Establishing Specialist Care.
    Inflamm Bowel Dis. 2020 Jun 3. pii: 5850604. doi: 10.1093.
    PubMed     Abstract available


  262. PEKOW J, Patel P
    Daily Aspirin Use Does Not Impact Clinical Outcomes in Patients With Inflammatory Bowel Disease. Reply Letter to Elia et al.
    Inflamm Bowel Dis. 2020 Jun 2. pii: 5850168. doi: 10.1093.
    PubMed    


  263. ELIA JR
    Aspirin, NSAIDs, and Inflammatory Bowel Disease: An Exercise Physiology Perspective.
    Inflamm Bowel Dis. 2020 Jun 2. pii: 5850171. doi: 10.1093.
    PubMed    


    May 2020
  264. RAMPAL R, Wari N, Singh AK, Das U, et al
    Retinoic Acid Is Elevated in the Mucosa of Patients With Active Ulcerative Colitis and Displays a Proinflammatory Role by Augmenting IL-17 and IFNgamma Production.
    Inflamm Bowel Dis. 2020 May 29. pii: 5848464. doi: 10.1093.
    PubMed     Abstract available


  265. NOURELDIN M, Cohen-Mekelburg S, Mahmood A, Stidham R, et al
    Trends of 5-Aminosalicylate Medication Use in Patients With Crohn Disease.
    Inflamm Bowel Dis. 2020 May 29. pii: 5848467. doi: 10.1093.
    PubMed     Abstract available


  266. LEUNG KK, Tandon P, Govardhanam V, Maxwell C, et al
    The Risk of Adverse Neonatal Outcomes With Maternal Inflammatory Bowel Disease: A Systematic Review and Meta-analysis.
    Inflamm Bowel Dis. 2020 May 29. pii: 5848466. doi: 10.1093.
    PubMed     Abstract available


  267. MURPHY LK, de la Vega R, Kohut SA, Kawamura JS, et al
    Systematic Review: Psychosocial Correlates of Pain in Pediatric Inflammatory Bowel Disease.
    Inflamm Bowel Dis. 2020 May 27. pii: 5847655. doi: 10.1093.
    PubMed     Abstract available


  268. VALDES DELGADO T, Maldonado Perez B, Castro Laria L
    Erythema Nodosum: As an Extraintestinal Manifestation or Complication in Ulcerative Colitis?
    Inflamm Bowel Dis. 2020 May 25. pii: 5843661. doi: 10.1093.
    PubMed     Abstract available


  269. KRONER PT, Lee A, Farraye FA
    Respiratory Tract Manifestations of Inflammatory Bowel Disease.
    Inflamm Bowel Dis. 2020 May 25. pii: 5843660. doi: 10.1093.
    PubMed     Abstract available


  270. QAZI T, Smith A, Alexander M, Hammer D, et al
    Disparities in Objective Sleep Quality as Assessed Through Wrist Actigraphy in Minority Patients With Inflammatory Bowel Disease.
    Inflamm Bowel Dis. 2020 May 25. pii: 5843655. doi: 10.1093.
    PubMed     Abstract available


  271. LYLES JL, Mulgund AA, Bauman LE, Su W, et al
    Effect of a Practice-wide Anti-TNF Proactive Therapeutic Drug Monitoring Program on Outcomes in Pediatric Patients with Inflammatory Bowel Disease.
    Inflamm Bowel Dis. 2020 May 25. pii: 5843647. doi: 10.1093.
    PubMed     Abstract available


  272. FASOULAS K, Kafalis N, Soufleris K
    Alphazathioprine-Induced Tremor: A Rare, Dose-Dependent Side Effect of Azathioprine in a Patient With Active Crohn Disease.
    Inflamm Bowel Dis. 2020 May 23. pii: 5843195. doi: 10.1093.
    PubMed    


  273. HUANG JS, Cruz R, Yueh R, Parker J, et al
    A Systemwide Electronic Health Record Checklist to Improve Comorbidity Screening of Children With Inflammatory Bowel Disease.
    Inflamm Bowel Dis. 2020 May 22. pii: 5841913. doi: 10.1093.
    PubMed    


  274. BARASH Y, Klang E, Tau N, Ben-Horin S, et al
    Evolution of Inflammatory Bowel Disease Research From a Bird's-Eye Perspective: A Text-Mining Analysis of Publication Trends and Topics.
    Inflamm Bowel Dis. 2020 May 22. pii: 5841908. doi: 10.1093.
    PubMed     Abstract available


  275. MARTINELLI M, Strisciuglio C, Fedele F, Miele E, et al
    Clinical and Psychological Issues in Children with Inflammatory Bowel Disease During COVID-19 Pandemic.
    Inflamm Bowel Dis. 2020 May 22. pii: 5841894. doi: 10.1093.
    PubMed    


  276. MINTZ MJ, Ananthakrishnan AN
    Phenotype and Natural History of Inflammatory Bowel Disease in Patients With Concomitant Eosinophilic Esophagitis.
    Inflamm Bowel Dis. 2020 May 20. pii: 5840920. doi: 10.1093.
    PubMed     Abstract available


  277. DRAGONI G, De Hertogh G, Vermeire S
    The Role of Citrullination in Inflammatory Bowel Disease: A Neglected Player in Triggering Inflammation and Fibrosis?
    Inflamm Bowel Dis. 2020 May 19. pii: 5840491. doi: 10.1093.
    PubMed     Abstract available


  278. YU A, Friedman S, Ananthakrishnan AN
    Characteristics and Long-Term Outcomes of Pregnancy-Onset Inflammatory Bowel Disease: A Case-Control Study.
    Inflamm Bowel Dis. 2020 May 19. pii: 5840482. doi: 10.1093.
    PubMed     Abstract available


  279. EGBERG MD, Phillips M, Galanko JA, Kappelman M, et al
    Total Abdominal Colectomies With Proctectomy Are Associated With Higher 30-Day Readmission Rates in Children With Ulcerative Colitis.
    Inflamm Bowel Dis. 2020 May 19. pii: 5840483. doi: 10.1093.
    PubMed     Abstract available


  280. RYBINSKI F, Weisser M, Niess JH, Hruz P, et al
    Amoebic Liver Abscess in Crohn Disease Treated With Ustekinumab.
    Inflamm Bowel Dis. 2020 May 14. pii: 5836916. doi: 10.1093.
    PubMed    


  281. BARNES EL, Bauer CM, Sandler RS, Kappelman MD, et al
    Black and White Patients With Inflammatory Bowel Disease Show Similar Biologic Use Patterns With Medicaid Insurance.
    Inflamm Bowel Dis. 2020 May 14. pii: 5836912. doi: 10.1093.
    PubMed     Abstract available


  282. ROSEN MH, Axelrad J, Hudesman D, Rubin DT, et al
    Management of Acute Severe Ulcerative Colitis in a Pregnant Woman With COVID-19 Infection: A Case Report and Review of the Literature.
    Inflamm Bowel Dis. 2020 May 12. pii: 5836016. doi: 10.1093.
    PubMed     Abstract available


  283. XU F, Chen D, Yang Y
    Response to "Derivation and Internal Validation of a Clinical Prediction Tool to Predict Nonalcoholic Fatty Liver Disease in Patients With Crohn's Disease".
    Inflamm Bowel Dis. 2020;26:e47.
    PubMed    


  284. MCHENRY S, Ciorba MA, Deepak P
    Reply to the Letter to the Editor: Derivation and Internal Validation of a Clinical Prediction Tool to Predict Nonalcoholic Fatty Liver Disease in Patients With Crohn's Disease.
    Inflamm Bowel Dis. 2020;26:e46.
    PubMed    


  285. DAVIS BC
    Safety of Biologic Therapy in Liver Transplant Recipients: Case Closed?
    Inflamm Bowel Dis. 2020;26:960.
    PubMed    


  286. ZUNDLER S
    Utilization of Diagnostic Imaging and Ionizing Radiation Exposure-Has the Tide Already Turned?
    Inflamm Bowel Dis. 2020;26:907-908.
    PubMed     Abstract available


  287. LUKIN DJ
    Predictors of Perianal Fistula Relapse in Crohn's Disease.
    Inflamm Bowel Dis. 2020;26:932-933.
    PubMed    


  288. KERUR B, Benchimol EI, Fiedler K, Stahl M, et al
    Natural History of Very Early Onset Inflammatory Bowel Disease in North America: A Retrospective Cohort Study.
    Inflamm Bowel Dis. 2020 May 9. pii: 5835042. doi: 10.1093.
    PubMed     Abstract available


  289. CORRIDONI D, Chapman T, Antanaviciute A, Satsangi J, et al
    Inflammatory Bowel Disease Through the Lens of Single-cell RNA-seq Technologies.
    Inflamm Bowel Dis. 2020 May 9. pii: 5834990. doi: 10.1093.
    PubMed     Abstract available


  290. GUZMAN-PRADO Y, Samson O, Segal JP, Limdi JK, et al
    Vitamin D Therapy in Adults With Inflammatory Bowel Disease: A Systematic Review and Meta-Analysis.
    Inflamm Bowel Dis. 2020 May 9. pii: 5834989. doi: 10.1093.
    PubMed     Abstract available


  291. TURSI A, Vetrone LM, Papa A
    Anti-TNF-alpha Agents in Inflammatory Bowel Disease and Course of COVID-19.
    Inflamm Bowel Dis. 2020 May 8. pii: 5831990. doi: 10.1093.
    PubMed    


  292. VAN GENNEP S, Evers SW, Rietdijk ST, Gielen ME, et al
    High Disease Burden Drives Indirect Costs in Employed Inflammatory Bowel Disease Patients: The WORK-IBD Study.
    Inflamm Bowel Dis. 2020 May 7. pii: 5831697. doi: 10.1093.
    PubMed     Abstract available


  293. PARK KT, Ehrlich OG, Allen JI, Meadows P, et al
    Corrigendum to The Cost of Inflammatory Bowel Disease: An Initiative From the Crohn's & Colitis Foundation.
    Inflamm Bowel Dis. 2020 May 6. pii: 5831199. doi: 10.1093.
    PubMed    


    April 2020
  294. JACOBS J, Clark-Snustad K, Lee S
    Case Report of a SARS-CoV-2 Infection in a Patient With Ulcerative Colitis on Tofacitinib.
    Inflamm Bowel Dis. 2020 Apr 28. pii: 5826022. doi: 10.1093.
    PubMed    


  295. FENTON CG, Taman H, Florholmen J, Sorbye SW, et al
    Transcriptional Signatures That Define Ulcerative Colitis in Remission.
    Inflamm Bowel Dis. 2020 Apr 23. pii: 5823961. doi: 10.1093.
    PubMed     Abstract available


  296. LEVHAR N, Ungar B, Kopylov U, Fudim E, et al
    Propagation of EBV-driven Lymphomatous Transformation of Peripheral Blood B Cells by Immunomodulators and Biologics Used in the Treatment of Inflammatory Bowel Disease.
    Inflamm Bowel Dis. 2020 Apr 23. pii: 5823959. doi: 10.1093.
    PubMed     Abstract available


  297. YAO J, Jiang X, You JHS
    A Systematic Review on Cost-effectiveness Analyses of Therapeutic Drug Monitoring for Patients with Inflammatory Bowel Disease: From Immunosuppressive to Anti-TNF Therapy.
    Inflamm Bowel Dis. 2020 Apr 20. pii: 5822887. doi: 10.1093.
    PubMed     Abstract available


  298. LINHARES M, Ramos D, Pereira F, Azevedo R, et al
    Hidradenitis Suppurativa and Crohn Disease: A Rare Association.
    Inflamm Bowel Dis. 2020 Apr 18. pii: 5822088. doi: 10.1093.
    PubMed    


  299. DERER S, Brethack AK, Pietsch C, Jendrek ST, et al
    Inflammatory Bowel Disease-associated GP2 Autoantibodies Inhibit Mucosal Immune Response to Adherent-invasive Bacteria.
    Inflamm Bowel Dis. 2020 Apr 18. pii: 5822108. doi: 10.1093.
    PubMed     Abstract available



  300. Corrigendum to: Serum Dipeptidyl Peptidase 4: A Predictor of Disease Activity and Prognosis in Inflammatory Bowel Disease.
    Inflamm Bowel Dis. 2020 Apr 18. pii: 5822087. doi: 10.1093.
    PubMed    



  301. DPP-4 as a Novel Biomarker for Inflammatory Bowel Disease: Is It Ready for Clinical Use?
    Inflamm Bowel Dis. 2020 Apr 16. pii: 5820737. doi: 10.1093.
    PubMed    


  302. TURNER D
    Antibiotics in Refractory IBD: Not Without Risks but Are the Alternatives Better? Response to Gilmore et al.
    Inflamm Bowel Dis. 2020;26:e42.
    PubMed    


  303. LIN S, Lin X, Li X, Chen M, et al
    Making Qualitative Intestinal Stricture Quantitative: Embracing Radiomics in IBD.
    Inflamm Bowel Dis. 2020;26:743-745.
    PubMed    


  304. LEE AS, Hubers J, Osman F, Caldera F, et al
    Don't Be Blue: A Case Series Describing Colonoscope Damage After Chromoendoscopy for Surveillance of Dysplasia in Inflammatory Bowel Disease.
    Inflamm Bowel Dis. 2020 Apr 6. pii: 5816423. doi: 10.1093.
    PubMed    


    March 2020
  305. BERTANI L, Rossari F, Barberio B, Demarzo MG, et al
    Novel Prognostic Biomarkers of Mucosal Healing in Ulcerative Colitis Patients Treated With Anti-TNF: Neutrophil-to-Lymphocyte Ratio and Platelet-to-Lymphocyte Ratio.
    Inflamm Bowel Dis. 2020 Mar 31. pii: 5813970. doi: 10.1093.
    PubMed     Abstract available


  306. PATEL P, Gao G, Gulotta G, Dalal S, et al
    Daily Aspirin Use Does Not Impact Clinical Outcomes in Patients With Inflammatory Bowel Disease.
    Inflamm Bowel Dis. 2020 Mar 27. pii: 5812729. doi: 10.1093.
    PubMed     Abstract available


  307. ORFANOUDAKI E, Foteinogiannopoulou K, Theodoraki E, Koutroubakis IE, et al
    Clinical Value of Proactive Infliximab Drug Monitoring in Patients With Inflammatory Bowel Disease.
    Inflamm Bowel Dis. 2020 Mar 24. pii: 5811190. doi: 10.1093.
    PubMed    


  308. MCCURDY JD, Benchimol EI
    Response to Letter, "Risk of Venous Thromboembolism After Hospital Discharge in Patients With Inflammatory Bowel Disease".
    Inflamm Bowel Dis. 2020 Mar 21. pii: 5810826. doi: 10.1093.
    PubMed    


  309. XIE H, Zeng D, Chen D, Tang W, et al
    Letter to the Editor: Risk of Venous Thromboembolism After Hospital Discharge in Patients With Inflammatory Bowel Disease: A Population-based Study.
    Inflamm Bowel Dis. 2020 Mar 20. pii: 5810369. doi: 10.1093.
    PubMed    


  310. NAYMAGON L, Tremblay D, Zubizarreta N, Moshier E, et al
    The Natural History, Treatments, and Outcomes of Portal Vein Thrombosis in Patients With Inflammatory Bowel Disease.
    Inflamm Bowel Dis. 2020 Mar 18. pii: 5809340. doi: 10.1093.
    PubMed     Abstract available


  311. OSTERMAN MT, Scott FI, Fogt FF, Gilroy ED, et al
    Endoscopic and Histological Assessment, Correlation, and Relapse in Clinically Quiescent Ulcerative Colitis (MARQUEE).
    Inflamm Bowel Dis. 2020 Mar 14. pii: 5805376. doi: 10.1093.
    PubMed     Abstract available


  312. YVELLEZ OV, Rai V, Sossenheimer PH, Hart J, et al
    Cumulative Histologic Inflammation Predicts Colorectal Neoplasia in Ulcerative Colitis: A Validation Study.
    Inflamm Bowel Dis. 2020 Mar 10. pii: 5802337. doi: 10.1093.
    PubMed     Abstract available


  313. BODIWALA V, Marshall T, Das KM, Brant SR, et al
    Comparison of Disease Phenotypes and Clinical Characteristics Among South Asian and White Patients with Inflammatory Bowel Disease at a Tertiary Referral Center.
    Inflamm Bowel Dis. 2020 Mar 7. pii: 5799010. doi: 10.1093.
    PubMed     Abstract available


  314. KARMIRIS K
    Racial Differences in Inflammatory Bowel Disease: A Race With Alternating Winners?
    Inflamm Bowel Dis. 2020 Mar 7. pii: 5799011. doi: 10.1093.
    PubMed    


  315. GEORGE LA, Cross RK
    How Do We Sequence Biologic Therapies in 2019?
    Inflamm Bowel Dis. 2020;26:617-618.
    PubMed    


  316. SYAL G, Melmed GY
    Is It Time For High Dose Influenza Vaccination In Inflammatory Bowel Diseases?
    Inflamm Bowel Dis. 2020;26:603-605.
    PubMed    


  317. ROSH JR
    The Cost of Pediatric IBD Care: How to Best Invest in our Children.
    Inflamm Bowel Dis. 2020;26:641-642.
    PubMed    


  318. LIMKETKAI BN, Gordon M, Mutlu EA, De Silva PS, et al
    Diet Therapy for Inflammatory Bowel Diseases: A Call to the Dining Table.
    Inflamm Bowel Dis. 2020;26:510-514.
    PubMed     Abstract available


  319. BRONSWIJK M, Moens A, Lenfant M, Tops S, et al
    Evaluating Efficacy, Safety, and Pharmacokinetics After Switching From Infliximab Originator to Biosimilar CT-P13: Experience From a Large Tertiary Referral Center.
    Inflamm Bowel Dis. 2020;26:628-634.
    PubMed     Abstract available


  320. JANGI S, Ruan A, Korzenik J, de Silva P, et al
    South Asian Patients With Inflammatory Bowel Disease in the United States Demonstrate More Fistulizing and Perianal Crohn Phenotype.
    Inflamm Bowel Dis. 2020 Mar 2. pii: 5771121. doi: 10.1093.
    PubMed     Abstract available


    February 2020
  321. LIN E, Katz S
    Acute Pancreatitis in a Patient With Ulcerative Colitis on Vedolizumab.
    Inflamm Bowel Dis. 2020 Feb 26. pii: 5758182. doi: 10.1093.
    PubMed    


  322. DAI C, Cao Q, Jiang M
    Risk of Venous Thromboembolism After Hospital Discharge in Patients with Inflammatory Bowel Disease Patients.
    Inflamm Bowel Dis. 2020 Feb 25. pii: 5755895. doi: 10.1093.
    PubMed    


  323. LI H, Tian F
    Toxic Epidermal Necrolysis Because of Various Herpesviruses Infection After Accelerated Infliximab Induction in a Chinese Patient With Acute Severe Ulcerative Colitis.
    Inflamm Bowel Dis. 2020 Feb 22. pii: 5748143. doi: 10.1093.
    PubMed    


  324. LEY D, Martin B, Caldera F
    Use of an iPhone Application to Increase Adherence in Patients With Ulcerative Colitis in Remission: A Randomized Controlled Trial.
    Inflamm Bowel Dis. 2020 Feb 22. pii: 5748139. doi: 10.1093.
    PubMed    


  325. PEVERELLE M, Mills C, Testro A, Gow P, et al
    Letter Re: Safety of Combination Biologic and Antirejection Therapy Post-liver Transplantation in Patients With Inflammatory Bowel Disease.
    Inflamm Bowel Dis. 2020 Feb 20. pii: 5741005. doi: 10.1093.
    PubMed    


  326. OKAMOTO D, Kawai Y, Kakuta Y, Naito T, et al
    Genetic Analysis of Ulcerative Colitis in Japanese Individuals Using Population-specific SNP Array.
    Inflamm Bowel Dis. 2020 Feb 19. pii: 5740361. doi: 10.1093.
    PubMed     Abstract available


  327. HAMDEH S, Aziz M, Altayar O, Olyaee M, et al
    Early vs Late Use of Anti-TNFa Therapy in Adult Patients With Crohn Disease: A Systematic Review and Meta-Analysis.
    Inflamm Bowel Dis. 2020 Feb 17. pii: 5739148. doi: 10.1093.
    PubMed     Abstract available


  328. LAW CCY, Koh D, Bao Y, Jairath V, et al
    Risk of Postoperative Infectious Complications From Medical Therapies in Inflammatory Bowel Disease: A Systematic Review and Meta-Analysis.
    Inflamm Bowel Dis. 2020 Feb 12. pii: 5734556. doi: 10.1093.
    PubMed     Abstract available


  329. PIGNICZKI D, Farkas K, Molnar T
    The Theoretical Scenario Experienced in a Real-Life Case of Ulcerative Colitis and Associated Primary Sclerosing Cholangitis: Case 123.
    Inflamm Bowel Dis. 2020 Feb 11. pii: 5733139. doi: 10.1093.
    PubMed    


  330. LEE TW
    Editorial: Risk of Cancer Development in IBD-Inflammation vs Immunosuppression.
    Inflamm Bowel Dis. 2020;26:460-461.
    PubMed    


  331. BERNSTEIN CN
    Is Antibiotic Use a Cause of IBD Worldwide?
    Inflamm Bowel Dis. 2020;26:448-449.
    PubMed    


  332. GARCIA MJ, Arminanzas C, Rivero M, Ramos M, et al
    Crohn's Disease and Immunosupressive Treatment: Hepatosplenic Lesions as an Atypical Case of Bartonella henselae.
    Inflamm Bowel Dis. 2020;26:e17-e18.
    PubMed    


  333. JUKEMA JB, Brandse JF, de Boer NKH
    Successful Treatment of Oral Crohn's Disease by Ustekinumab.
    Inflamm Bowel Dis. 2020;26:e19.
    PubMed    


  334. SAYOC-BECERRA A, Krishnan M, Fan S, Jimenez J, et al
    The JAK-Inhibitor Tofacitinib Rescues Human Intestinal Epithelial Cells and Colonoids from Cytokine-Induced Barrier Dysfunction.
    Inflamm Bowel Dis. 2020;26:407-422.
    PubMed     Abstract available


  335. JUN X, Ning C, Yang S, Zhe W, et al
    Alteration of Fungal Microbiota After 5-ASA Treatment in UC Patients.
    Inflamm Bowel Dis. 2020;26:380-390.
    PubMed     Abstract available


  336. CORDES F, Lenker E, Spille LJ, Weinhage T, et al
    Tofacitinib Reprograms Human Monocytes of IBD Patients and Healthy Controls Toward a More Regulatory Phenotype.
    Inflamm Bowel Dis. 2020;26:391-406.
    PubMed     Abstract available


  337. VASUDEVAN A, Ip F, Liew D, van Langenberg DR, et al
    The Cost-effectiveness of Initial Immunomodulators or Infliximab Using Modern Optimization Strategies for Crohn's Disease in the Biosimilar Era.
    Inflamm Bowel Dis. 2020;26:369-379.
    PubMed     Abstract available


  338. GAINES LS, Slaughter JC, Schwartz DA, Beaulieu DB, et al
    Does Reverse Causality Underlie the Temporal Relationship Between Depression and Crohn's Disease?
    Inflamm Bowel Dis. 2020;26:423-428.
    PubMed     Abstract available


  339. EL-DALLAL M, Chen Y, Lin Q, Rakowsky S, et al
    Meta-analysis of Virtual-based Chromoendoscopy Compared With Dye-spraying Chromoendoscopy Standard and High-definition White Light Endoscopy in Patients With Inflammatory Bowel Disease at Increased Risk of Colon Cancer.
    Inflamm Bowel Dis. 2020 Feb 8. pii: 5731339. doi: 10.1093.
    PubMed     Abstract available


  340. KORNBLUTH A
    Histologic Healing in Ulcerative Colitis: Benefits. And Risks. Was Voltaire Right?
    Inflamm Bowel Dis. 2020 Feb 7. pii: 5729887. doi: 10.1093.
    PubMed    


  341. CARNEY H, Marrie RA, Bolton JM, Patten SB, et al
    Prevalence and Risk Factors of Substance Use Disorder in Inflammatory Bowel Disease.
    Inflamm Bowel Dis. 2020 Feb 6. pii: 5728525. doi: 10.1093.
    PubMed     Abstract available


  342. PENG Y, Thomas AS, Wei D, Tan D, et al
    An Aggressive Approach Toward a Case of Refractory Ulcerative Colitis With Uncertain Etiology in the Context of Chronic Myeloid Leukemia.
    Inflamm Bowel Dis. 2020 Feb 4. pii: 5721970. doi: 10.1093.
    PubMed    


  343. JABANDZIEV P, Bohosova J, Pinkasova T, Kunovsky L, et al
    The Emerging Role of Noncoding RNAs in Pediatric Inflammatory Bowel Disease.
    Inflamm Bowel Dis. 2020 Feb 3. pii: 5721205. doi: 10.1093.
    PubMed     Abstract available


    January 2020
  344. MCCURDY JD, Kuenzig ME, Smith G, Spruin S, et al
    Risk of Venous Thromboembolism After Hospital Discharge in Patients With Inflammatory Bowel Disease: A Population-based Study.
    Inflamm Bowel Dis. 2020 Jan 29. pii: 5717328. doi: 10.1093.
    PubMed     Abstract available


  345. BAFFORD AC, Cross RK
    Risk of Venous Thromboembolism in Patients with Inflammatory Bowel Disease Extends beyond Hospitalization.
    Inflamm Bowel Dis. 2020 Jan 29. pii: 5717307. doi: 10.1093.
    PubMed    


  346. SZANTO KJ, Rutka M, Pigniczki D, Farkas K, et al
    Serological Status of Inflammatory Bowel Disease Patients Before Starting Biological Therapy - Data From a Tertiary Centre of the Best Vaccined Country.
    Inflamm Bowel Dis. 2020 Jan 24. pii: 5715025. doi: 10.1093.
    PubMed    


  347. MARTINELLI M, Miele E
    Implementation and Widespread of Inflammatory Bowel Disease Vaccination and Immunization Guidelines: Not an Easy Task.
    Inflamm Bowel Dis. 2020 Jan 24. pii: 5715024. doi: 10.1093.
    PubMed    


  348. LEE AA, Rao K, Limsrivilai J, Gillilland M, et al
    Temporal Gut Microbial Changes Predict Recurrent Clostridiodes Difficile Infection in Patients With and Without Ulcerative Colitis.
    Inflamm Bowel Dis. 2020 Jan 23. pii: 5714595. doi: 10.1093.
    PubMed     Abstract available


  349. COLLINS SM
    Interrogating the Gut-Brain Axis in the Context of Inflammatory Bowel Disease: A Translational Approach.
    Inflamm Bowel Dis. 2020 Jan 22. pii: 5714219. doi: 10.1093.
    PubMed     Abstract available


  350. HOU G, Bishu S
    Th17 Cells in Inflammatory Bowel Disease: An Update for the Clinician.
    Inflamm Bowel Dis. 2020 Jan 22. pii: 5714220. doi: 10.1093.
    PubMed    


  351. CONRAD MA, Kelsen JR
    Editorial to Temporal Gut Microbial Changes Predict Recurrent Clostridium difficile Infection in Patients With and Without Ulcerative Colitis.
    Inflamm Bowel Dis. 2020 Jan 22. pii: 5714218. doi: 10.1093.
    PubMed    


  352. GUPTA N, Liu C, King E, Sylvester F, et al
    Continued Statural Growth in Older Adolescents and Young Adults With Crohn's Disease and Ulcerative Colitis Beyond the Time of Expected Growth Plate Closure.
    Inflamm Bowel Dis. 2020 Jan 22. pii: 5714217. doi: 10.1093.
    PubMed     Abstract available


  353. PRATHAPAN KM, Ramos Rivers C, Anderson A, Koutroumpakis F, et al
    Peripheral Blood Eosinophilia and Long-term Severity in Pediatric-Onset Inflammatory Bowel Disease.
    Inflamm Bowel Dis. 2020 Jan 21. pii: 5711281. doi: 10.1093.
    PubMed     Abstract available


  354. GUBATAN J, Mehigan GA, Villegas F, Mitsuhashi S, et al
    Cathelicidin Mediates a Protective Role of Vitamin D in Ulcerative Colitis and Human Colonic Epithelial Cells.
    Inflamm Bowel Dis. 2020 Jan 18. pii: 5709590. doi: 10.1093.
    PubMed     Abstract available


  355. DIN H, Anderson AJ, Ramos Rivers C, Proksell S, et al
    Disease Characteristics and Severity in Patients With Inflammatory Bowel Disease With Coexistent Diabetes Mellitus.
    Inflamm Bowel Dis. 2020 Jan 16. pii: 5707489. doi: 10.1093.
    PubMed     Abstract available


  356. MARTINELLI M, Miele E
    Evaluation of EBV Status and Thiopurine Use in Pediatric Inflammatory Bowel Disease: Time to be a Standard of Care.
    Inflamm Bowel Dis. 2020 Jan 16. pii: 5707490. doi: 10.1093.
    PubMed    


  357. EL-MATARY W
    Routine Testing for EBV Status in Children With Inflammatory Bowel Disease: Are We Overreacting?
    Inflamm Bowel Dis. 2020 Jan 16. pii: 5707482. doi: 10.1093.
    PubMed    


  358. KATINIOS G, Casado-Bedmar M, Walter SA, Vicario M, et al
    Increased Colonic Epithelial Permeability and Mucosal Eosinophilia in Ulcerative Colitis in Remission Compared With Irritable Bowel Syndrome and Health.
    Inflamm Bowel Dis. 2020 Jan 16. pii: 5707481. doi: 10.1093.
    PubMed     Abstract available


  359. PEVERELLE M, Paleri S, Hughes J, De Cruz P, et al
    Activity of Inflammatory Bowel Disease After Liver Transplantation for Primary Sclerosing Cholangitis Predicts Poorer Clinical Outcomes.
    Inflamm Bowel Dis. 2020 Jan 16. pii: 5707461. doi: 10.1093.
    PubMed     Abstract available


  360. WONG U, Cross RK
    Are Inflammatory Bowel Disease Patients With Diabetes Mellitus at Increased Risk for Poor Outcomes Including Greater Health Care Utilization?
    Inflamm Bowel Dis. 2020 Jan 16. pii: 5707487. doi: 10.1093.
    PubMed    


  361. PERRY C, Kapur N, Barrett TA
    DDP-4 as a Novel Biomarker for Inflammatory Bowel Disease: Is It Ready for Clinical Use?
    Inflamm Bowel Dis. 2020 Jan 8. pii: 5698302. doi: 10.1093.
    PubMed    


  362. PINTO-LOPES P, Afonso J, Pinto-Lopes R, Rocha C, et al
    Serum Dipeptidyl Peptidase 4: A Predictor of Disease Activity and Prognosis in Inflammatory Bowel Disease.
    Inflamm Bowel Dis. 2020 Jan 8. pii: 5698249. doi: 10.1093.
    PubMed     Abstract available


  363. ROOSENBOOM B, van Lochem EG, Smids C, Groenen MJM, et al
    Analysis of Intestinal T-Cell Subsets in Inflammatory Bowel Disease.
    Inflamm Bowel Dis. 2020;26:e13.
    PubMed    


  364. BAUER CM, Younis A, Herfarth H, Barnes EL, et al
    Response to Infliximab After Loss of Response to Adalimumab in Crohn's Disease.
    Inflamm Bowel Dis. 2020;26:e5.
    PubMed    


  365. CASANOVA MJ, Chaparro M, Gisbert JP
    Response to the Letter to the Editor: "Response to Infliximab After Loss of Response to Adalimumab in Crohn's Disease".
    Inflamm Bowel Dis. 2020;26:e6.
    PubMed    


  366. BARNES EL
    Opportunistic Infections and Opportunities for Action.
    Inflamm Bowel Dis. 2020;26:301-303.
    PubMed    


  367. ANNESE V
    TDM of Anti-TNF Agents: The Importance of Being Active!
    Inflamm Bowel Dis. 2020;26:271-272.
    PubMed    


  368. CHANG S, Hamilton M, Lees C, Atreja A, et al
    Mobile Health in IBD: Enhancing Care, One Phone at a Time.
    Inflamm Bowel Dis. 2020;26:163-166.
    PubMed    


  369. WANDERS LK, Cordes M, Voorham Q, Sie D, et al
    IBD-Associated Dysplastic Lesions Show More Chromosomal Instability Than Sporadic Adenomas.
    Inflamm Bowel Dis. 2020;26:167-180.
    PubMed     Abstract available


  370. KARUPPUCHAMY T, Tyler CJ, Lundborg LR, Perez-Jeldres T, et al
    Sphingosine-1-Phosphate Lyase Inhibition Alters the S1P Gradient and Ameliorates Crohn's-Like Ileitis by Suppressing Thymocyte Maturation.
    Inflamm Bowel Dis. 2020;26:216-228.
    PubMed     Abstract available


  371. WANG X, Bootsma H, Kroese F, Dijkstra G, et al
    Senescent Stem and Transient Amplifying Cells in Crohn's Disease Intestine.
    Inflamm Bowel Dis. 2020;26:e8-e9.
    PubMed    


  372. LEWIS JD, Rutgeerts P, Feagan BG, D'haens G, et al
    Correlation of Stool Frequency and Abdominal Pain Measures With Simple Endoscopic Score for Crohn's Disease.
    Inflamm Bowel Dis. 2020;26:304-313.
    PubMed     Abstract available


  373. EGBERG MD, Galanko JA, Kappelman MD
    Weekend Surgical Admissions of Pediatric IBD Patients Have a Higher Risk of Complication in Hospitals Across the US.
    Inflamm Bowel Dis. 2020;26:254-260.
    PubMed     Abstract available


  374. LAURETI S, Gionchetti P, Cappelli A, Vittori L, et al
    Refractory Complex Crohn's Perianal Fistulas: A Role for Autologous Microfragmented Adipose Tissue Injection.
    Inflamm Bowel Dis. 2020;26:321-330.
    PubMed     Abstract available


  375. MORAES L, Magnusson MK, Mavroudis G, Polster A, et al
    Systemic Inflammatory Protein Profiles Distinguish Irritable Bowel Syndrome (IBS) and Ulcerative Colitis, Irrespective of Inflammation or IBS-Like Symptoms.
    Inflamm Bowel Dis. 2020 Jan 4. pii: 5696669. doi: 10.1093.
    PubMed     Abstract available


  376. YU A, Friedman S, Ananthakrishnan AN
    Incidence and Predictors of Flares in the Postpartum Year Among Women With Inflammatory Bowel Disease.
    Inflamm Bowel Dis. 2020 Jan 2. pii: 5694104. doi: 10.1093.
    PubMed     Abstract available


  377. KUROWSKI JA, Achkar JP
    Underutilization of Combination Anti-TNF Therapy in Population-based Study.
    Inflamm Bowel Dis. 2020;26:158-159.
    PubMed    


  378. DE FELICE KM
    Patients Perception of Risks and Benefits of Biologic Therapy.
    Inflamm Bowel Dis. 2020;26:147-149.
    PubMed     Abstract available


  379. FRANCO DL, Click B
    Proactive Versus Reactive Therapeutic Drug Monitoring of Infliximab in Crohn's Disease: Is the Juice Worth the Squeeze?
    Inflamm Bowel Dis. 2020;26:112-113.
    PubMed    


  380. SILVA JC, Rodrigues A, Carvalho J
    Spontaneous Resolution of Enterocutaneous Fistula After Disseminated Tuberculosis Treatment in a Patient With Crohn's Disease: Challenges in Biologic Therapy.
    Inflamm Bowel Dis. 2020;26:e1-e2.
    PubMed    


  381. CHIBA M, Tsuji T, Nakane K, Obara Y, et al
    Swift Efficacy with Infliximab 4 Years after Initial Standard Induction Therapy Followed by Severe Delayed Infusion Reaction in Crohn's Disease.
    Inflamm Bowel Dis. 2020;26:e4.
    PubMed    


  382. SHANKAR U, Vijayasekar K, Bansal R, Walfish A, et al
    Treatment of Rituximab-induced Crohn's Disease With Ustekinumab Induction and Long-term Maintenance of Remission.
    Inflamm Bowel Dis. 2020;26:e3.
    PubMed    


  383. FAHAD H, Abu-Elmagd K, Lashner B, Fiocchi C, et al
    Recurrence of Crohn's Disease After Small Bowel Transplantation: Fact or Fiction.
    Inflamm Bowel Dis. 2020;26:21-23.
    PubMed     Abstract available


  384. YU Y, Yang W, Li Y, Cong Y, et al
    Enteroendocrine Cells: Sensing Gut Microbiota and Regulating Inflammatory Bowel Diseases.
    Inflamm Bowel Dis. 2020;26:11-20.
    PubMed     Abstract available


  385. WILSON R, Gundamaraju R, Vemuri R, Angelucci C, et al
    Identification of Key Pro-Survival Proteins in Isolated Colonic Goblet Cells of Winnie, a Murine Model of Spontaneous Colitis.
    Inflamm Bowel Dis. 2020;26:80-92.
    PubMed     Abstract available


  386. ELIAS ED, Targownik LE, Singh H, Bernstein CN, et al
    A Population-Based Study of Combination vs Monotherapy of Anti-TNF in Persons With IBD.
    Inflamm Bowel Dis. 2020;26:150-157.
    PubMed     Abstract available


  387. KOLIANI-PACE JL, Haron AM, Zisman-Ilani Y, Thompson KD, et al
    Patients' Perceive Biologics to Be Riskier and More Dreadful Than Other IBD Medications.
    Inflamm Bowel Dis. 2020;26:141-146.
    PubMed     Abstract available


  388. STOLZER I, Kaden-Volynets V, Ruder B, Letizia M, et al
    Environmental Microbial Factors Determine the Pattern of Inflammatory Lesions in a Murine Model of Crohn's Disease-Like Inflammation.
    Inflamm Bowel Dis. 2020;26:66-79.
    PubMed     Abstract available


  389. CHRISTIAN KE, Russman KM, Rajan DP, Barr EA, et al
    Gender Differences and Other Factors Associated with Weight Gain Following Initiation of Infliximab: A Post Hoc Analysis of Clinical Trials.
    Inflamm Bowel Dis. 2020;26:125-131.
    PubMed     Abstract available


  390. WINTER RW, Friedman S
    Understanding the Cause of Weight Gain in Patients With IBD on Anti-TNF Medications.
    Inflamm Bowel Dis. 2020;26:132-133.
    PubMed    


  391. NEGOESCU DM, Enns EA, Swanhorst B, Baumgartner B, et al
    Proactive Vs Reactive Therapeutic Drug Monitoring of Infliximab in Crohn's Disease: A Cost-Effectiveness Analysis in a Simulated Cohort.
    Inflamm Bowel Dis. 2020;26:103-111.
    PubMed     Abstract available


  392. PASHA SF, Pennazio M, Rondonotti E, Wolf D, et al
    Capsule Retention in Crohn's Disease: A Meta-analysis.
    Inflamm Bowel Dis. 2020;26:33-42.
    PubMed     Abstract available


    December 2019
  393. DAI C, Jiang M, Sun MJ
    Disease Duration and the Risk of Treatment Failure in Biologic-Treated Patients with Ulcerative Colitis.
    Inflamm Bowel Dis. 2019 Dec 30. pii: 5690100. doi: 10.1093.
    PubMed    


  394. KEVANS D, Kirsch R, Dargavel C, Kabakchiev B, et al
    Histological Markers of Clinical Relapse in Endoscopically Quiescent Ulcerative Colitis.
    Inflamm Bowel Dis. 2019 Dec 28. pii: 5688912. doi: 10.1093.
    PubMed     Abstract available


  395. ESCUDERO-HERNANDEZ C, Montalvillo E, Antolin B, Bernardo D, et al
    Different Intraepithelial CD3+ Cell Numbers in Crohn's Disease and Ulcerative Colitis.
    Inflamm Bowel Dis. 2019 Dec 28. pii: 5688873. doi: 10.1093.
    PubMed    


  396. FAYE AS, Oh A, Kumble LD, Kiran RP, et al
    Fertility Impact of Initial Operation Type for Female Ulcerative Colitis Patients.
    Inflamm Bowel Dis. 2019 Dec 27. pii: 5688242. doi: 10.1093.
    PubMed     Abstract available


  397. KUENZIG ME, Hawken S, Wilson K, Talarico R, et al
    Serum Newborn Screening Blood Metabolites Are not Associated With Childhood-onset Inflammatory Bowel Disease: A Population-based Matched Case-control Study.
    Inflamm Bowel Dis. 2019 Dec 12. pii: 5674034. doi: 10.1093.
    PubMed     Abstract available


  398. CHEN LA
    Intestinal Microbiota Transplantation for Patients With Inflammatory Bowel Disease Prevents Recurrence of C. difficile Infections but Not Recurrence of Gastrointestinal Symptoms.
    Inflamm Bowel Dis. 2019 Dec 10. pii: 5673070. doi: 10.1093.
    PubMed    


  399. TARIQ R, Disbrow MB, Dibaise JK, Orenstein R, et al
    Efficacy of Fecal Microbiota Transplantation for Recurrent C. Difficile Infection in Inflammatory Bowel Disease.
    Inflamm Bowel Dis. 2019 Dec 9. pii: 5673067. doi: 10.1093.
    PubMed     Abstract available


  400. POUILLON L, Hoefkens E, Verheyen V, Bronswijk M, et al
    Letter to the Editor: Feasibility and Efficiency of an E-Health Preadmission Assessment System for Intravenous Therapy in Inflammatory Bowel Disease.
    Inflamm Bowel Dis. 2019 Dec 3. pii: 5650900. doi: 10.1093.
    PubMed    


  401. YANG B, Liu X, Mei Q
    HMGB1-Positive Platelet Microparticles May Be a Biomarker of Inflammatory Bowel Disease.
    Inflamm Bowel Dis. 2019 Dec 3. pii: 5650909. doi: 10.1093.
    PubMed    



  402. Corrigendum to A Diagnosis of Inflammatory Bowel Disease and Access to Psychotherapy: Rural Patients Who Accept Treatment Report Psychosomatic Benefits.
    Inflamm Bowel Dis. 2019 Dec 3. pii: 5650796. doi: 10.1093.
    PubMed    


  403. OUAHED J, Spencer E, Kotlarz D, Shouval DS, et al
    Very Early Onset Inflammatory Bowel Disease: A Clinical Approach With a Focus on the Role of Genetics and Underlying Immune Deficiencies.
    Inflamm Bowel Dis. 2019 Dec 3. pii: 5675340. doi: 10.1093.
    PubMed     Abstract available


    November 2019
  404. CHENG J, Shen H, Chowdhury R, Abdi T, et al
    Potential of Electrical Neuromodulation for Inflammatory Bowel Disease.
    Inflamm Bowel Dis. 2019 Nov 29. pii: 5648005. doi: 10.1093.
    PubMed     Abstract available


  405. JODELEIT H, Caesar J, Villarroel Aguilera C, Sterz S, et al
    The Combination of Patient Profiling and Preclinical Studies in a Mouse Model Based on NOD/Scid IL2Rgamma null Mice Reconstituted With Peripheral Blood Mononuclear Cells From Patients With Ulcerative Colitis May Lead to Stratification of Patients for
    Inflamm Bowel Dis. 2019 Nov 29. pii: 5648003. doi: 10.1093.
    PubMed     Abstract available


  406. CHATEAU T, Peyrin-Biroulet L
    Two Cases of Inflammatory Bowel Disease Patients Treated With Ustekinumab 90 mg Every 3 Weeks.
    Inflamm Bowel Dis. 2019 Nov 26. pii: 5643743. doi: 10.1093.
    PubMed    


  407. CHANDRAKUMAR A, Zohni H, El-Matary W
    Clostridioides difficile Infection in Children With Inflammatory Bowel Disease.
    Inflamm Bowel Dis. 2019 Nov 25. pii: 5643019. doi: 10.1093.
    PubMed     Abstract available


  408. BASSON AR, Gomez-Nguyen A, Menghini P, Butto LF, et al
    Human Gut Microbiome Transplantation in Ileitis Prone Mice: A Tool for the Functional Characterization of the Microbiota in Inflammatory Bowel Disease Patients.
    Inflamm Bowel Dis. 2019 Nov 21. pii: 5637456. doi: 10.1093.
    PubMed     Abstract available


  409. NGUYEN NH, Kurnool S, Dulai PS, Boland BS, et al
    Short Disease Duration Is Associated With Increased Risk of Treatment Failure in Biologic-Treated Patients With Ulcerative Colitis.
    Inflamm Bowel Dis. 2019 Nov 21. pii: 5636894. doi: 10.1093.
    PubMed     Abstract available


  410. MARCIL V, Levy E, Amre D, Bitton A, et al
    Erratum: A Cross-Sectional Study on Malnutrition in Inflammatory Bowel Disease: Is There a Difference Based on Pediatric or Adult Age Grouping?
    Inflamm Bowel Dis. 2019 Nov 20. pii: 5634260. doi: 10.1093.
    PubMed    


  411. THAKUR ER, Sansgiry S, Kramer JR, Waljee AK, et al
    The Incidence and Prevalence of Anxiety, Depression, and Post-traumatic Stress Disorder in a National Cohort of US Veterans With Inflammatory Bowel Disease.
    Inflamm Bowel Dis. 2019 Nov 15. pii: 5625871. doi: 10.1093.
    PubMed     Abstract available


  412. HANSEN TM, Sabourin BC, Oketola B, Bernstein CN, et al
    Cannabis Use in Persons With Inflammatory Bowel Disease and Vulnerability to Substance Misuse.
    Inflamm Bowel Dis. 2019 Nov 14. pii: 5625670. doi: 10.1093.
    PubMed     Abstract available


  413. SHMIDT E, Saha S, Sands BE
    Reply to Letter to the Editor of Dr. Lai and Colleagues.
    Inflamm Bowel Dis. 2019;25:e166.
    PubMed    


  414. FAYE AS, Hung KW, Cheng K, Blackett JW, et al
    Minor Hematochezia Decreases Use of Venous Thromboembolism Prophylaxis in Patients with Inflammatory Bowel Disease.
    Inflamm Bowel Dis. 2019 Nov 5. pii: 5613524. doi: 10.1093.
    PubMed     Abstract available


  415. MARTINELLI M, Giugliano FP, Strisciuglio C, Urbonas V, et al
    Vaccinations and Immunization Status in Pediatric Inflammatory Bowel Disease: A Multicenter Study From the Pediatric IBD Porto Group of the ESPGHAN.
    Inflamm Bowel Dis. 2019 Nov 5. pii: 5613525. doi: 10.1093.
    PubMed     Abstract available


  416. LOPETUSO LR, Gasbarrini A
    Fighting the Hype for Predictors of Efficacy in Inflammatory Bowel Disease.
    Inflamm Bowel Dis. 2019 Nov 5. pii: 5613523. doi: 10.1093.
    PubMed    


  417. VADSTRUP K, Alulis S, Borsi A, Gustafsson N, et al
    Cost Burden of Crohn's Disease and Ulcerative Colitis in the 10-Year Period Before Diagnosis-A Danish Register-Based Study From 2003-2015.
    Inflamm Bowel Dis. 2019 Nov 4. pii: 5613986. doi: 10.1093.
    PubMed     Abstract available


  418. DE JONG ME, Gillis VELM, Derikx LAAP, Hoentjen F, et al
    No Increased Risk of Colorectal Neoplasia in Patients With Inflammatory Bowel Disease and Postinflammatory Polyps.
    Inflamm Bowel Dis. 2019 Nov 2. pii: 5611176. doi: 10.1093.
    PubMed     Abstract available


    October 2019
  419. SHAH NB, Haydek J, Slaughter J, Ashton JR, et al
    Risk Factors for Medication Nonadherence to Self-Injectable Biologic Therapy in Adult Patients With Inflammatory Bowel Disease.
    Inflamm Bowel Dis. 2019 Oct 31. pii: 5610710. doi: 10.1093.
    PubMed     Abstract available


  420. CLICK B, Lopez R, Arrigain S, Schold J, et al
    Shifting Cost-drivers of Health Care Expenditures in Inflammatory Bowel Disease.
    Inflamm Bowel Dis. 2019 Oct 31. pii: 5610752. doi: 10.1093.
    PubMed     Abstract available


  421. TRUTA B, Leeds IL, Canner JK, Efron JE, et al
    Early Discontinuation of Infliximab in Pregnant Women With Inflammatory Bowel Disease.
    Inflamm Bowel Dis. 2019 Oct 31. pii: 5610578. doi: 10.1093.
    PubMed     Abstract available


  422. GU P, Feagins LA
    Dining With Inflammatory Bowel Disease: A Review of the Literature on Diet in the Pathogenesis and Management of IBD.
    Inflamm Bowel Dis. 2019 Oct 31. pii: 5610412. doi: 10.1093.
    PubMed     Abstract available


  423. AL DRAIWEESH S, Ma C, Alkhattabi M, McDonald C, et al
    Safety of Combination Biologic and Antirejection Therapy Post-Liver Transplantation in Patients With Inflammatory Bowel Disease.
    Inflamm Bowel Dis. 2019 Oct 28. pii: 5608313. doi: 10.1093.
    PubMed     Abstract available


  424. MCCOMBIE A, Walmsley R, Barclay M, Ho C, et al
    A Noninferiority Randomized Clinical Trial of the Use of the Smartphone-Based Health Applications IBDsmart and IBDoc in the Care of Inflammatory Bowel Disease Patients.
    Inflamm Bowel Dis. 2019 Oct 23. pii: 5603780. doi: 10.1093.
    PubMed     Abstract available


  425. CALVET X, Saldana R, Carpio D, Minguez M, et al
    Improving Quality of Care in Inflammatory Bowel Disease Through Patients' Eyes: IQCARO Project.
    Inflamm Bowel Dis. 2019 Oct 21. pii: 5571234. doi: 10.1093.
    PubMed     Abstract available


  426. BARNES EL, Jiang Y, Kappelman MD, Long MD, et al
    Decreasing Colectomy Rate for Ulcerative Colitis in the United States Between 2007 and 2016: A Time Trend Analysis.
    Inflamm Bowel Dis. 2019 Oct 21. pii: 5601649. doi: 10.1093.
    PubMed     Abstract available


  427. HAAC BE, Nemirovsky A, Teeter W, Geyer A, et al
    Injury Characteristics and Outcomes of Patients With Inflammatory Bowel Disease After Trauma: A Propensity Score Matched Analysis.
    Inflamm Bowel Dis. 2019 Oct 21. pii: 5601417. doi: 10.1093.
    PubMed     Abstract available


  428. GROSSI V, Hyams JS, Glidden NC, Knight BE, et al
    Characterizing Clinical Features and Creating a Gene Expression Profile Associated With Pain Burden in Children With Inflammatory Bowel Disease.
    Inflamm Bowel Dis. 2019 Oct 18. pii: 5599699. doi: 10.1093.
    PubMed     Abstract available


  429. KRISTENSEN MS, Kjaerulff TM, Ersboll AK, Green A, et al
    Erratum: The Influence of Antidepressants on the Disease Course Among Patients With Crohn's Disease and Ulcerative Colitis-A Danish Nationwide Register-Based Cohort Study.
    Inflamm Bowel Dis. 2019;25:e152.
    PubMed    


  430. WANG MH, Mousa OY, Friton JJ, Raffals LE, et al
    Unique Phenotypic Characteristics and Clinical Course in Patients With Ulcerative Colitis and Primary Sclerosing Cholangitis: A Multicenter US Experience.
    Inflamm Bowel Dis. 2019 Oct 18. pii: 5593848. doi: 10.1093.
    PubMed     Abstract available


  431. VAN DER HAVE M, Oldenburg B
    Is Ulcerative Colitis Associated With Primary Sclerosing Cholangitis an Undertreated Condition?
    Inflamm Bowel Dis. 2019 Oct 18. pii: 5598454. doi: 10.1093.
    PubMed    


  432. SINGH A, Koenen B, Kirby DF
    Bariatric Surgery and Its Complications in Inflammatory Bowel Disease Patients.
    Inflamm Bowel Dis. 2019 Oct 18. pii: 5598917. doi: 10.1093.
    PubMed     Abstract available


  433. KANE S
    Contraception and Antibiotics.
    Inflamm Bowel Dis. 2019;25:e148.
    PubMed    


  434. MIRJALALI H, Shahrokh S, Asadzadeh Aghdaei H, Zali MR, et al
    Letter to the Editor: Activated Toxoplasma May Attenuate the Effect of Azathioprine and Deteriorate the Symptoms in IBD Patients via mTORC1 Manipulation.
    Inflamm Bowel Dis. 2019;25:e137.
    PubMed    


  435. EISENSTEIN S, Holubar SD, Hilbert N, Bordeianou L, et al
    The ACS National Surgical Quality Improvement Program-Inflammatory Bowel Disease Collaborative: Design, Implementation, and Validation of a Disease-specific Module.
    Inflamm Bowel Dis. 2019 Oct 17. pii: 5589173. doi: 10.1093.
    PubMed     Abstract available


  436. LAI SW, Kuo YH, Fang CW, Liao KF, et al
    Inflammatory Bowel Disease and the Risk of Erectile Dysfunction.
    Inflamm Bowel Dis. 2019 Oct 17. pii: 5589171. doi: 10.1093.
    PubMed    


  437. WATT P
    Recommendations for the Provision of Psychological Support in a Rural Inflammatory Bowel Disease Clinic.
    Inflamm Bowel Dis. 2019 Oct 17. pii: 5589169. doi: 10.1093.
    PubMed    


  438. NETO MBB, Gregory MH, Ramos GP, Bazerbachi F, et al
    Impact of Bariatric Surgery on the Long-term Disease Course of Inflammatory Bowel Disease.
    Inflamm Bowel Dis. 2019 Oct 15. pii: 5588067. doi: 10.1093.
    PubMed     Abstract available


  439. KAFIL TS, Nguyen TM, MacDonald JK, Chande N, et al
    Cannabis for the Treatment of Crohn's Disease and Ulcerative Colitis: Evidence From Cochrane Reviews.
    Inflamm Bowel Dis. 2019 Oct 15. pii: 5588062. doi: 10.1093.
    PubMed     Abstract available


  440. LAI SW, Kuo YH, Liao KF
    Cancer Risk in Inflammatory Bowel Disease.
    Inflamm Bowel Dis. 2019 Oct 14. pii: 5587055. doi: 10.1093.
    PubMed    


  441. SCHOFIELD JB, Haboubi N
    Histopathological Mimics of Inflammatory Bowel Disease.
    Inflamm Bowel Dis. 2019 Oct 10. pii: 5584939. doi: 10.1093.
    PubMed     Abstract available


  442. KRISHNA M, Salako A, Fofanova T, Kellermayer R, et al
    Parental Education May Differentially Impact Pediatric Inflammatory Bowel Disease Phenotype Risk.
    Inflamm Bowel Dis. 2019 Oct 6. pii: 5581966. doi: 10.1093.
    PubMed     Abstract available


  443. DAY AS
    Re: Parental Education May Differentially Modulate Pediatric Inflammatory Bowel Disease Phenotype Risk.
    Inflamm Bowel Dis. 2019 Oct 6. pii: 5581964. doi: 10.1093.
    PubMed    


  444. NARDONE OM, Shivaji UN, Ferruzza V, Ghosh S, et al
    Soluble Blood Markers of Mucosal Healing in Inflammatory Bowel Disease: The Future of Noninvasive Monitoring.
    Inflamm Bowel Dis. 2019 Oct 6. pii: 5581902. doi: 10.1093.
    PubMed     Abstract available


  445. KAYAL M, Plietz M, Rizvi A, Radcliffe M, et al
    Inflammatory Pouch Conditions Are Common After Ileal Pouch Anal Anastomosis in Ulcerative Colitis Patients.
    Inflamm Bowel Dis. 2019 Oct 6. pii: 5581903. doi: 10.1093.
    PubMed     Abstract available


    September 2019
  446. DANILUK U, Daniluk J, Ciborowski M
    Reply to Letter to the Editor of Dr. Sitkin et al., Regarding "Altered Sphingolipid Metabolism and its Interaction With the Intestinal Microbiome is Another Key to the Pathogenesis of Inflammatory Bowel Disease".
    Inflamm Bowel Dis. 2019 Sep 27. pii: 5574842. doi: 10.1093.
    PubMed    


  447. SITKIN S, Demyanova E, Vakhitov T, Pokrotnieks J, et al
    Altered Sphingolipid Metabolism and its Interaction With the Intestinal Microbiome Is Another Key to the Pathogenesis of Inflammatory Bowel Disease.
    Inflamm Bowel Dis. 2019 Sep 27. pii: 5574840. doi: 10.1093.
    PubMed    


  448. CHANDE N, Costello SP, Limketkai BN, Parker CE, et al
    Alternative and Complementary Approaches for the Treatment of Inflammatory Bowel Disease: Evidence From Cochrane Reviews.
    Inflamm Bowel Dis. 2019 Sep 27. pii: 5574841. doi: 10.1093.
    PubMed    


  449. MOSER T, Bubel NE, Machegger L, Pikija S, et al
    Cerebral Vasculitis in Crohn's Disease: Always a Complication of Inflammatory Bowel Disease or Tumor Necrosis Factor-Alpha Inhibition?
    Inflamm Bowel Dis. 2019 Sep 27. pii: 5574838. doi: 10.1093.
    PubMed    


  450. KELSEN JR, Conrad MA, Dawany N, Patel T, et al
    The Unique Disease Course of Children with Very Early onset-Inflammatory Bowel Disease.
    Inflamm Bowel Dis. 2019 Sep 27. pii: 5575070. doi: 10.1093.
    PubMed     Abstract available


  451. GIRON F, Pasto A, Tasciotti E, Abraham BP, et al
    Nanotechnology in the Treatment of Inflammatory Bowel Disease.
    Inflamm Bowel Dis. 2019 Sep 27. pii: 5574918. doi: 10.1093.
    PubMed     Abstract available


  452. LONG MD, Smith TW, Dibonaventura M, Gruben D, et al
    Real-world Effectiveness of Advanced Therapies Among Patients With Moderate to Severe Ulcerative Colitis in the United States.
    Inflamm Bowel Dis. 2019 Sep 27. pii: 5574848. doi: 10.1093.
    PubMed     Abstract available


  453. ABU-SBEIH H, Wang Y
    Management Considerations for Immune Checkpoint Inhibitor-Induced Enterocolitis Based on Management of Inflammatory Bowel Disease.
    Inflamm Bowel Dis. 2019 Sep 27. pii: 5574910. doi: 10.1093.
    PubMed     Abstract available


  454. NGUYEN GC, Low D, Chong RY, Diong C, et al
    Utilization of Diagnostic Imaging and Ionization Radiation Exposure Among an Inflammatory Bowel Disease Inception Cohort.
    Inflamm Bowel Dis. 2019 Sep 27. pii: 5574895. doi: 10.1093.
    PubMed     Abstract available


  455. CHIBA M, Nakane K, Abe H, Komatsu M, et al
    Onset of Ulcerative Colitis in a Patient with Nonalcoholic Fatty Liver Disease (NAFLD): Dramatic Effect of Plant-based Diet for NAFLD.
    Inflamm Bowel Dis. 2019 Sep 27. pii: 5574851. doi: 10.1093.
    PubMed     Abstract available


  456. CLARKE WT, Papamichael K, Casteele NV, Germansky KA, et al
    Infliximab and Adalimumab Concentrations May Vary Between the Enzyme-Linked Immunosorbent Assay and the Homogeneous Mobility Shift Assay in Patients With Inflammatory Bowel Disease: A Prospective Cross-Sectional Observational Study.
    Inflamm Bowel Dis. 2019 Sep 27. pii: 5574728. doi: 10.1093.
    PubMed    


  457. VAN DE VEN SEM, Derikx LAAP, Nagtegaal ID, van Herpen CM, et al
    Laryngeal Carcinoma in Patients With Inflammatory Bowel Disease: Clinical Outcomes and Risk Factors.
    Inflamm Bowel Dis. 2019 Sep 27. pii: 5574717. doi: 10.1093.
    PubMed     Abstract available


  458. BOLAND K, Greener T, Kabakchiev B, Stempak J, et al
    Identification of Target Golimumab Levels in Maintenance Therapy of Crohn's Disease and Ulcerative Colitis Associated With Mucosal Healing.
    Inflamm Bowel Dis. 2019 Sep 17. pii: 5570706. doi: 10.1093.
    PubMed     Abstract available


  459. ZHUANG X, Li T, Li M, Huang S, et al
    Systematic Review and Meta-analysis: Short-Chain Fatty Acid Characterization in Patients With Inflammatory Bowel Disease.
    Inflamm Bowel Dis. 2019 Sep 9. pii: 5566405. doi: 10.1093.
    PubMed     Abstract available


  460. LUTHER J, Dave M
    Rising Inflammatory Bowel Disease Prevalence Highlights the Need for Effective, Cost-Effective Therapies.
    Inflamm Bowel Dis. 2019 Sep 7. pii: 5565004. doi: 10.1093.
    PubMed    


    August 2019
  461. LIN Z, Wu H, Fu Y, Dai S, et al
    Application of Herbaceous Medications for Inflammatory Bowel Disease as a Complementary and Alternative Therapy.
    Inflamm Bowel Dis. 2019 Aug 31. pii: 5557802. doi: 10.1093.
    PubMed     Abstract available


  462. GEORGE J, Singh S, Dulai PS, Ma C, et al
    Corticosteroid-Free Remission vs Overall Remission in Clinical Trials of Moderate-Severe Ulcerative Colitis and Crohn's Disease.
    Inflamm Bowel Dis. 2019 Aug 30. pii: 5556866. doi: 10.1093.
    PubMed     Abstract available


  463. CASANOVA MJ, Chaparro M, Minguez M, Ricart E, et al
    Effectiveness and Safety of the Sequential Use of a Second and Third Anti-TNF Agent in Patients With Inflammatory Bowel Disease: Results From the Eneida Registry.
    Inflamm Bowel Dis. 2019 Aug 29. pii: 5556445. doi: 10.1093.
    PubMed     Abstract available


  464. KOKLU S, Koklu H
    Rectal Candidiasis Mimicking Ulcerative Colitis in an Immunocompetent Patient.
    Inflamm Bowel Dis. 2019 Aug 29. pii: 5556472. doi: 10.1093.
    PubMed    


  465. BARBERIO B, D'Inca R, Facchin S, Dalla Gasperina M, et al
    Matrix Metalloproteinase 3 Predicts Therapeutic Response in Inflammatory Bowel Disease Patients Treated With Infliximab.
    Inflamm Bowel Dis. 2019 Aug 29. pii: 5556462. doi: 10.1093.
    PubMed     Abstract available


  466. GREGORY MH, Ciorba MA, Wiitala WL, Stidham RW, et al
    The Association of Medications and Vaccination with Risk of Pneumonia in Inflammatory Bowel Disease.
    Inflamm Bowel Dis. 2019 Aug 27. pii: 5555523. doi: 10.1093.
    PubMed     Abstract available


  467. ROSEIRA J, Magro F, Fernandes S, Simoes C, et al
    Sexual Quality of Life in Inflammatory Bowel Disease: A Multicenter, National-Level Study.
    Inflamm Bowel Dis. 2019 Aug 27. pii: 5555468. doi: 10.1093.
    PubMed     Abstract available


  468. QIN X
    Impaired Inactivation of Digestive Proteases in Lower Gut Due to Inhibition of Gut Bacteria by Food Additives Such as Saccharin and Sucralose as Main Cause of Inflammatory Bowel Disease: A Two-Decades-Long Hypothesis Warrants Testing.
    Inflamm Bowel Dis. 2019 Aug 24. pii: 5554159. doi: 10.1093.
    PubMed    


  469. CALDERA F, Hillman L, Saha S, Wald A, et al
    Immunogenicity of High Dose Influenza Vaccine for Patients with Inflammatory Bowel Disease on Anti-TNF Monotherapy: A Randomized Clinical Trial.
    Inflamm Bowel Dis. 2019 Aug 24. pii: 5554370. doi: 10.1093.
    PubMed     Abstract available


  470. EROS A, Soos A, Hegyi P, Szakacs Z, et al
    Spotlight on Transition in Patients With Inflammatory Bowel Disease: A Systematic Review.
    Inflamm Bowel Dis. 2019 Aug 24. pii: 5554155. doi: 10.1093.
    PubMed     Abstract available


  471. KAIMAKLIOTIS P, Ramadugu A, Kang J, Trivedi I, et al
    Comment on: "Improving the Quality of Inpatient Ulcerative Colitis Management: Promoting Evidence-Based Practice and Reducing Care Variation With an Inpatient Protocol".
    Inflamm Bowel Dis. 2019 Aug 24. pii: 5554376. doi: 10.1093.
    PubMed    


  472. YE Y, Manne S, Treem WR, Bennett D, et al
    Prevalence of Inflammatory Bowel Disease in Pediatric and Adult Populations: Recent Estimates From Large National Databases in the United States, 2007-2016.
    Inflamm Bowel Dis. 2019 Aug 24. pii: 5554163. doi: 10.1093.
    PubMed     Abstract available


  473. FONDELL AW, Mosha MH, Frank CR, Brangi JM, et al
    Health Care Cost for Children Newly Diagnosed With Inflammatory Bowel Disease.
    Inflamm Bowel Dis. 2019 Aug 24. pii: 5554164. doi: 10.1093.
    PubMed     Abstract available


  474. KHALILI H
    The Changing Epidemiology of Inflammatory Bowel Disease: What Goes Up May Come Down.
    Inflamm Bowel Dis. 2019 Aug 23. pii: 5554124. doi: 10.1093.
    PubMed     Abstract available


  475. TORABI M, Bernstein CN, Yu BN, Wickramasinghe L, et al
    Geographical Variation and Factors Associated With Inflammatory Bowel Disease in a Central Canadian Province.
    Inflamm Bowel Dis. 2019 Aug 23. pii: 5554123. doi: 10.1093.
    PubMed     Abstract available


  476. DEBRUYN J
    Response to the Letter by Dr. Freddy Calder.
    Inflamm Bowel Dis. 2019;25:e104.
    PubMed    


  477. BHATTACHARYA S, Cross RK
    Is Endoscopic Remission in Ulcerative Colitis Still Good Enough?
    Inflamm Bowel Dis. 2019 Aug 14. pii: 5550113. doi: 10.1093.
    PubMed    


  478. LAI SW, Kuo YH, Liao KF
    Increased Risk of Parkinson Disease in Inflammatory Bowel Disease Patients.
    Inflamm Bowel Dis. 2019 Aug 13. pii: 5548979. doi: 10.1093.
    PubMed    


  479. WEIMERS P, Halfvarson J, Saunders-Pullman R, Ludvigsson JF, et al
    Inflammatory Bowel Disease and Parkinson's Disease: A Reply to Letter to the Editor of Shih-Wei Lai.
    Inflamm Bowel Dis. 2019 Aug 13. pii: 5548981. doi: 10.1093.
    PubMed    


  480. LEGA S, Pin A, Arrigo S, Cifaldi C, et al
    Diagnostic Approach to Monogenic Inflammatory Bowel Disease in Clinical Practice: A Ten-Year Multicentric Experience.
    Inflamm Bowel Dis. 2019 Aug 3. pii: 5543289. doi: 10.1093.
    PubMed     Abstract available


  481. DREESEN E, Kantasiripitak W, Detrez I, Stefanovic S, et al
    A Population Pharmacokinetic and Exposure-Response Model of Golimumab for Targeting Endoscopic Remission in Patients With Ulcerative Colitis.
    Inflamm Bowel Dis. 2019 Aug 2. pii: 5542810. doi: 10.1093.
    PubMed     Abstract available


  482. LISKA D, Bora Cengiz T, Novello M, Aiello A, et al
    Do Patients With Inflammatory Bowel Disease Benefit from an Enhanced Recovery Pathway?
    Inflamm Bowel Dis. 2019 Aug 2. pii: 5542814. doi: 10.1093.
    PubMed     Abstract available


  483. KAYAL M, Radcliffe M, Plietz M, Rosman A, et al
    Portomesenteric Venous Thrombosis in Patients Undergoing Surgery for Medically Refractory Ulcerative Colitis.
    Inflamm Bowel Dis. 2019 Aug 2. pii: 5542812. doi: 10.1093.
    PubMed     Abstract available


  484. LIGHTNER AL
    Should Surgical Inflammatory Bowel Disease Patients Be Given Extended Venous Thromboembolic Prophylaxis Postoperatively?
    Inflamm Bowel Dis. 2019 Aug 2. pii: 5542811. doi: 10.1093.
    PubMed    


    July 2019
  485. NIKLINSKA-SCHIRTZ BJ, Kugathasan S
    Anti-TNF Therapy Is Emerging as the Primary Treatment Modality in Pediatric Inflammatory Bowel Disease.
    Inflamm Bowel Dis. 2019 Jul 19. pii: 5536295. doi: 10.1093.
    PubMed    


  486. EL-MATARY W, Leung S, Tennakoon A, Benchimol EI, et al
    Trends of Utilization of Tumor Necrosis Factor Antagonists in Children With Inflammatory Bowel Disease: A Canadian Population-Based Study.
    Inflamm Bowel Dis. 2019 Jul 19. pii: 5536313. doi: 10.1093.
    PubMed     Abstract available


  487. BIANCONE L, Armuzzi A, Scribano ML, Castiglione F, et al
    Cancer Risk in Inflammatory Bowel Disease: A 6-Year Prospective Multicenter Nested Case-Control IG-IBD Study.
    Inflamm Bowel Dis. 2019 Jul 19. pii: 5536256. doi: 10.1093.
    PubMed     Abstract available


  488. WATT P, Abbass A
    A Comparative Case Study of the Impact of Psychotherapy on Inflammatory Bowel Disease Patients.
    Inflamm Bowel Dis. 2019 Jul 18. pii: 5531848. doi: 10.1093.
    PubMed    


  489. SHERIFF MZ, Mansoor E, Luther J, Ananthakrishnan AN, et al
    Opportunistic Infections Are More Prevalent in Crohn's Disease and Ulcerative Colitis: A Large Population-Based Study.
    Inflamm Bowel Dis. 2019 Jul 17. pii: 5533446. doi: 10.1093.
    PubMed     Abstract available


  490. BORUM ML, Taneja SL, Corinaldi M
    Health Literacy Assessments May Be Inconsistently Conducted in IBD Patients.
    Inflamm Bowel Dis. 2019;25:e94.
    PubMed    


  491. SAROLI PALUMBO C, Bessissow T, Sebastiani G
    Reply to "Transient Elastography in IBD Patients".
    Inflamm Bowel Dis. 2019;25:e95.
    PubMed    


  492. VAN EVERDINGEN CK, Meijer B, Gearry RB
    Transient Elastography in IBD Patients.
    Inflamm Bowel Dis. 2019;25:e96.
    PubMed    


  493. GOYAL A, Morowitz M
    Author's Reply to Drs. Franco Scaldaferri and Valentina Petito, PhD.
    Inflamm Bowel Dis. 2019;25:e102.
    PubMed    


  494. KOCHAR B, Long MD, Herfarth HH
    Antidepressants in IBD: Healthy Adherer Effect?
    Inflamm Bowel Dis. 2019;25:e98.
    PubMed    


  495. NARULA N, Pinto-Sanchez MI, Calo NC, Ford AC, et al
    Response to Letter by Moulton et al.
    Inflamm Bowel Dis. 2019;25:e99.
    PubMed    


  496. VELEGRAKI M, Flamourakis M, Kazamias G, Georgiou G, et al
    Replacement Resistant Iron Deficiency Anemia in a Patient With Ulcerative Colitis in Remission: Investigating Beyond the Obvious.
    Inflamm Bowel Dis. 2019 Jul 13. pii: 5532048. doi: 10.1093.
    PubMed    



  497. Corrigendum to Age-Related Survival Differences in Patients With Inflammatory Bowel Disease-Associated Colorectal Cancer: A Population-Based Cohort Study.
    Inflamm Bowel Dis. 2019 Jul 13. pii: 5532047. doi: 10.1093.
    PubMed    


  498. MANTAKA A, Orfanoudaki E, Koutroubakis IE
    Letter to the Editor: Is There a Role for Switching Infliximab in Order to Regain Anti-TNF Response in Cases With Active Inflammatory Bowel Disease?
    Inflamm Bowel Dis. 2019 Jul 13. pii: 5531850. doi: 10.1093.
    PubMed    


  499. YAO D, Dong M, Dai C, Wu S, et al
    Inflammation and Inflammatory Cytokine Contribute to the Initiation and Development of Ulcerative Colitis and Its Associated Cancer.
    Inflamm Bowel Dis. 2019 Jul 9. pii: 5530266. doi: 10.1093.
    PubMed     Abstract available


  500. BAUMAN LE, Xiong Y, Mizuno T, Minar P, et al
    Improved Population Pharmacokinetic Model for Predicting Optimized Infliximab Exposure in Pediatric Inflammatory Bowel Disease.
    Inflamm Bowel Dis. 2019 Jul 9. pii: 5530269. doi: 10.1093.
    PubMed     Abstract available


  501. TROELSEN FS, Jick S
    Antibiotic Use in Childhood and Adolescence and Risk of Inflammatory Bowel Disease: A Case-Control Study in the UK Clinical Practice Research Datalink.
    Inflamm Bowel Dis. 2019 Jul 2. pii: 5527229. doi: 10.1093.
    PubMed     Abstract available


    June 2019
  502. POYATO-BORREGO M, Segura-Sampedro JJ, Martin-Gonzalez J, Torres-Dominguez Y, et al
    High Prevalence of Apical Periodontitis in Patients With Inflammatory Bowel Disease: An Age- and Gender- matched Case-control Study.
    Inflamm Bowel Dis. 2019 Jun 27. pii: 5524347. doi: 10.1093.
    PubMed     Abstract available


  503. BARTA Z
    Apical Periodontitis in Patients With Inflammatory Bowel Disease: A Puppet Master?
    Inflamm Bowel Dis. 2019 Jun 27. pii: 5524346. doi: 10.1093.
    PubMed     Abstract available


  504. LIAO KF, Lai SW
    Increased Incidence of Herpes Zoster Infection in Patients With Inflammatory Bowel Disease.
    Inflamm Bowel Dis. 2019 Jun 27. pii: 5524337. doi: 10.1093.
    PubMed    


  505. FERNANDES SR, Bernardo S, Simoes C, Goncalves AR, et al
    Proactive Infliximab Drug Monitoring Is Superior to Conventional Management in Inflammatory Bowel Disease.
    Inflamm Bowel Dis. 2019 Jun 27. pii: 5524344. doi: 10.1093.
    PubMed     Abstract available


  506. MENCHINI CB
    Pediatric Inflammatory Bowel Disease Complications Are More Likely on the Weekend.
    Inflamm Bowel Dis. 2019 Jun 27. pii: 5524339. doi: 10.1093.
    PubMed    


  507. TARGOWNIK LE, Benchimol EI, Witt J, Bernstein CN, et al
    The Effect of Initiation of Anti-TNF Therapy on the Subsequent Direct Health Care Costs of Inflammatory Bowel Disease.
    Inflamm Bowel Dis. 2019 Jun 18. pii: 5520231. doi: 10.1093.
    PubMed     Abstract available


  508. FERRER-PICON E, Dotti I, Corraliza AM, Mayorgas A, et al
    Intestinal Inflammation Modulates the Epithelial Response to Butyrate in Patients With Inflammatory Bowel Disease.
    Inflamm Bowel Dis. 2019 Jun 18. pii: 5520228. doi: 10.1093.
    PubMed     Abstract available


  509. EL-MATARY W, Kuenzig ME, Singh H, Okoli G, et al
    Disease-Associated Costs in Children With Inflammatory Bowel Disease: A Systematic Review.
    Inflamm Bowel Dis. 2019 Jun 18. pii: 5520192. doi: 10.1093.
    PubMed     Abstract available


  510. ZHAO S, Xie Q, Zhao Z
    Reply to Comment on "Inflammatory Bowel Diseases Were Associated With Risk of Sexual Dysfunction in Both Sexes: A Meta-analysis" by Li Y and Liu X.
    Inflamm Bowel Dis. 2019;25:e78-e81.
    PubMed    


  511. GIANNINI EG, Demarzo MG, Bodini G
    Reproducibility and Transportability of the Absence of Incremental Infectious Adverse Events in Patients With Higher Anti-TNF Drug Levels.
    Inflamm Bowel Dis. 2019;25:e73.
    PubMed    


  512. KRUGER AJ, Hinton A, Afzali A
    To the Editors: Index Severity Score and Early Readmission Predicts Increased Mortality in Crohn's Disease Patients.
    Inflamm Bowel Dis. 2019;25:e74-e76.
    PubMed    


  513. KURIN M, Katz J, Kodish E, Lashner B, et al
    Informed Consent in IBD Trials: Where We Are and Where We Need to Go.
    Inflamm Bowel Dis. 2019;25:1115-1119.
    PubMed     Abstract available


  514. GROSSBERG LB
    A Case Report of Successful Treatment of Crohn's Disease and Psoriasis With Guselkumab.
    Inflamm Bowel Dis. 2019;25:e84.
    PubMed    


  515. GARCIA GARCIA MJ, Rivero Tirado M, Callizo MEP
    Paradoxical Arthritis in Inflammatory Bowel Diasease Patients on Ustekinumab Treatment.
    Inflamm Bowel Dis. 2019;25:e89.
    PubMed    


  516. SIMONS-LINARES CR, Chahal P
    Successful EUS-guided Drainage of a Persistent Subdiaphragmatic Fluid Collection in a Patient With Crohn's Disease.
    Inflamm Bowel Dis. 2019;25:e85-e86.
    PubMed    


  517. LIGHTNER AL, Alsughayer A, Wang Z, McKenna NP, et al
    Short- and Long-term Outcomes After Ileal Pouch Anal Anastomosis in Pediatric Patients: A Systematic Review.
    Inflamm Bowel Dis. 2019;25:1152-1168.
    PubMed     Abstract available


  518. KRISHNAKUMAR C, Ballengee CR, Liu C, Kim MO, et al
    Variation in Care in the Management of Children With Crohn's Disease: Data From a Multicenter Inception Cohort Study.
    Inflamm Bowel Dis. 2019;25:1208-1217.
    PubMed     Abstract available


  519. ZHAO M, Lo BZS, Vester-Andersen MK, Vind I, et al
    A 10-Year Follow-up Study of the Natural History of Perianal Crohn's Disease in a Danish Population-Based Inception Cohort.
    Inflamm Bowel Dis. 2019;25:1227-1236.
    PubMed     Abstract available


  520. EVERHOV AH, Khalili H, Askling J, Myrelid P, et al
    Work Loss Before and After Diagnosis of Crohn's Disease.
    Inflamm Bowel Dis. 2019;25:1237-1247.
    PubMed     Abstract available


  521. JIN L, Li L, Hu C, Paez-Cortez J, et al
    Integrative Analysis of Transcriptomic and Proteomic Profiling in Inflammatory Bowel Disease Colon Biopsies.
    Inflamm Bowel Dis. 2019 Jun 7. pii: 5512545. doi: 10.1093.
    PubMed     Abstract available


  522. DALEY SK, Witte MH, Washington J, Bernas M, et al
    Role of Lymphatic Deficiency in the Pathogenesis and Progression of Inflammatory Bowel Disease to Colorectal Cancer in an Experimental Mouse Model.
    Inflamm Bowel Dis. 2019 Jun 7. pii: 5512544. doi: 10.1093.
    PubMed     Abstract available


  523. CALDERA F, Farraye FA, Rosh JR, Hayney MS, et al
    Prudence Using Serology to Determine Vaccine-Induced Immunity to Measles and Varicella in Patients With Inflammatory Bowel Disease.
    Inflamm Bowel Dis. 2019 Jun 5. pii: 5511553. doi: 10.1093.
    PubMed    


    May 2019
  524. JULSGAARD M, Hvas CL, Gearry RB, Gibson PR, et al
    Anti-TNF Therapy in Pregnant Women With Inflammatory Bowel Disease: Effects of Therapeutic Strategies on Disease Behavior and Birth Outcomes.
    Inflamm Bowel Dis. 2019 May 29. pii: 5506434. doi: 10.1093.
    PubMed     Abstract available


  525. MEI Y, Ye S, Han W, Yang Q, et al
    Clinical Significance of Potassium Channel and NLRP3 Expression in Platelets of Active Ulcerative Colitis.
    Inflamm Bowel Dis. 2019 May 29. pii: 5505410. doi: 10.1093.
    PubMed    


  526. MAGG T, Shcherbina A, Arslan D, Desai MM, et al
    CARMIL2 Deficiency Presenting as Very Early Onset Inflammatory Bowel Disease.
    Inflamm Bowel Dis. 2019 May 22. pii: 5496841. doi: 10.1093.
    PubMed     Abstract available


  527. LONG MD
    A Novel Index to Measure Patient-Reported Outcomes in Clinical Practice and Research: The Inflammatory Bowel Disease Symptom Inventory-Ready for Prime Time?
    Inflamm Bowel Dis. 2019 May 22. pii: 5497447. doi: 10.1093.
    PubMed    


  528. TOKARZ R, Hyams JS, Mack DR, Boyle B, et al
    Characterization of Stool Virome in Children Newly Diagnosed With Moderate to Severe Ulcerative Colitis.
    Inflamm Bowel Dis. 2019 May 21. pii: 5493583. doi: 10.1093.
    PubMed     Abstract available


  529. PARK KT, Ehrlich OG, Allen JI, Meadows P, et al
    The Cost of Inflammatory Bowel Disease: An Initiative From the Crohn's & Colitis Foundation.
    Inflamm Bowel Dis. 2019 May 21. pii: 5490919. doi: 10.1093.
    PubMed     Abstract available


  530. KEYASHIAN K, Dehghan M, Sceats L, Kin C, et al
    Comparative Incidence of Inflammatory Bowel Disease in Different Age Groups in the United States.
    Inflamm Bowel Dis. 2019 May 16. pii: 5490623. doi: 10.1093.
    PubMed     Abstract available


  531. HORTA D, Lira A, Sanchez-Lloansi M, Villoria A, et al
    A Prospective Pilot Randomized Study: Electroacupuncture vs. Sham Procedure for the Treatment of Fatigue in Patients With Quiescent Inflammatory Bowel Disease.
    Inflamm Bowel Dis. 2019 May 15. pii: 5489814. doi: 10.1093.
    PubMed     Abstract available


  532. ALLEY K, Singla A, Afzali A
    Opioid Use Is Associated With Higher Health Care Costs and Emergency Encounters in Inflammatory Bowel Disease.
    Inflamm Bowel Dis. 2019 May 14. pii: 5489158. doi: 10.1093.
    PubMed     Abstract available


  533. LEBER A, Hontecillas R, Zoccoli-Rodriguez V, Colombel JF, et al
    The Safety, Tolerability, and Pharmacokinetics Profile of BT-11, an Oral, Gut-Restricted Lanthionine Synthetase C-Like 2 Agonist Investigational New Drug for Inflammatory Bowel Disease: A Randomized, Double-Blind, Placebo-Controlled Phase I Clinical T
    Inflamm Bowel Dis. 2019 May 11. pii: 5488461. doi: 10.1093.
    PubMed     Abstract available


  534. DIAB J, Hansen T, Goll R, Stenlund H, et al
    Lipidomics in Ulcerative Colitis Reveal Alteration in Mucosal Lipid Composition Associated With the Disease State.
    Inflamm Bowel Dis. 2019 May 11. pii: 5488457. doi: 10.1093.
    PubMed     Abstract available


  535. BRENNER EJ, Jhaveri R, Kappelman MD, Gulati AS, et al
    Evaluating Hepatitis B Seroprotection and Revaccination for Children With Inflammatory Bowel Disease.
    Inflamm Bowel Dis. 2019 May 11. pii: 5488459. doi: 10.1093.
    PubMed    


  536. GUERRERO VINSARD D, Wakefield D, Vaziri H, Karagozian R, et al
    Vaccine-Preventable Diseases in Hospitalized Patients With Inflammatory Bowel Disease: A Nationwide Cohort Analysis.
    Inflamm Bowel Dis. 2019 May 8. pii: 5487145. doi: 10.1093.
    PubMed     Abstract available


  537. BOGACH J, Pond G, Esckicioglu C, Seow H, et al
    Age-Related Survival Differences in Patients With Inflammatory Bowel Disease-Associated Colorectal Cancer: A Population-Based Cohort Study.
    Inflamm Bowel Dis. 2019 May 8. pii: 5486981. doi: 10.1093.
    PubMed     Abstract available


  538. DELDAY M, Mulder I, Logan ET, Grant G, et al
    Reply to the Letter to the Editor of Drs. Sitkin and Pokrotnieks.
    Inflamm Bowel Dis. 2019;25:e72.
    PubMed    


  539. FUKUDA T, Naganuma M, Kanai T
    How Can We Assess "Complete Healing" Beyond Endoscopic Remission?
    Inflamm Bowel Dis. 2019;25:e68.
    PubMed    


  540. BRYANT RV, Schultz CG, Ooi S, Goess C, et al
    Authors' reply: The Association Between Visceral Adipose Tissue and Stricturing Crohn's Disease Behavior, Fecal Calprotectin and Quality of Life.
    Inflamm Bowel Dis. 2019;25:e62-e63.
    PubMed    


  541. DAI C, Jiang M, Huang YH
    The Association Between Visceral Adipose Tissue and Stricturing Crohn's Disease Behavior, Fecal Calprotectin, and Quality of Life.
    Inflamm Bowel Dis. 2019;25:e61.
    PubMed    


  542. GREENFEST A, Szvarca D, Clarke L, Tabbara N, et al
    New Vaccine, New Guidelines, Same Problem: The Rates of Herpes Zoster Infection and Vaccination in IBD Patients.
    Inflamm Bowel Dis. 2019;25:e60.
    PubMed    


  543. COUCH DG, Cook H, Ortori C, Barrett D, et al
    Palmitoylethanolamide and Cannabidiol Prevent Inflammation-induced Hyperpermeability of the Human Gut In Vitro and In Vivo-A Randomized, Placebo-controlled, Double-blind Controlled Trial.
    Inflamm Bowel Dis. 2019;25:1006-1018.
    PubMed     Abstract available


  544. CALDERA F, Hayney MS, Cross RK
    Using Number Needed to Harm to Put the Risk of Herpes Zoster From Tofacitinib in Perspective.
    Inflamm Bowel Dis. 2019;25:955-957.
    PubMed    


  545. MOORE AC, Huang VW, Bourdages R, Fedorak RN, et al
    IBDoc Canadian User Performance Evaluation.
    Inflamm Bowel Dis. 2019;25:1107-1114.
    PubMed     Abstract available


  546. KOTZEV A, Tanchev L, Encheva L, Kovachev N, et al
    Sigmoidouterine Fistula in Crohn's Disease: A First Case Report.
    Inflamm Bowel Dis. 2019;25:e65-e66.
    PubMed    


  547. QAZI T, Verma R, Hamilton MJ, Kaplan ER, et al
    The Use of Actigraphy Differentiates Sleep Disturbances in Active and Inactive Crohn's Disease.
    Inflamm Bowel Dis. 2019;25:1044-1053.
    PubMed     Abstract available


  548. SADO AI, Kalla R, Sharma A
    A Case of IBD Immunosuppression Related Salmonella Aortitis Requiring Emergency Vascular Grafting.
    Inflamm Bowel Dis. 2019;25:e64.
    PubMed    


  549. SCHMIDT T, Feagins LA
    How Can We Improve to Keep Our Patients Out of the Hospital?
    Inflamm Bowel Dis. 2019;25:980-986.
    PubMed     Abstract available


  550. PARK SH, Aniwan S, Scott Harmsen W, Tremaine WJ, et al
    Update on the Natural Course of Fistulizing Perianal Crohn's Disease in a Population-Based Cohort.
    Inflamm Bowel Dis. 2019;25:1054-1060.
    PubMed     Abstract available


  551. PLEVRIS N, Lyons M, Jenkinson PW, Chuah CS, et al
    Higher Adalimumab Drug Levels During Maintenance Therapy for Crohn's Disease Are Associated With Biologic Remission.
    Inflamm Bowel Dis. 2019;25:1036-1043.
    PubMed     Abstract available


  552. VAN DEN BRINK G, Stapersma L, Bom AS, Rizopolous D, et al
    Effect of Cognitive Behavioral Therapy on Clinical Disease Course in Adolescents and Young Adults With Inflammatory Bowel Disease and Subclinical Anxiety and/or Depression: Results of a Randomized Trial.
    Inflamm Bowel Dis. 2019 May 3. pii: 5485288. doi: 10.1093.
    PubMed     Abstract available


  553. GRASS F, Fletcher JG, Alsughayer A, Petersen M, et al
    Development of an Objective Model to Define Near-Term Risk of Ileocecal Resection in Patients with Terminal Ileal Crohn Disease.
    Inflamm Bowel Dis. 2019 May 3. pii: 5485212. doi: 10.1093.
    PubMed     Abstract available


    April 2019
  554. LEONE D, Gilardi D, Corro BE, Menichetti J, et al
    Psychological Functioning of Patients With Inflammatory Bowel Disease.
    Inflamm Bowel Dis. 2019 Apr 30. pii: 5482244. doi: 10.1093.
    PubMed    


  555. LIMKETKAI BN, Singh S, Jairath V, Sandborn WJ, et al
    US Practice Patterns and Impact of Monitoring for Mucosal Inflammation After Biologic Initiation in Inflammatory Bowel Disease.
    Inflamm Bowel Dis. 2019 Apr 30. pii: 5482264. doi: 10.1093.
    PubMed     Abstract available


  556. DALAL RS, Vajravelu RK, Lewis JD, Lichtenstein GR, et al
    Hospitalization Outcomes for Inflammatory Bowel Disease in Teaching vs Nonteaching Hospitals.
    Inflamm Bowel Dis. 2019 Apr 30. pii: 5482270. doi: 10.1093.
    PubMed     Abstract available


  557. CHOI H, Bou-Abboud Matta C, Fu G, Trichonas G, et al
    Central Retinal Vein Occlusion: A Rare Ocular Complication of Inflammatory Bowel Disease-A Case Series.
    Inflamm Bowel Dis. 2019 Apr 26. pii: 5480053. doi: 10.1093.
    PubMed    


  558. PERL D, Waljee AK, Bishu S, Higgins PDR, et al
    Imaging Features Associated With Failure of Nonoperative Management of Intraabdominal Abscesses in Crohn Disease.
    Inflamm Bowel Dis. 2019 Apr 25. pii: 5479566. doi: 10.1093.
    PubMed     Abstract available


  559. CANETE F, Manosa M, Casanova MJ, Gonzalez-Sueyro RC, et al
    Adalimumab or Infliximab for the Prevention of Early Postoperative Recurrence of Crohn Disease: Results From the ENEIDA Registry.
    Inflamm Bowel Dis. 2019 Apr 22. pii: 5475919. doi: 10.1093.
    PubMed     Abstract available


  560. BOLIA R, Rajanayagam J, Hardikar W, Alex G, et al
    Impact of Changing Treatment Strategies on Outcomes in Pediatric Ulcerative Colitis.
    Inflamm Bowel Dis. 2019 Apr 19. pii: 5475303. doi: 10.1093.
    PubMed     Abstract available


  561. AXELRAD JE, Sharma R, Laszkowska M, Packey C, et al
    Increased Healthcare Utilization by Patients With Inflammatory Bowel Disease Covered by Medicaid at a Tertiary Care Center.
    Inflamm Bowel Dis. 2019 Apr 16. pii: 5467405. doi: 10.1093.
    PubMed     Abstract available


  562. TAFT TH, Quinton S, Tomasino K, Craven M, et al
    Letter to the Editor: Patients With Inflammatory Bowel Disease Demonstrate an Inherent Lack of Psychopathology.
    Inflamm Bowel Dis. 2019 Apr 16. pii: 5469113. doi: 10.1093.
    PubMed    


  563. KHAN N, Vallarino C, Lissoos T, Darr U, et al
    Risk of Infection and Types of Infection Among Elderly Patients With Inflammatory Bowel Disease: A Retrospective Database Analysis.
    Inflamm Bowel Dis. 2019 Apr 13. pii: 5455214. doi: 10.1093.
    PubMed     Abstract available


  564. WU B, Tong J, Ran Z
    Tacrolimus Therapy in Steroid-Refractory Ulcerative Colitis: A Review.
    Inflamm Bowel Dis. 2019 Apr 13. pii: 5455220. doi: 10.1093.
    PubMed     Abstract available


  565. LEWIN SM, McConnell RA, Patel R, Sharpton SR, et al
    Improving the Quality of Inpatient Ulcerative Colitis Management: Promoting Evidence-Based Practice and Reducing Care Variation With an Inpatient Protocol.
    Inflamm Bowel Dis. 2019 Apr 13. pii: 5455217. doi: 10.1093.
    PubMed     Abstract available


  566. PAUWELS RWM, de Vries AC, van der Woude CJ
    Comment on "Predictors and Management of Loss of Response to Vedolizumab in Inflammatory Bowel Disease".
    Inflamm Bowel Dis. 2019;25:e59.
    PubMed    


  567. SHMIDT E, Dulai PS
    Reply to the Letter to the Editor of Dr. Pauwels et al.
    Inflamm Bowel Dis. 2019;25:e58.
    PubMed    


  568. JUN S
    Ethnicity May Be Important for Studying the Role of the Microbiome and Vitamin D Receptor in IBD.
    Inflamm Bowel Dis. 2019;25:e54.
    PubMed    


  569. SZYMCZAK-TOMCZAK A, Krela-Kazmierczak I, Kaczmarek-Rys M, Hryhorowicz S, et al
    Does Only Sex Matter? Complexity of the Association Between Vdr Gene BsmI Single Nucleotide Polymorphism and Immune Response in IBD.
    Inflamm Bowel Dis. 2019;25:e56-e57.
    PubMed    


  570. CHETCUTI ZAMMIT S, McAlindon ME, Hale MF, Sanders DS, et al
    Small Bowel Ulcers on Capsule Endoscopy and Their Significance.
    Inflamm Bowel Dis. 2019;25:e55.
    PubMed    


  571. KANE S
    Leter to the Editor.
    Inflamm Bowel Dis. 2019;25:e52.
    PubMed    


  572. FRANCO DL, Holubar SD, Lightner AL, Lashner BA, et al
    Local Stem Cell Therapy for Crohn's Perianal Fistulae.
    Inflamm Bowel Dis. 2019;25:816-819.
    PubMed    


  573. SCOTT FI, Johnson FR, Bewtra M, Brensinger CM, et al
    Improved Quality of Life With Anti-TNF Therapy Compared With Continued Corticosteroid Utilization in Crohn's Disease.
    Inflamm Bowel Dis. 2019;25:925-936.
    PubMed     Abstract available


  574. CHUDY-ONWUGAJE KO, Christian KE, Farraye FA, Cross RK, et al
    A State-of-the-Art Review of New and Emerging Therapies for the Treatment of IBD.
    Inflamm Bowel Dis. 2019;25:820-830.
    PubMed     Abstract available


  575. CLICK B, Regueiro M
    A Practical Guide to the Safety and Monitoring of New IBD Therapies.
    Inflamm Bowel Dis. 2019;25:831-842.
    PubMed     Abstract available


  576. NUCERA E, Andriollo G, Buonomo A, Di Rienzo A, et al
    Interesting Case of Infliximab IV Type Hypersensitivity.
    Inflamm Bowel Dis. 2019;25:e49-e51.
    PubMed    


  577. MAHADEVAN U, Robinson C, Bernasko N, Boland B, et al
    Erratum: Inflammatory Bowel Disease in Pregnancy Clinical Care Pathway: A Report From the American Gastroenterological Association IBD Parenthood Project Working Group.
    Inflamm Bowel Dis. 2019 Apr 4. pii: 5427975. doi: 10.1093.
    PubMed    


  578. ROBERTA N, Valentina B, Luigi M, Carmine P, et al
    Shiga Toxin Producing Escherichia coli-Hemolytic Uremic Syndrome Mimicking Acute Severe Ulcerative Colitis in a Child With Bloody Diarrhea.
    Inflamm Bowel Dis. 2019 Apr 1. pii: 5424809. doi: 10.1093.
    PubMed    


  579. CLICK B, Regueiro M
    The Inflammatory Bowel Disease Medical Home: From Patients to Populations.
    Inflamm Bowel Dis. 2019 Apr 1. pii: 5424811. doi: 10.1093.
    PubMed     Abstract available


  580. BERG DR, Colombel JF, Ungaro R
    The Role of Early Biologic Therapy in Inflammatory Bowel Disease.
    Inflamm Bowel Dis. 2019 Apr 1. pii: 5424853. doi: 10.1093.
    PubMed     Abstract available


  581. FAVALE A, Onali S, Caprioli F, Pugliese D, et al
    Comparative Efficacy of Vedolizumab and Adalimumab in Ulcerative Colitis Patients Previously Treated With Infliximab.
    Inflamm Bowel Dis. 2019 Apr 1. pii: 5424157. doi: 10.1093.
    PubMed     Abstract available


    March 2019
  582. SEXTON KA, Walker JR, Targownik LE, Graff LA, et al
    The Inflammatory Bowel Disease Symptom Inventory: A Patient-report Scale for Research and Clinical Application.
    Inflamm Bowel Dis. 2019 Mar 27. pii: 5421080. doi: 10.1093.
    PubMed     Abstract available


  583. ZOU ZY, Shen B, Fan JG
    Systematic Review With Meta-analysis: Epidemiology of Nonalcoholic Fatty Liver Disease in Patients With Inflammatory Bowel Disease.
    Inflamm Bowel Dis. 2019 Mar 27. pii: 5421081. doi: 10.1093.
    PubMed     Abstract available


  584. ROOSENBOOM B, Wahab PJ, Smids C, Groenen MJM, et al
    Intestinal CD103+CD4+ and CD103+CD8+ T-Cell Subsets in the Gut of Inflammatory Bowel Disease Patients at Diagnosis and During Follow-up.
    Inflamm Bowel Dis. 2019 Mar 27. pii: 5421083. doi: 10.1093.
    PubMed     Abstract available


  585. MALMBORG P, Mouratidou N, Sachs MC, Hammar U, et al
    Effects of Childhood-onset Inflammatory Bowel Disease on School Performance: A Nationwide Population-based Cohort Study Using Swedish Health and Educational Registers.
    Inflamm Bowel Dis. 2019 Mar 27. pii: 5420619. doi: 10.1093.
    PubMed     Abstract available


  586. OPSTELTEN JL, Vaartjes I, Bots ML, Oldenburg B, et al
    Mortality After First Hospital Admission for Inflammatory Bowel Disease: A Nationwide Registry Linkage Study.
    Inflamm Bowel Dis. 2019 Mar 27. pii: 5421033. doi: 10.1093.
    PubMed     Abstract available


  587. HOOPER KM, Casanova V, Kemp S, Staines KA, et al
    The Inflammatory Bowel Disease Drug Azathioprine Induces Autophagy via mTORC1 and the Unfolded Protein Response Sensor PERK.
    Inflamm Bowel Dis. 2019 Mar 19. pii: 5393636. doi: 10.1093.
    PubMed     Abstract available


  588. LEWIS K, Marrie RA, Bernstein CN, Graff LA, et al
    The Prevalence and Risk Factors of Undiagnosed Depression and Anxiety Disorders Among Patients With Inflammatory Bowel Disease.
    Inflamm Bowel Dis. 2019 Mar 19. pii: 5388163. doi: 10.1093.
    PubMed     Abstract available


  589. BUCHNER AM
    Confocal Laser Endomicroscopy in the Evaluation of Inflammatory Bowel Disease.
    Inflamm Bowel Dis. 2019 Mar 16. pii: 5382084. doi: 10.1093.
    PubMed     Abstract available


  590. LIMDI JK, Farraye J, Cannon R, Woodhams E, et al
    Contraception, Venous Thromboembolism, and Inflammatory Bowel Disease: What Clinicians (and Patients) Should Know.
    Inflamm Bowel Dis. 2019 Mar 16. pii: 5382083. doi: 10.1093.
    PubMed     Abstract available


  591. LI Y, Liu X
    Shall Patients With a History of Inflammatory Bowel Disease-Related Surgery Be Excluded in the Assessment of Sexual Function?
    Inflamm Bowel Dis. 2019 Mar 15. pii: 5381151. doi: 10.1093.
    PubMed     Abstract available


  592. LASHNER BA, Cominelli F
    Conflicts of Interest in Clinical Practice Guidelines.
    Inflamm Bowel Dis. 2019;25:646.
    PubMed    


  593. SORRENTINO D, Nguyen VQ
    Small Bowel Inflammation in Crohn's Disease and Other Conditions.
    Inflamm Bowel Dis. 2019;25:e46.
    PubMed    


  594. RODRIGUEZ-PALACIOS A, Cominelli F
    Crohn's Disease-Like Ileitis and the Inhibitory Effect of Sucralose on Streptococci.
    Inflamm Bowel Dis. 2019;25:e34-e37.
    PubMed    


  595. GOREN I, Godny L, Reshef L, Yanai H, et al
    Starch Consumption May Modify Antiglycan Antibodies and Fecal Fungal Composition in Patients With Ileo-Anal Pouch.
    Inflamm Bowel Dis. 2019;25:742-749.
    PubMed     Abstract available


  596. ZHAO S, Wang J, Liu Y, Luo L, et al
    Inflammatory Bowel Diseases Were Associated With Risk of Sexual Dysfunction in Both Sexes: A Meta-analysis.
    Inflamm Bowel Dis. 2019;25:699-707.
    PubMed     Abstract available


  597. WEAVER KN, Gregory M, Syal G, Hoversten P, et al
    Ustekinumab Is Effective for the Treatment of Crohn's Disease of the Pouch in a Multicenter Cohort.
    Inflamm Bowel Dis. 2019;25:767-774.
    PubMed     Abstract available


  598. DURICOVA D, Dvorakova E, Hradsky O, Mitrova K, et al
    Safety of Anti-TNF-Alpha Therapy During Pregnancy on Long-term Outcome of Exposed Children: A Controlled, Multicenter Observation.
    Inflamm Bowel Dis. 2019;25:789-796.
    PubMed     Abstract available


  599. CARUSO ML, Cavalcanti E, Ignazzi A, Lantone G, et al
    Infliximab Has a Number of Well-Described Adverse Effects. Is Myeloid Metaplasia One of These in Elderly Long-standing IBD Patients?
    Inflamm Bowel Dis. 2019;25:e44-e45.
    PubMed    


  600. SHMIDT E, Suarez-Farinas M, Mallette M, Moniz H, et al
    Erectile Dysfunction Is Highly Prevalent in Men With Newly Diagnosed Inflammatory Bowel Disease.
    Inflamm Bowel Dis. 2019 Mar 11. pii: 5376643. doi: 10.1093.
    PubMed     Abstract available


  601. FILIPPONE RT, Sahakian L, Apostolopoulos V, Nurgali K, et al
    Eosinophils in Inflammatory Bowel Disease.
    Inflamm Bowel Dis. 2019 Mar 11. pii: 5374663. doi: 10.1093.
    PubMed     Abstract available


  602. HIRTEN RP, Grinspan A, Fu SC, Luo Y, et al
    Microbial Engraftment and Efficacy of Fecal Microbiota Transplant for Clostridium Difficile in Patients With and Without Inflammatory Bowel Disease.
    Inflamm Bowel Dis. 2019 Mar 10. pii: 5372769. doi: 10.1093.
    PubMed     Abstract available


  603. TAFT TH, Bedell A, Craven MR, Guadagnoli L, et al
    Initial Assessment of Post-traumatic Stress in a US Cohort of Inflammatory Bowel Disease Patients.
    Inflamm Bowel Dis. 2019 Mar 7. pii: 5370427. doi: 10.1093.
    PubMed     Abstract available


  604. PETITO V, Fiore L, Lopetuso LR, Scaldaferri F, et al
    Commentary to "Safety, Clinical Response, and Microbiome Findings Following Fecal Microbiota Transplant in Children With Inflammatory Bowel Disease".
    Inflamm Bowel Dis. 2019 Mar 6. pii: 5370426. doi: 10.1093.
    PubMed    


  605. CHEN C, Hartzema AG, Xiao H, Wei YJ, et al
    Real-world Pattern of Biologic Use in Patients With Inflammatory Bowel Disease: Treatment Persistence, Switching, and Importance of Concurrent Immunosuppressive Therapy.
    Inflamm Bowel Dis. 2019 Mar 6. pii: 5370024. doi: 10.1093.
    PubMed     Abstract available


  606. DAO A, Abidian M, Lestrange A, Mattar M, et al
    Oral Vancomycin Induces and Maintains Remission of Ulcerative Colitis in the Subset of Patients With Associated Primary Sclerosing Cholangitis.
    Inflamm Bowel Dis. 2019 Mar 6. pii: 5369961. doi: 10.1093.
    PubMed    


  607. MOULTON CD, Hopkins CWP, Mohamedali Z, Powell N, et al
    Out of Sight, Out of Mind: The Limitations of the Hospital Anxiety and Depression Scale in Inflammatory Bowel Disease.
    Inflamm Bowel Dis. 2019 Mar 2. pii: 5368192. doi: 10.1093.
    PubMed    


  608. MAHADEVAN U, Robinson C, Bernasko N, Boland B, et al
    Inflammatory Bowel Disease in Pregnancy Clinical Care Pathway: A Report From the American Gastroenterological Association IBD Parenthood Project Working Group.
    Inflamm Bowel Dis. 2019 Mar 1. pii: 5368148. doi: 10.1093.
    PubMed    


    February 2019
  609. HANSEN TM, Targownik LE, Karimuddin A, Leung Y, et al
    Management of Biological Therapy Before Elective Inflammatory Bowel Disease Surgeries.
    Inflamm Bowel Dis. 2019 Feb 22. pii: 5362644. doi: 10.1093.
    PubMed     Abstract available


  610. YAN P, Wang Y, Meng X, Yang H, et al
    Whole Exome Sequencing of Ulcerative Colitis-associated Colorectal Cancer Based on Novel Somatic Mutations Identified in Chinese Patients.
    Inflamm Bowel Dis. 2019 Feb 22. pii: 5362640. doi: 10.1093.
    PubMed     Abstract available


  611. MARCIL V, Levy E, Amre D, Serban D, et al
    A Cross-Sectional Study on Malnutrition in Inflammatory Bowel Disease: Is There a Difference Based on Pediatric or Adult Age Grouping?
    Inflamm Bowel Dis. 2019 Feb 22. pii: 5320531. doi: 10.1093.
    PubMed     Abstract available


  612. EAST JE, Boyapati RK, Torres J, Parker CE, et al
    Controversies in Inflammatory Bowel Disease: Exploring Clinical Dilemmas Using Cochrane Reviews.
    Inflamm Bowel Dis. 2019;25:472-478.
    PubMed     Abstract available


  613. KHAN N
    Factors Predicting Severity of Herpes and Improving Herpes Vaccination Among IBD Patients.
    Inflamm Bowel Dis. 2019;25:e24.
    PubMed    


  614. APTE M, Reich J, Zahorian T, Farraye FA, et al
    Improving Vaccination Rates for IBD Patients Through the Use of Local Pharmacies.
    Inflamm Bowel Dis. 2019;25:e19.
    PubMed    


  615. QIN X
    May Dysbiosis Caused by Dietary Chemicals Such as Sucralose and Saccharin Be More Detrimental to the Gut and Health Than Antibiotics? How?
    Inflamm Bowel Dis. 2019;25:e20.
    PubMed    


  616. MAO R, Kurada S, Gordon IO, Baker ME, et al
    The Mesenteric Fat and Intestinal Muscle Interface: Creeping Fat Influencing Stricture Formation in Crohn's Disease.
    Inflamm Bowel Dis. 2019;25:421-426.
    PubMed     Abstract available


  617. BRYANT RV, Schultz CG, Ooi S, Goess C, et al
    Visceral Adipose Tissue Is Associated With Stricturing Crohn's Disease Behavior, Fecal Calprotectin, and Quality of Life.
    Inflamm Bowel Dis. 2019;25:592-600.
    PubMed     Abstract available


  618. ARMUZZI A, Fiorino G, Variola A, Manetti N, et al
    The PROSIT Cohort of Infliximab Biosimilar in IBD: A Prolonged Follow-up on the Effectiveness and Safety Across Italy.
    Inflamm Bowel Dis. 2019;25:568-579.
    PubMed     Abstract available


  619. DENSON LA, Jurickova I, Karns R, Shaw KA, et al
    Genetic and Transcriptomic Variation Linked to Neutrophil Granulocyte-Macrophage Colony-Stimulating Factor Signaling in Pediatric Crohn's Disease.
    Inflamm Bowel Dis. 2019;25:547-560.
    PubMed     Abstract available


  620. QUINN KP, Lightner AL, Faubion WA, Raffals LE, et al
    A Comprehensive Approach to Pouch Disorders.
    Inflamm Bowel Dis. 2019;25:460-471.
    PubMed     Abstract available


  621. NUGENT Z, Singh H, Targownik LE, Bernstein CN, et al
    Herpes Zoster Infection and Herpes Zoster Vaccination in a Population-Based Sample of Persons With IBD: Is There Still an Unmet Need?
    Inflamm Bowel Dis. 2019;25:532-540.
    PubMed     Abstract available


  622. MIZUNO S, Naganuma M, Kanai T
    Idiopathic Thrombocytopenic Purpura Responsive to Surgery for Crohn's Disease.
    Inflamm Bowel Dis. 2019;25:e26.
    PubMed    


  623. NOVELLO M, Shen B, Stocchi L
    Pouchitis as an Indication for Ileal Pouch Surgical Revision.
    Inflamm Bowel Dis. 2019;25:e25.
    PubMed    


  624. GLAPA A, Waraczewski K, Nowak JK, Paszkowski J, et al
    Vitamin K Deficiency in Patients After Restorative Proctocolectomy.
    Inflamm Bowel Dis. 2019;25:e17-e18.
    PubMed    


  625. EL OUALI S, Kessler H, Shen B
    Self-Expandable Metal Stent in the Treatment of Refractory Long Pouch Inlet Stricture.
    Inflamm Bowel Dis. 2019;25:e13-e14.
    PubMed    


  626. DANILUK U, Daniluk J, Kucharski R, Kowalczyk T, et al
    Untargeted Metabolomics and Inflammatory Markers Profiling in Children With Crohn's Disease and Ulcerative Colitis-A Preliminary Study.
    Inflamm Bowel Dis. 2019 Feb 17. pii: 5321879. doi: 10.1093.
    PubMed     Abstract available


  627. BHAT S, Zahorian T, Robert R, Farraye FA, et al
    Advocating for Patients With Inflammatory Bowel Disease: How to Navigate the Prior Authorization Process.
    Inflamm Bowel Dis. 2019 Feb 8. pii: 5310379. doi: 10.1093.
    PubMed     Abstract available


  628. NEXOE AB, Pilecki B, Von Huth S, Husby S, et al
    Colonic Epithelial Surfactant Protein D Expression Correlates with Inflammation in Clinical Colonic Inflammatory Bowel Disease.
    Inflamm Bowel Dis. 2019 Feb 8. pii: 5310373. doi: 10.1093.
    PubMed     Abstract available


  629. ADEDOKUN OJ, Gunn GR 3rd, Leu JH, Gargano C, et al
    Immunogenicity of Golimumab and its Clinical Relevance in Patients With Ulcerative Colitis.
    Inflamm Bowel Dis. 2019 Feb 8. pii: 5310409. doi: 10.1093.
    PubMed     Abstract available


  630. DALAL RS, Osterman MT, Buchner AM, Praestgaard A, et al
    A User-Friendly Prediction Tool to Identify Colectomy Risk in Patients With Ulcerative Colitis.
    Inflamm Bowel Dis. 2019 Feb 8. pii: 5310380. doi: 10.1093.
    PubMed     Abstract available


  631. SHMIDT E, Suarez-Farinas M, Mallette M, Moniz H, et al
    A Longitudinal Study of Sexual Function in Women With Newly Diagnosed Inflammatory Bowel Disease.
    Inflamm Bowel Dis. 2019 Feb 6. pii: 5307860. doi: 10.1093.
    PubMed     Abstract available


  632. BRETON J, Kastl A, Hoffmann N, Rogers R, et al
    Efficacy of Combination Antibiotic Therapy for Refractory Pediatric Inflammatory Bowel Disease.
    Inflamm Bowel Dis. 2019 Feb 4. pii: 5306187. doi: 10.1093.
    PubMed     Abstract available


    January 2019
  633. VELASCO RODRIGUEZ-BELVIS M, Viada Bris JF, Palomino Perez L, Munoz Codoceo RA, et al
    Regain of Response to Adalimumab in a Steroid-Dependent Pediatric Patient With Ulcerative Colitis After Undergoing Selective Granulocyte and Monocyte Apheresis.
    Inflamm Bowel Dis. 2019 Jan 30. pii: 5304206. doi: 10.1093.
    PubMed    


  634. BYNDLOSS MX, Litvak Y, Baumler AJ
    Microbiota-nourishing Immunity and Its Relevance for Ulcerative Colitis.
    Inflamm Bowel Dis. 2019 Jan 30. pii: 5304210. doi: 10.1093.
    PubMed    


  635. LEONE D, Gilardi D, Corro BE, Menichetti J, et al
    Psychological Characteristics of Inflammatory Bowel Disease Patients: A Comparison Between Active and Nonactive Patients.
    Inflamm Bowel Dis. 2019 Jan 28. pii: 5303250. doi: 10.1093.
    PubMed     Abstract available


  636. VASUDEVAN A, Gibson PR, Van Langenberg DR
    Systematic Review: Cost-effective Strategies of Optimizing Anti-tumor Necrosis and Immunomodulators in Inflammatory Bowel Disease.
    Inflamm Bowel Dis. 2019 Jan 25. pii: 5300059. doi: 10.1093.
    PubMed     Abstract available


  637. TACK GJ, de Boer NKH
    Let Us Not Forget HPV Vaccination in Women and Men in IBD.
    Inflamm Bowel Dis. 2019;25:e11.
    PubMed    


  638. WANG X, Guo J, Liu Y, Yu H, et al
    Sucralose Increased Susceptibility to Colitis in Rats.
    Inflamm Bowel Dis. 2019;25:e3-e4.
    PubMed    


  639. RODRIGUEZ-PALACIOS A, Cominelli F
    Myeloperoxidases and Proteobacteria: Reliable Interspecies Biomarkers to Identify and Monitor Pro-inflammatory Diets in Humans.
    Inflamm Bowel Dis. 2019;25:e1-e2.
    PubMed    


  640. BERNSTEIN CN, Shafer LA, Singh H, Targownik L, et al
    Reply to Letter to Editor of Dr. Elia.
    Inflamm Bowel Dis. 2019;25:e9.
    PubMed    


  641. ELIA JR
    IBD Disability Measure: Are Objective Disability Measures and Physical Therapy Strategies Next Logical Steps?
    Inflamm Bowel Dis. 2019;25:e10.
    PubMed    


  642. OPSTELTEN JL, Oldenburg B
    Reply.
    Inflamm Bowel Dis. 2019;25:e5.
    PubMed    


  643. QIN X
    The Effect of Splenda on Gut Microbiota of Humans Could be Much More Detrimental Than in Animals and Deserves More Extensive Research.
    Inflamm Bowel Dis. 2019;25:e7.
    PubMed    


  644. RODRIGUEZ-PALACIOS A, Cominelli F
    Artificial Diets and the Assessment of Negative Effects on the Digestive Health of Humans.
    Inflamm Bowel Dis. 2019;25:e8.
    PubMed    


  645. DOVROLIS N, Drygiannakis I, Filidou E, Kandilogiannakis L, et al
    Gut Microbial Signatures Underline Complicated Crohn's Disease but Vary Between Cohorts; An In Silico Approach.
    Inflamm Bowel Dis. 2019;25:217-225.
    PubMed     Abstract available


  646. WEIZMAN AV, Nguyen GC, Seow CH, Targownik L, et al
    Appropriateness of Biologics in the Management of Crohn's Disease Using RAND/UCLA Appropriateness Methodology.
    Inflamm Bowel Dis. 2019;25:328-335.
    PubMed     Abstract available


  647. SHEN W, Li Y, Zou Y, Cao L, et al
    Mesenteric Adipose Tissue Alterations in Crohn's Disease Are Associated With the Lymphatic System.
    Inflamm Bowel Dis. 2019;25:283-293.
    PubMed     Abstract available


  648. SCHIRBEL A, Rebert N, Sadler T, West G, et al
    Mutual Regulation of TLR/NLR and CEACAM1 in the Intestinal Microvasculature: Implications for IBD Pathogenesis and Therapy.
    Inflamm Bowel Dis. 2019;25:294-305.
    PubMed     Abstract available


  649. BEN-SHACHAR S, Finezilber Y, Elad H, Rabinowitz K, et al
    Genotype-Serotype Interactions Shed Light on Genetic Components of Inflammatory Bowel Diseases.
    Inflamm Bowel Dis. 2019;25:336-344.
    PubMed     Abstract available


  650. BITTON A, Vutcovici M, Lytvyak E, Kachan N, et al
    Selection of Quality Indicators in IBD: Integrating Physician and Patient Perspectives.
    Inflamm Bowel Dis. 2019;25:403-409.
    PubMed     Abstract available


  651. DURICOVA D, Sarter H, Savoye G, Leroyer A, et al
    Impact of Extra-Intestinal Manifestations at Diagnosis on Disease Outcome in Pediatric- and Elderly-Onset Crohn's Disease: A French Population-Based Study.
    Inflamm Bowel Dis. 2019;25:394-402.
    PubMed     Abstract available


  652. XU Y, Yang L, An P, Zhou B, et al
    Meta-Analysis: The Influence of Preoperative Infliximab Use on Postoperative Complications of Crohn's Disease.
    Inflamm Bowel Dis. 2019;25:261-269.
    PubMed     Abstract available


  653. DEEPAK P, Fowler KJ, Fletcher JG, Bruining DH, et al
    Novel Imaging Approaches in Inflammatory Bowel Diseases.
    Inflamm Bowel Dis. 2019;25:248-260.
    PubMed     Abstract available


  654. SHAFER LA, Walker JR, Restall G, Chhibba T, et al
    Association Between IBD Disability and Reduced Work Productivity (Presenteeism): A Population-Based Study in Manitoba, Canada.
    Inflamm Bowel Dis. 2019;25:352-359.
    PubMed     Abstract available


  655. RIVERA ED, Coffey JC, Walsh D, Ehrenpreis ED, et al
    The Mesentery, Systemic Inflammation, and Crohn's Disease.
    Inflamm Bowel Dis. 2019;25:226-234.
    PubMed     Abstract available


  656. LINSON EA, Hanauer SB
    More Than a Tumor Marker...A Potential Role for Alpha-Feto Protein in Inflammatory Bowel Disease.
    Inflamm Bowel Dis. 2019 Jan 8. pii: 5280837. doi: 10.1093.
    PubMed     Abstract available


  657. NARULA N, Pinto-Sanchez MI, Calo NC, Ford AC, et al
    Anxiety But Not Depression Predicts Poor Outcomes in Inflammatory Bowel Disease.
    Inflamm Bowel Dis. 2019 Jan 7. pii: 5280101. doi: 10.1093.
    PubMed     Abstract available


  658. MA D, Cao Y, Wang Z, He J, et al
    CCAT1 lncRNA Promotes Inflammatory Bowel Disease Malignancy by Destroying Intestinal Barrier via Downregulating miR-185-3p.
    Inflamm Bowel Dis. 2019 Jan 4. pii: 5273768. doi: 10.1093.
    PubMed     Abstract available


  659. CHOY MC, Seah D, Faleck DM, Shah SC, et al
    Systematic Review and Meta-analysis: Optimal Salvage Therapy in Acute Severe Ulcerative Colitis.
    Inflamm Bowel Dis. 2019 Jan 3. pii: 5272589. doi: 10.1093.
    PubMed     Abstract available


  660. ARIHIRO S, Nakashima A, Matsuoka M, Suto S, et al
    Randomized Trial of Vitamin D Supplementation to Prevent Seasonal Influenza and Upper Respiratory Infection in Patients With Inflammatory Bowel Disease.
    Inflamm Bowel Dis. 2019 Jan 2. pii: 5270748. doi: 10.1093.
    PubMed     Abstract available


  661. RENOUF MJ, Cho YH, McPhee JB
    Emergent Behavior of IBD-Associated Escherichia coli During Disease.
    Inflamm Bowel Dis. 2019;25:33-44.
    PubMed     Abstract available


  662. BUTTO LF, Jia LG, Arseneau KO, Tamagawa H, et al
    Death-Domain-Receptor 3 Deletion Normalizes Inflammatory Gene Expression and Prevents Ileitis in Experimental Crohn's Disease.
    Inflamm Bowel Dis. 2019;25:14-26.
    PubMed     Abstract available


  663. ZHANG YG, Lu R, Xia Y, Zhou D, et al
    Lack of Vitamin D Receptor Leads to Hyperfunction of Claudin-2 in Intestinal Inflammatory Responses.
    Inflamm Bowel Dis. 2019;25:97-110.
    PubMed     Abstract available


  664. DELDAY M, Mulder I, Logan ET, Grant G, et al
    Bacteroides thetaiotaomicron Ameliorates Colon Inflammation in Preclinical Models of Crohn's Disease.
    Inflamm Bowel Dis. 2019;25:85-96.
    PubMed     Abstract available


  665. STEINHART AH, Panaccione R, Targownik L, Bressler B, et al
    Clinical Practice Guideline for the Medical Management of Perianal Fistulizing Crohn's Disease: The Toronto Consensus.
    Inflamm Bowel Dis. 2019;25:1-13.
    PubMed     Abstract available


  666. CUSHING KC, Mclean R, McDonald KG, Gustafsson JK, et al
    Predicting Risk of Postoperative Disease Recurrence in Crohn's Disease: Patients With Indolent Crohn's Disease Have Distinct Whole Transcriptome Profiles at the Time of First Surgery.
    Inflamm Bowel Dis. 2019;25:180-193.
    PubMed     Abstract available


  667. SPENCER E, Norris E, Williams C, Dubinsky MC, et al
    The Impact of Thiopurine Metabolite Monitoring on the Durability of Thiopurine Monotherapy in Pediatric IBD.
    Inflamm Bowel Dis. 2019;25:142-149.
    PubMed     Abstract available


  668. EL-MATARY W, Walters TD, Huynh HQ, deBruyn J, et al
    Higher Postinduction Infliximab Serum Trough Levels Are Associated With Healing of Fistulizing Perianal Crohn's Disease in Children.
    Inflamm Bowel Dis. 2019;25:150-155.
    PubMed     Abstract available


  669. SAROLI PALUMBO C, Restellini S, Chao CY, Aruljothy A, et al
    Screening for Nonalcoholic Fatty Liver Disease in Inflammatory Bowel Diseases: A Cohort Study Using Transient Elastography.
    Inflamm Bowel Dis. 2019;25:124-133.
    PubMed     Abstract available


  670. LEGA S, Phan BL, Rosenthal CJ, Gordon J, et al
    Proactively Optimized Infliximab Monotherapy Is as Effective as Combination Therapy in IBD.
    Inflamm Bowel Dis. 2019;25:134-141.
    PubMed     Abstract available


  671. DOTSON JL, Kappelman MD, Bricker J, Andridge R, et al
    Multicenter Evaluation of Emergency Department Treatment for Children and Adolescents With Crohn's Disease According to Race/Ethnicity and Insurance Payor Status.
    Inflamm Bowel Dis. 2019;25:194-203.
    PubMed     Abstract available


    December 2018
  672. KARIYAWASAM VC, Kim S, Mourad FH, Selinger CP, et al
    Comorbidities Rather Than Age Are Associated With the Use of Immunomodulators in Elderly-onset Inflammatory Bowel Disease.
    Inflamm Bowel Dis. 2018 Dec 29. pii: 5266808. doi: 10.1093.
    PubMed     Abstract available


  673. HOOPER KM, Barlow PG, Henderson P, Stevens C, et al
    Interactions Between Autophagy and the Unfolded Protein Response: Implications for Inflammatory Bowel Disease.
    Inflamm Bowel Dis. 2018 Dec 24. pii: 5259659. doi: 10.1093.
    PubMed     Abstract available


  674. BARNES EL, Long MD, Kappelman MD, Martin CF, et al
    High Patient Activation Is Associated With Remission in Patients With Inflammatory Bowel Disease.
    Inflamm Bowel Dis. 2018 Dec 22. pii: 5257738. doi: 10.1093.
    PubMed     Abstract available


  675. MACALUSO FS, Maida M, Ventimiglia M, Renna S, et al
    Factors Affecting Clinical and Endoscopic Outcomes of Placebo Arm in Trials of Biologics and Small Molecule Drugs in Ulcerative Colitis: A Meta-Analysis.
    Inflamm Bowel Dis. 2018 Dec 22. pii: 5257772. doi: 10.1093.
    PubMed     Abstract available


  676. LIN SC, Goldowsky A, Papamichael K, Cheifetz AS, et al
    The Treatment of Inflammatory Bowel Disease in Patients With a History of Malignancy.
    Inflamm Bowel Dis. 2018 Dec 22. pii: 5257774. doi: 10.1093.
    PubMed     Abstract available


  677. FUKAURA K, Iboshi Y, Ogino H, Ihara E, et al
    Mucosal Profiles of Immune Molecules Related to T Helper and Regulatory T Cells Predict Future Relapse in Patients With Quiescent Ulcerative Colitis.
    Inflamm Bowel Dis. 2018 Dec 20. pii: 5298886. doi: 10.1093.
    PubMed     Abstract available


  678. SITKIN S, Pokrotnieks J
    Gut Microbiota as a Host Defender and a Foe: The 2 Faces of Commensal Bacteroides thetaiotaomicron in Inflammatory Bowel Disease.
    Inflamm Bowel Dis. 2018 Dec 17. pii: 5250879. doi: 10.1093.
    PubMed    


  679. ASHTON JJ, Borca F, Mossotto E, Phan HTT, et al
    Analysis and Hierarchical Clustering of Blood Results Before Diagnosis in Pediatric Inflammatory Bowel Disease.
    Inflamm Bowel Dis. 2018 Dec 17. pii: 5250787. doi: 10.1093.
    PubMed     Abstract available


  680. KRISTENSEN MS, Kjaerulff TM, Ersboll AK, Green A, et al
    The Influence of Antidepressants on the Disease Course Among Patients With Crohn's Disease and Ulcerative Colitis-A Danish Nationwide Register-Based Cohort Study.
    Inflamm Bowel Dis. 2018 Dec 14. pii: 5247629. doi: 10.1093.
    PubMed     Abstract available


  681. DEBRUYN JCC, Soon IS, Fonseca K, Feng S, et al
    Serologic Status of Routine Childhood Vaccines, Cytomegalovirus, and Epstein-Barr Virus in Children With Inflammatory Bowel Disease.
    Inflamm Bowel Dis. 2018 Dec 14. pii: 5247477. doi: 10.1093.
    PubMed     Abstract available


  682. PABLA BS, Scoville EA, Sarker S, Dalal RL, et al
    Histoplasmosis as a Complication of Inflammatory Bowel Disease Therapy: A Case Series.
    Inflamm Bowel Dis. 2018 Dec 13. pii: 5244945. doi: 10.1093.
    PubMed    


  683. OBRAZTSOV IV, Shirokikh KE, Obraztsova OI, Shapina MV, et al
    Multiple Cytokine Profiling: A New Model to Predict Response to Tumor Necrosis Factor Antagonists in Ulcerative Colitis Patients.
    Inflamm Bowel Dis. 2018 Dec 13. pii: 5245415. doi: 10.1093.
    PubMed     Abstract available


  684. SONG G, Fiocchi C, Achkar JP
    Acupuncture in Inflammatory Bowel Disease.
    Inflamm Bowel Dis. 2018 Dec 11. pii: 5238704. doi: 10.1093.
    PubMed     Abstract available


  685. YANG L, Tang S, Baker SS, Arijs I, et al
    Difference in Pathomechanism Between Crohn's Disease and Ulcerative Colitis Revealed by Colon Transcriptome.
    Inflamm Bowel Dis. 2018 Dec 4. pii: 5230141. doi: 10.1093.
    PubMed     Abstract available


    November 2018
  686. PANHWAR MS, Mansoor E, Al-Kindi SG, Sinh P, et al
    Risk of Myocardial Infarction in Inflammatory Bowel Disease: A Population-based National Study.
    Inflamm Bowel Dis. 2018 Nov 30. pii: 5220868. doi: 10.1093.
    PubMed     Abstract available


  687. MALDONADO FJ, Al Bawardy BF, Nehra AK, Lee YS, et al
    Findings of CT-Derived Bone Strength Assessment in Inflammatory Bowel Disease Patients Undergoing CT Enterography in Clinical Practice.
    Inflamm Bowel Dis. 2018 Nov 27. pii: 5209842. doi: 10.1093.
    PubMed     Abstract available


  688. FRIEDMAN S
    A Meta-analysis of Sexual Function in Patients With Inflammatory Bowel Disease: Examining a Small Piece of the Puzzle.
    Inflamm Bowel Dis. 2018 Nov 23. pii: 5203541. doi: 10.1093.
    PubMed    


  689. DIAB J, Al-Mahdi R, Gouveia-Figueira S, Hansen T, et al
    A Quantitative Analysis of Colonic Mucosal Oxylipins and Endocannabinoids in Treatment-Naive and Deep Remission Ulcerative Colitis Patients and the Potential Link With Cytokine Gene Expression.
    Inflamm Bowel Dis. 2018 Nov 22. pii: 5198657. doi: 10.1093.
    PubMed     Abstract available


  690. SCAIOLI E, Belluzzi A
    Endoscopic and Histological Normalization as a Target to Prevent Clinical Relapse in Ulcerative Colitis Patients.
    Inflamm Bowel Dis. 2018 Nov 21. pii: 5194185. doi: 10.1093.
    PubMed    


  691. OH SH, Sung YH, Kim I, Sim CK, et al
    Novel Compound Heterozygote Mutation in IL10RA in a Patient With Very Early-Onset Inflammatory Bowel Disease.
    Inflamm Bowel Dis. 2018 Nov 21. pii: 5194406. doi: 10.1093.
    PubMed     Abstract available



  692. Erratum to Malignancy and Mortality in Pediatric-onset Inflammatory Bowel Disease: A Systematic Review.
    Inflamm Bowel Dis. 2018 Nov 19. pii: 5191226. doi: 10.1093.
    PubMed    


  693. VINAYAGA-PAVAN M, Frampton M, Pontikos N, Levine AP, et al
    Elevation in Cell Cycle and Protein Metabolism Gene Transcription in Inactive Colonic Tissue From Icelandic Patients With Ulcerative Colitis.
    Inflamm Bowel Dis. 2018 Nov 19. pii: 5193210. doi: 10.1093.
    PubMed     Abstract available


  694. KHERA AJ, Chase JW, Salzberg M, Thompson AJV, et al
    Gut-Directed Pelvic Floor Behavioral Treatment for Fecal Incontinence and Constipation in Patients with Inflammatory Bowel Disease.
    Inflamm Bowel Dis. 2018 Nov 19. pii: 5191232. doi: 10.1093.
    PubMed     Abstract available


  695. KELLY OB, Li N, Smith M, Chan J, et al
    The Prevalence and Clinical Associations of Subclinical Sacroiliitis in Inflammatory Bowel Disease.
    Inflamm Bowel Dis. 2018 Nov 14. pii: 5183322. doi: 10.1093.
    PubMed     Abstract available


  696. AHMED Z, Sarvepalli S, Garber A, Regueiro M, et al
    Value-Based Health Care in Inflammatory Bowel Disease.
    Inflamm Bowel Dis. 2018 Nov 9. pii: 5168541. doi: 10.1093.
    PubMed     Abstract available


  697. VIADA BRIS JF, Velasco Rodriguez-Belvis M, de Lucas Collantes C, Aparicio Lopez C, et al
    Erratum to Ulcerative Colitis and Atypical Hemolytic-Uremic Syndrome: An Unusual But Potentially Life-threatening Complication.
    Inflamm Bowel Dis. 2018 Nov 8. pii: 5167023. doi: 10.1093.
    PubMed    


  698. RAY G, Longworth MS
    Epigenetics, DNA Organization, and Inflammatory Bowel Disease.
    Inflamm Bowel Dis. 2018 Nov 8. pii: 5166720. doi: 10.1093.
    PubMed     Abstract available


  699. QAZI T, Farraye FA
    Sleep and Inflammatory Bowel Disease: An Important Bi-Directional Relationship.
    Inflamm Bowel Dis. 2018 Nov 2. pii: 5155657. doi: 10.1093.
    PubMed     Abstract available


    October 2018
  700. FEAGAN BG, Schreiber S, Wolf DC, Axler JL, et al
    Sustained Clinical Remission With Vedolizumab in Patients With Moderate-to-Severe Ulcerative Colitis.
    Inflamm Bowel Dis. 2018 Oct 25. pii: 5144762. doi: 10.1093.
    PubMed     Abstract available


  701. SWAMINATH A, Berlin EP, Cheifetz A, Hoffenberg E, et al
    The Role of Cannabis in the Management of Inflammatory Bowel Disease: A Review of Clinical, Scientific, and Regulatory Information: Commissioned by the Crohn's and Colitis Foundation.
    Inflamm Bowel Dis. 2018 Oct 24. pii: 5144402. doi: 10.1093.
    PubMed     Abstract available


  702. GHERSIN I, Khateeb N, Katz LH, Daher S, et al
    Anthropometric Measures in Adolescents With Inflammatory Bowel Disease: A Population-Based Study.
    Inflamm Bowel Dis. 2018 Oct 24. pii: 5144270. doi: 10.1093.
    PubMed     Abstract available


  703. DROBIN K, Assadi G, Hong MG, Andersson E, et al
    Targeted Analysis of Serum Proteins Encoded at Known Inflammatory Bowel Disease Risk Loci.
    Inflamm Bowel Dis. 2018 Oct 24. pii: 5144272. doi: 10.1093.
    PubMed     Abstract available


  704. DE JONG DC, Lo Wenberg M, Koumoutsos I, Ray S, et al
    Validation and Investigation of the Operating Characteristics of the Ulcerative Colitis Endoscopic Index of Severity.
    Inflamm Bowel Dis. 2018 Oct 17. pii: 5134157. doi: 10.1093.
    PubMed     Abstract available


  705. POUILLON L, Baumann C, Rousseau H, Choukour M, et al
    Treatment Persistence of Infliximab Versus Adalimumab in Ulcerative Colitis: A 16-Year Single-Center Experience.
    Inflamm Bowel Dis. 2018 Oct 16. pii: 5133439. doi: 10.1093.
    PubMed     Abstract available


  706. KATSANOS KH, Saridi M, Albani E, Mantzouranis G, et al
    Sexual Dysfunction in Patients With Inflammatory Bowel Disease.
    Inflamm Bowel Dis. 2018;24:2348-2349.
    PubMed    


  707. TINSLEY A, Navabi S, Williams ED, Liu G, et al
    Erratum to Increased Risk of Influenza and Influenza-Related Complications Among 140,480 Patients With Inflammatory Bowel Disease.
    Inflamm Bowel Dis. 2018 Oct 12. pii: 5128779. doi: 10.1093.
    PubMed    


  708. LUKIN DJ, Lawlor G, Hudesman DP, Durbin L, et al
    Escalation of Immunosuppressive Therapy for Inflammatory Bowel Disease Is Not Associated With Adverse Outcomes After Infection With Clostridium difficile.
    Inflamm Bowel Dis. 2018 Oct 12. pii: 5124548. doi: 10.1093.
    PubMed     Abstract available


  709. MUNIZ PEDROGO DA, Chen J, Hillmann B, Jeraldo P, et al
    An Increased Abundance of Clostridiaceae Characterizes Arthritis in Inflammatory Bowel Disease and Rheumatoid Arthritis: A Cross-sectional Study.
    Inflamm Bowel Dis. 2018 Oct 12. pii: 5128781. doi: 10.1093.
    PubMed     Abstract available


  710. EGBERG MD, Galanko JA, Barnes EL, Kappelman MD, et al
    Thrombotic and Infectious Risks of Parenteral Nutrition in Hospitalized Pediatric Inflammatory Bowel Disease.
    Inflamm Bowel Dis. 2018 Oct 10. pii: 5126394. doi: 10.1093.
    PubMed     Abstract available


  711. GRINDAL AW, Khan R, Scaffidi MA, Rumman A, et al
    Financial Conflicts of Interest in Inflammatory Bowel Disease Guidelines.
    Inflamm Bowel Dis. 2018 Oct 5. pii: 5120389. doi: 10.1093.
    PubMed     Abstract available


  712. COTE-DAIGNEAULT J, Bessissow T, Nicolae MV, Nie R, et al
    Herpes Zoster Incidence in Inflammatory Bowel Disease Patients: A Population-Based Study.
    Inflamm Bowel Dis. 2018 Oct 5. pii: 5120076. doi: 10.1093.
    PubMed     Abstract available


  713. REINISCH W, Bressler B, Curtis R, Parikh A, et al
    Fecal Calprotectin Responses Following Induction Therapy With Vedolizumab in Moderate to Severe Ulcerative Colitis: A Post Hoc Analysis of GEMINI 1.
    Inflamm Bowel Dis. 2018 Oct 5. pii: 5119830. doi: 10.1093.
    PubMed     Abstract available


  714. TRAN L, Mulligan K
    A Systematic Review of Self-Management Interventions for Children and Adolescents With Inflammatory Bowel Disease.
    Inflamm Bowel Dis. 2018 Oct 5. pii: 5117847. doi: 10.1093.
    PubMed     Abstract available


  715. BATTAT R, Dulai PS, Vande Casteele N, Evans E, et al
    Biomarkers Are Associated With Clinical and Endoscopic Outcomes With Vedolizumab Treatment in Ulcerative Colitis.
    Inflamm Bowel Dis. 2018 Oct 5. pii: 5117434. doi: 10.1093.
    PubMed     Abstract available


  716. GREENSTEIN R, Brown S
    A Data-Based Hypothesis That Inflammatory Bowel Disease Unclassified (IBD-U) May Indicate That IBD Is a Spectrum of a Single Infectious Intestinal Disease.
    Inflamm Bowel Dis. 2018 Oct 5. pii: 5116939. doi: 10.1093.
    PubMed    


    September 2018
  717. FUKUDA T, Naganuma M, Sugimoto S, Ono K, et al
    Efficacy of Therapeutic Intervention for Patients With an Ulcerative Colitis Mayo Endoscopic Score of 1.
    Inflamm Bowel Dis. 2018 Sep 27. pii: 5108467. doi: 10.1093.
    PubMed     Abstract available


  718. SELINGER CP, Ochieng AO, George V, Leong RW, et al
    The Accuracy of Adherence Self-report Scales in Patients on Thiopurines for Inflammatory Bowel Disease: A Comparison With Drug Metabolite Levels and Medication Possession Ratios.
    Inflamm Bowel Dis. 2018 Sep 27. pii: 5108473. doi: 10.1093.
    PubMed     Abstract available


  719. SOLANKY D, Pardi DS, Loftus EV Jr, Khanna S, et al
    Colon Surgery Risk With Corticosteroids Versus Immunomodulators or Biologics in Inflammatory Bowel Disease Patients With Clostridium difficile Infection.
    Inflamm Bowel Dis. 2018 Sep 26. pii: 5107525. doi: 10.1093.
    PubMed     Abstract available


  720. HABOUBI N
    Reporting Colonic Biopsies in Patients With Inflammatory Bowel Disease; a Practical Approach.
    Inflamm Bowel Dis. 2018 Sep 25. pii: 5106751. doi: 10.1093.
    PubMed     Abstract available


  721. MAO EJ, Sheibani S, Martin C, Bloomfeld RS, et al
    Preventive Health Care Among Postpartum Women With Inflammatory Bowel Disease: Results From the PIANO Registry.
    Inflamm Bowel Dis. 2018 Sep 25. pii: 5106752. doi: 10.1093.
    PubMed     Abstract available


  722. KHANNA R, Vande Casteele N
    Use of Precision Medicine in Clinical Trials in Inflammatory Bowel Disease.
    Inflamm Bowel Dis. 2018 Sep 25. pii: 5106774. doi: 10.1093.
    PubMed     Abstract available


  723. KRUGER AJ, Hinton A, Afzali A
    Index Severity Score and Early Readmission Predicts Increased Mortality in Ulcerative Colitis Patients.
    Inflamm Bowel Dis. 2018 Sep 20. pii: 5104366. doi: 10.1093.
    PubMed     Abstract available


  724. ZHENG C, Huang Y, Hu W, Shi J, et al
    Phenotypic Characterization of Very Early-Onset Inflammatory Bowel Disease with Interleukin-10 Signaling Deficiency: Based on a Large Cohort Study.
    Inflamm Bowel Dis. 2018 Sep 13. pii: 5096668. doi: 10.1093.
    PubMed     Abstract available


  725. MINACAPELLI CD, Bajpai M, Geng X, Van Gurp J, et al
    miR-206 as a Biomarker for Response to Mesalamine Treatment in Ulcerative Colitis.
    Inflamm Bowel Dis. 2018 Sep 11. pii: 5094859. doi: 10.1093.
    PubMed     Abstract available


  726. BORREN NZ, Khalili H, Luther J, Colizzo FP, et al
    Second-Look Endoscopy in Hospitalized Severe Ulcerative Colitis: A Retrospective Cohort Study.
    Inflamm Bowel Dis. 2018 Sep 11. pii: 5094888. doi: 10.1093.
    PubMed     Abstract available


  727. REICH J, Guo L, Groshek J, Weinberg J, et al
    Social Media Use and Preferences in Patients With Inflammatory Bowel Disease.
    Inflamm Bowel Dis. 2018 Sep 7. pii: 5092671. doi: 10.1093.
    PubMed     Abstract available


    August 2018
  728. JACKSON BD, De Cruz P
    Quality of Care in Patients With Inflammatory Bowel Disease.
    Inflamm Bowel Dis. 2018 Aug 29. pii: 5086256. doi: 10.1093.
    PubMed     Abstract available


  729. KAMAL A, Padival R, Lashner B
    Inflammatory Bowel Disease and Irritable Bowel Syndrome: What to Do When There Is an Overlap.
    Inflamm Bowel Dis. 2018 Aug 29. pii: 5086585. doi: 10.1093.
    PubMed    


  730. AL-BAWARDY B, Ramos GP, Willrich MAV, Jenkins SM, et al
    Vedolizumab Drug Level Correlation With Clinical Remission, Biomarker Normalization, and Mucosal Healing in Inflammatory Bowel Disease.
    Inflamm Bowel Dis. 2018 Aug 24. pii: 5079133. doi: 10.1093.
    PubMed     Abstract available


  731. PEREZ-JELDRES T, Tyler CJ, Boyer JD, Karuppuchamy T, et al
    Cell Trafficking Interference in Inflammatory Bowel Disease: Therapeutic Interventions Based on Basic Pathogenesis Concepts.
    Inflamm Bowel Dis. 2018 Aug 24. pii: 5079145. doi: 10.1093.
    PubMed     Abstract available


  732. FRITZ J, Walia C, Elkadri A, Pipkorn R, et al
    A Systematic Review of Micronutrient Deficiencies in Pediatric Inflammatory Bowel Disease.
    Inflamm Bowel Dis. 2018 Aug 21. pii: 5077382. doi: 10.1093.
    PubMed     Abstract available


  733. NISSEN LHC, Derikx LAAP, Jacobs AME, van Herpen CM, et al
    Risk Factors and Clinical Outcomes of Head and Neck Cancer in Inflammatory Bowel Disease: A Nationwide Cohort Study.
    Inflamm Bowel Dis. 2018;24:2015-2026.
    PubMed     Abstract available


  734. DAI C, Jiang M, Sun MJ
    The Effect of Smoking on the Risk of Pouchitis in Ulcerative Colitis Patients With Ileal Pouch-anal Anastomosis.
    Inflamm Bowel Dis. 2018 Aug 14. pii: 5074361. doi: 10.1093.
    PubMed    


  735. ISHIKAWA D, Sasaki T, Takahashi M, Kuwahara-Arai K, et al
    The Microbial Composition of Bacteroidetes Species in Ulcerative Colitis Is Effectively Improved by Combination Therapy With Fecal Microbiota Transplantation and Antibiotics.
    Inflamm Bowel Dis. 2018 Aug 14. pii: 5074053. doi: 10.1093.
    PubMed     Abstract available


  736. GORREPATI VS, Stuart A, Deiling S, Koltun W, et al
    Response to the Letter to the Editor from Dai et al, Regarding "Smoking and the Risk of Pouchitis in Ulcerative Colitis Patients with Ileal Pouch Anal Anastomosis".
    Inflamm Bowel Dis. 2018 Aug 13. pii: 5073207. doi: 10.1093.
    PubMed    


  737. NORGARD BM, Magnussen B, Fedder J, de Silva PS, et al
    The Risk of Elective Abortion in Women With Crohn's Disease and Ulcerative Colitis: A Nationwide Cohort Study.
    Inflamm Bowel Dis. 2018 Aug 10. pii: 5069528. doi: 10.1093.
    PubMed     Abstract available


  738. AZUARA D, Ausso S, Rodriguez-Moranta F, Guardiola J, et al
    New Methylation Biomarker Panel for Early Diagnosis of Dysplasia or Cancer in High-Risk Inflammatory Bowel Disease Patients.
    Inflamm Bowel Dis. 2018 Aug 7. pii: 5067818. doi: 10.1093.
    PubMed     Abstract available


  739. BERNARDO S, Fernandes SR, Goncalves AR, Valente A, et al
    Predicting the Course of Disease in Hospitalized Patients With Acute Severe Ulcerative Colitis.
    Inflamm Bowel Dis. 2018 Aug 6. pii: 5067145. doi: 10.1093.
    PubMed     Abstract available


  740. SITKIN S, Pokrotnieks J
    Clinical Potential of Anti-inflammatory Effects of Faecalibacterium prausnitzii and Butyrate in Inflammatory Bowel Disease.
    Inflamm Bowel Dis. 2018 Aug 6. pii: 5067149. doi: 10.1093.
    PubMed    


  741. GUADAGNO E, De Rosa F, Borrelli G, Luglio G, et al
    High-grade MiNEN in a Long-standing History of Ulcerative Colitis: An Unexpected Evolution.
    Inflamm Bowel Dis. 2018 Aug 6. pii: 5067338. doi: 10.1093.
    PubMed    


  742. LYNCH B, Roberts A, Lee Grotz V
    Is Splenda, or Sucralose, Causally Linked to Inflammatory Bowel Disease?
    Inflamm Bowel Dis. 2018 Aug 6. pii: 5067397. doi: 10.1093.
    PubMed    


  743. TEN HOVE JR, Bogaerts JMK, Bak MTJ, Lacle MM, et al
    Malignant and Nonmalignant Complications of the Rectal Stump in Patients with Inflammatory Bowel Disease.
    Inflamm Bowel Dis. 2018 Aug 1. pii: 5063333. doi: 10.1093.
    PubMed     Abstract available


    July 2018
  744. OUAHED J, Gordon W, Canavan JB, Zhou H, et al
    Mucosal Gene Expression in Pediatric and Adult Patients With Ulcerative Colitis Permits Modeling of Ideal Biopsy Collection Strategy for Transcriptomic Analysis.
    Inflamm Bowel Dis. 2018 Jul 31. pii: 5062951. doi: 10.1093.
    PubMed     Abstract available


  745. LAMBDIN JT, Borum M
    Cervical Cancer Screening in Patients with Inflammatory Bowel Disease.
    Inflamm Bowel Dis. 2018 Jul 31. pii: 5061940. doi: 10.1093.
    PubMed    


  746. WATT PJ, Irving MA
    A Diagnosis of Inflammatory Bowel Disease and Access to Psychotherapy: Rural Patients Who Accept Treatment Report Psychosomatic Benefits.
    Inflamm Bowel Dis. 2018 Jul 21. pii: 5056917. doi: 10.1093.
    PubMed    


  747. TINSLEY A, Navabi S, Williams ED, Liu G, et al
    Increased Risk of Influenza and Influenza-Related Complications Among 140,480 Patients With Inflammatory Bowel Disease.
    Inflamm Bowel Dis. 2018 Jul 18. pii: 5055346. doi: 10.1093.
    PubMed     Abstract available


  748. PORTER RJ, Andrews C, Brice DP, Durum SK, et al
    Can We Target Endogenous Anti-inflammatory Responses as a Therapeutic Strategy for Inflammatory Bowel Disease?
    Inflamm Bowel Dis. 2018 Jul 18. pii: 5055343. doi: 10.1093.
    PubMed     Abstract available



  749. Corrigendum to Postoperative Outcomes in Vedolizumab-Treated Patients Undergoing Major Abdominal Operations for Inflammatory Bowel Disease: Retrospective Multicenter Cohort Study.
    Inflamm Bowel Dis. 2018 Jul 17. pii: 5054631. doi: 10.1093.
    PubMed    


  750. VOLK N, Siegel CA
    Defining Failure of Medical Therapy for Inflammatory Bowel Disease.
    Inflamm Bowel Dis. 2018 Jul 16. pii: 5054534. doi: 10.1093.
    PubMed     Abstract available


  751. TORMEY LK, Reich J, Chen YS, Singh A, et al
    Limited Health Literacy Is Associated With Worse Patient-Reported Outcomes in Inflammatory Bowel Disease.
    Inflamm Bowel Dis. 2018 Jul 10. pii: 5051146. doi: 10.1093.
    PubMed     Abstract available


  752. BERNSTEIN CN, Hitchon CA, Walld R, Bolton JM, et al
    Increased Burden of Psychiatric Disorders in Inflammatory Bowel Disease.
    Inflamm Bowel Dis. 2018 Jul 7. pii: 5050505. doi: 10.1093.
    PubMed     Abstract available


  753. WREN AA, Bensen R, Sceats L, Dehghan M, et al
    Starting Young: Trends in Opioid Therapy Among US Adolescents and Young Adults With Inflammatory Bowel Disease in the Truven MarketScan Database Between 2007 and 2015.
    Inflamm Bowel Dis. 2018 Jul 7. pii: 5050495. doi: 10.1093.
    PubMed     Abstract available


  754. KUENZIG ME, Benchimol EI
    Chronic Opioid Use Among Youth With Inflammatory Bowel Disease: A New Approach Is Needed.
    Inflamm Bowel Dis. 2018 Jul 7. pii: 5050494. doi: 10.1093.
    PubMed    


  755. REINISCH W, Colombel JF, Gibson PR, Rutgeerts P, et al
    Continuous Clinical Response Is Associated With a Change of Disease Course in Patients With Moderate to Severe Ulcerative Colitis Treated With Golimumab.
    Inflamm Bowel Dis. 2018 Jul 6. pii: 5049378. doi: 10.1093.
    PubMed     Abstract available



  756. Corrigendum to Evaluation of the Quality of Semen and Sexual Function in Men with Inflammatory Bowel Disease.
    Inflamm Bowel Dis. 2018 Jul 5. pii: 5049267. doi: 10.1093.
    PubMed    


  757. KHAN N, Trivedi C, Kavani H, Lewis J, et al
    Frequency of Herpes Zoster Vaccination Among Inflammatory Bowel Disease Patients.
    Inflamm Bowel Dis. 2018 Jul 5. pii: 5049271. doi: 10.1093.
    PubMed     Abstract available



  758. Corrigendum to Reviewing the Risk of Colorectal Cancer in Inflammatory Bowel Disease After Liver Transplantation for Primary Sclerosing Cholangitis.
    Inflamm Bowel Dis. 2018 Jul 5. pii: 5049258. doi: 10.1093.
    PubMed    


  759. MAHADEVAN U, Dubinsky MC, Su C, Lawendy N, et al
    Outcomes of Pregnancies With Maternal/Paternal Exposure in the Tofacitinib Safety Databases for Ulcerative Colitis.
    Inflamm Bowel Dis. 2018 Jul 2. pii: 5047917. doi: 10.1093.
    PubMed     Abstract available


    June 2018
  760. SMITS LJT, van Esch AAJ, Derikx LAAP, Boshuizen R, et al
    Drug Survival and Immunogenicity After Switching From Remicade to Biosimilar CT-P13 in Inflammatory Bowel Disease Patients: Two-year Follow-up of a Prospective Observational Cohort Study.
    Inflamm Bowel Dis. 2018 Jun 27. pii: 5045878. doi: 10.1093.
    PubMed     Abstract available


  761. SHIVASHANKAR R, Lichtenstein GR
    Mimics of Inflammatory Bowel Disease.
    Inflamm Bowel Dis. 2018 Jun 27. pii: 5045858. doi: 10.1093.
    PubMed     Abstract available


  762. XUE M, Shi L, Wang W, Chen S, et al
    An Overview of Molecular Profiles in Ulcerative Colitis-Related Cancer.
    Inflamm Bowel Dis. 2018 Jun 25. pii: 5044833. doi: 10.1093.
    PubMed     Abstract available


  763. DE SILVA PS, O'Toole A, Marc LG, Ulysse CA, et al
    Development of a Sexual Dysfunction Scale for Women With Inflammatory Bowel Disease.
    Inflamm Bowel Dis. 2018 Jun 22. pii: 5042958. doi: 10.1093.
    PubMed     Abstract available


  764. VIADA BRIS JF, Velasco Rodriguez-Belvis M, de Lucas Collantes C, Aparicio Lopez C, et al
    Ulcerative Colitis and Atypical Hemolytic-Uremic Syndrome: An Unusual But Potentially Life-threating Life Complication.
    Inflamm Bowel Dis. 2018 Jun 20. pii: 5040737. doi: 10.1093.
    PubMed     Abstract available


  765. TAIDA T, Arai M, Fujie M, Akizue N, et al
    Real-time Endoscopy-Guided Measurement of Rectal Mucosal Admittance Is a Novel and Safe Method for Predicting Ulcerative Colitis Relapse.
    Inflamm Bowel Dis. 2018 Jun 19. pii: 5040214. doi: 10.1093.
    PubMed     Abstract available


  766. PICORARO JA, Lee D, Heller CA, Weaver A, et al
    Pediatric Inflammatory Bowel Disease Clinical Innovations Meeting of the Crohn's & Colitis Foundation: Charting the Future of Pediatric IBD.
    Inflamm Bowel Dis. 2018 Jun 19. pii: 5040260. doi: 10.1093.
    PubMed     Abstract available


  767. BOSSUYT P, Baert F, D'Heygere F, Nakad A, et al
    Early Mucosal Healing Predicts Favorable Outcomes in Patients With Moderate to Severe Ulcerative Colitis Treated With Golimumab: Data From the Real-life BE-SMART Cohort.
    Inflamm Bowel Dis. 2018 Jun 15. pii: 5038936. doi: 10.1093.
    PubMed     Abstract available


  768. LEE CK, Melmed GY, Mann A, Danovitch I, et al
    A Multidisciplinary Approach to Biopsychosocial Care for Adults With Inflammatory Bowel Disease: A Pilot Study.
    Inflamm Bowel Dis. 2018 Jun 15. pii: 5038934. doi: 10.1093.
    PubMed     Abstract available


  769. PHILPOTT JR, Kurowski JA
    Challenges in Transitional Care in Inflammatory Bowel Disease: A Review of the Current Literature in Transition Readiness and Outcomes.
    Inflamm Bowel Dis. 2018 Jun 11. pii: 5035657. doi: 10.1093.
    PubMed     Abstract available


  770. SLONIM-NEVO V, Sarid O, Friger M, Schwartz D, et al
    Effect of Social Support on Psychological Distress and Disease Activity in Inflammatory Bowel Disease Patients.
    Inflamm Bowel Dis. 2018;24:1389-1400.
    PubMed     Abstract available


  771. TYLER CJ, Perez-Jeldres T, Ehinger E, Capaldo B, et al
    Implementation of Mass Cytometry as a Tool for Mechanism of Action Studies in Inflammatory Bowel Disease.
    Inflamm Bowel Dis. 2018 Jun 8. pii: 5034710. doi: 10.1093.
    PubMed     Abstract available


  772. WHITEOAK SR, Claridge A, Balendran CA, Harris RJ, et al
    MicroRNA-31 Targets Thymic Stromal Lymphopoietin in Mucosal Infiltrated CD4+ T Cells: A Role in Achieving Mucosal Healing in Ulcerative Colitis?
    Inflamm Bowel Dis. 2018 Jun 8. pii: 5034803. doi: 10.1093.
    PubMed     Abstract available


  773. WHALEY KG, Rosen MJ
    Contemporary Medical Management of Acute Severe Ulcerative Colitis.
    Inflamm Bowel Dis. 2018 Jun 7. pii: 5034511. doi: 10.1093.
    PubMed     Abstract available


  774. RYAN E, McNicholas D, Creavin B, Kelly ME, et al
    Sarcopenia and Inflammatory Bowel Disease: A Systematic Review.
    Inflamm Bowel Dis. 2018 Jun 7. pii: 5034590. doi: 10.1093.
    PubMed     Abstract available


  775. BLAZQUEZ ML, Hernani MT, Calatayud GA, Gonzalez-Pinto LC, et al
    Transition Care Program of Adolescents With Inflammatory Bowel Disease: Perceptions From A Survey for Patients.
    Inflamm Bowel Dis. 2018 Jun 5. pii: 5033090. doi: 10.1093.
    PubMed    


  776. ATREJA A
    Smarter Care for Patients With Inflammatory Bowel Disease: A Necessity for IBD Home, Value-Based Health Care and Treat-to-Target Strategies.
    Inflamm Bowel Dis. 2018 Jun 4. pii: 5032596. doi: 10.1093.
    PubMed    


  777. KELSO M, Feagins LA
    Can Smartphones Help Deliver Smarter Care for Patients With Inflammatory Bowel Disease?
    Inflamm Bowel Dis. 2018 Jun 4. pii: 5032595. doi: 10.1093.
    PubMed     Abstract available


    May 2018
  778. ANDERSON A, Click B, Ramos-Rivers C, Koutroubakis IE, et al
    The Association Between Sustained Poor Quality of Life and Future Opioid Use in Inflammatory Bowel Disease.
    Inflamm Bowel Dis. 2018 May 31. pii: 5025926. doi: 10.1093.
    PubMed     Abstract available


  779. WINTHROP KL, Melmed GY, Vermeire S, Long MD, et al
    Herpes Zoster Infection in Patients With Ulcerative Colitis Receiving Tofacitinib.
    Inflamm Bowel Dis. 2018 May 30. pii: 5025191. doi: 10.1093.
    PubMed     Abstract available


  780. WIERSTRA K, Sutton R, Bal J, Ismond K, et al
    Innovative Online Educational Portal Improves Disease-Specific Reproductive Knowledge Among Patients With Inflammatory Bowel Disease.
    Inflamm Bowel Dis. 2018 May 30. pii: 5025410. doi: 10.1093.
    PubMed     Abstract available


  781. CHANDRADEVAN R, Hofmekler T, Mondal K, Harun N, et al
    Evolution of Pediatric Inflammatory Bowel Disease Unclassified (IBD-U): Incorporated With Serological and Gene Expression Profiles.
    Inflamm Bowel Dis. 2018 May 30. pii: 5025792. doi: 10.1093.
    PubMed     Abstract available


  782. ELIA J, Kane S
    Adult Inflammatory Bowel Disease, Physical Rehabilitation, and Structured Exercise.
    Inflamm Bowel Dis. 2018 May 29. pii: 5020214. doi: 10.1093.
    PubMed     Abstract available


  783. CHUDY-ONWUGAJE K, Abutaleb A, Buchwald A, Langenberg P, et al
    Age Modifies the Association Between Depressive Symptoms and Adherence to Self-Testing With Telemedicine in Patients With Inflammatory Bowel Disease.
    Inflamm Bowel Dis. 2018 May 28. pii: 5017268. doi: 10.1093.
    PubMed     Abstract available


  784. KHANNA R, Narula N, Feagan BG
    The Role of Biomarkers in Clinical Trials of Inflammatory Bowel Disease.
    Inflamm Bowel Dis. 2018 May 28. pii: 5017276. doi: 10.1093.
    PubMed     Abstract available


  785. HOSOE N, Nakano M, Takeuchi K, Endo Y, et al
    Establishment of a Novel Scoring System for Colon Capsule Endoscopy to Assess the Severity of Ulcerative Colitis-Capsule Scoring of Ulcerative Colitis.
    Inflamm Bowel Dis. 2018 May 26. pii: 5011158. doi: 10.1093.
    PubMed     Abstract available


  786. BESSISSOW T, Dulai PS, Restellini S, Landry T, et al
    Comparison of Endoscopic Dysplasia Detection Techniques in Patients With Ulcerative Colitis: A Systematic Review and Network Meta-analysis.
    Inflamm Bowel Dis. 2018 May 25. pii: 5004810. doi: 10.1093.
    PubMed     Abstract available


  787. SOFIA MA, Ciorba MA, Meckel K, Lim CK, et al
    Tryptophan Metabolism through the Kynurenine Pathway is Associated with Endoscopic Inflammation in Ulcerative Colitis.
    Inflamm Bowel Dis. 2018 May 22. pii: 5001501. doi: 10.1093.
    PubMed     Abstract available


  788. PENG K, Qian X, Huang Z, Lu J, et al
    Umbilical Cord Blood Transplantation Corrects Very Early-Onset Inflammatory Bowel Disease in Chinese Patients With IL10RA-Associated Immune Deficiency.
    Inflamm Bowel Dis. 2018 May 18. pii: 4999329. doi: 10.1093.
    PubMed     Abstract available


  789. BOSCH S, van Gaal N, Zuurbier RP, Covington JA, et al
    Differentiation Between Pediatric Irritable Bowel Syndrome and Inflammatory Bowel Disease Based on Fecal Scent: Proof of Principle Study.
    Inflamm Bowel Dis. 2018 May 18. pii: 4999303. doi: 10.1093.
    PubMed     Abstract available


  790. SPAGNUOLO R, Dattilo V, D'Antona L, Cosco C, et al
    Deregulation of SGK1 in Ulcerative Colitis: A Paradoxical Relationship Between Immune Cells and Colonic Epithelial Cells.
    Inflamm Bowel Dis. 2018 May 18. pii: 4999450. doi: 10.1093.
    PubMed     Abstract available


  791. DORREEN A, Heisler C, Jones J
    Treatment of Inflammatory Bowel Disease in the Older Patient.
    Inflamm Bowel Dis. 2018;24:1155-1166.
    PubMed     Abstract available


  792. SZETO W, van der Bent A, Petty CR, Reich J, et al
    Use of Social Media for Health-Related Tasks by Adolescents With Inflammatory Bowel Disease: A Step in the Pathway of Transition.
    Inflamm Bowel Dis. 2018;24:1114-1122.
    PubMed     Abstract available


  793. SUH JH, Degagne E, Gleghorn EE, Setty M, et al
    Sphingosine-1-Phosphate Signaling and Metabolism Gene Signature in Pediatric Inflammatory Bowel Disease: A Matched-case Control Pilot Study.
    Inflamm Bowel Dis. 2018;24:1321-1334.
    PubMed     Abstract available


  794. DIBLEY L, Czuber-Dochan W, Woodward S, Wade T, et al
    Development and Psychometric Properties of the Inflammatory Bowel Disease Distress Scale (IBD-DS): A New Tool to Measure Disease-Specific Distress.
    Inflamm Bowel Dis. 2018 May 18. pii: 4999398. doi: 10.1093.
    PubMed     Abstract available


  795. KOPYLOV U, Verstockt B, Biedermann L, Sebastian S, et al
    Effectiveness and Safety of Vedolizumab in Anti-TNF-Naive Patients With Inflammatory Bowel Disease-A Multicenter Retrospective European Study.
    Inflamm Bowel Dis. 2018 May 18. pii: 4999380. doi: 10.1093.
    PubMed     Abstract available


  796. SHMIDT E, Kochhar G, Hartke J, Chilukuri P, et al
    Predictors and Management of Loss of Response to Vedolizumab in Inflammatory Bowel Disease.
    Inflamm Bowel Dis. 2018 May 18. pii: 4999184. doi: 10.1093.
    PubMed     Abstract available


  797. MITCHELL NE, Harrison N, Junga Z, Singla M, et al
    Heart Under Attack: Cardiac Manifestations of Inflammatory Bowel Disease.
    Inflamm Bowel Dis. 2018 May 18. pii: 4999386. doi: 10.1093.
    PubMed     Abstract available


  798. KHANNA R, Zou G, Feagan BG
    Evolution of the Randomized Controlled Trial in Inflammatory Bowel Disease: Current Challenges and Future Solutions.
    Inflamm Bowel Dis. 2018 May 18. pii: 4999190. doi: 10.1093.
    PubMed     Abstract available


  799. ZHANG M, Merlin D
    Nanoparticle-Based Oral Drug Delivery Systems Targeting the Colon for Treatment of Ulcerative Colitis.
    Inflamm Bowel Dis. 2018 May 18. pii: 4999330. doi: 10.1093.
    PubMed     Abstract available


  800. ABUTALEB A, Buchwald A, Chudy-Onwugaje K, Langenberg P, et al
    Inflammatory Bowel Disease Telemedicine Clinical Trial: Impact of Educational Text Messages on Disease-Specific Knowledge Over 1 Year.
    Inflamm Bowel Dis. 2018 May 18. pii: 4999387. doi: 10.1093.
    PubMed     Abstract available


  801. MERKER AM, Riaz M, Friedman S, Allegretti JR, et al
    Legalization of Medicinal Marijuana Has Minimal Impact on Use Patterns in Patients With Inflammatory Bowel Disease.
    Inflamm Bowel Dis. 2018 May 18. pii: 4999337. doi: 10.1093.
    PubMed     Abstract available


  802. BARNES EL, Kochar B, Long MD, Pekow J, et al
    Lack of Difference in Treatment Patterns and Clinical Outcomes Between Black and White Patients With Inflammatory Bowel Disease.
    Inflamm Bowel Dis. 2018 May 18. pii: 4999440. doi: 10.1093.
    PubMed     Abstract available


  803. NAVABI S, Gorrepati VS, Yadav S, Chintanaboina J, et al
    Influences and Impact of Anxiety and Depression in the Setting of Inflammatory Bowel Disease.
    Inflamm Bowel Dis. 2018 May 17. pii: 4999008. doi: 10.1093.
    PubMed     Abstract available


  804. HARTMAN DJ, Binion DG, Regueiro MD, Miller C, et al
    Distinct Histopathologic and Molecular Alterations in Inflammatory Bowel Disease-Associated Intestinal Adenocarcinoma: c-MYC Amplification is Common and Associated with Mucinous/Signet Ring Cell Differentiation.
    Inflamm Bowel Dis. 2018 May 17. pii: 4998978. doi: 10.1093.
    PubMed     Abstract available


  805. YUNG DE, Horesh N, Lightner AL, Ben-Horin S, et al
    Systematic Review and Meta-analysis: Vedolizumab and Postoperative Complications in Inflammatory Bowel Disease.
    Inflamm Bowel Dis. 2018 May 17. pii: 4998839. doi: 10.1093.
    PubMed     Abstract available


  806. LIU R, Tang A, Wang X, Shen S, et al
    Assessment of Quality of Life in Chinese Patients With Inflammatory Bowel Disease and their Caregivers.
    Inflamm Bowel Dis. 2018 May 17. pii: 4999056. doi: 10.1093.
    PubMed     Abstract available


  807. ZHENG C, Huang Y, Ye Z, Wang Y, et al
    Infantile Onset Intractable Inflammatory Bowel Disease Due to Novel Heterozygous Mutations in TNFAIP3 (A20).
    Inflamm Bowel Dis. 2018 May 17. pii: 4999659. doi: 10.1093.
    PubMed     Abstract available


  808. HEMPERLY A, Sandborn WJ, Vande Casteele N
    Clinical Pharmacology in Adult and Pediatric Inflammatory Bowel Disease.
    Inflamm Bowel Dis. 2018 May 17. pii: 4998913. doi: 10.1093.
    PubMed     Abstract available


  809. KOSLOWSKY B, Grisaru-Granovsky S, Livovsky DM, Milgrom Y, et al
    Pregnancy-Onset Inflammatory Bowel Disease: A Subtle Diagnosis.
    Inflamm Bowel Dis. 2018 May 17. pii: 4998813. doi: 10.1093.
    PubMed     Abstract available


  810. AL-AMODI O, Jodeleit H, Beigel F, Wolf E, et al
    CD1a-Expressing Monocytes as Mediators of Inflammation in Ulcerative Colitis.
    Inflamm Bowel Dis. 2018 May 17. pii: 4998980. doi: 10.1093.
    PubMed     Abstract available


  811. RESTELLINI S, Khanna R, Afif W
    Therapeutic Drug Monitoring With Ustekinumab and Vedolizumab in Inflammatory Bowel Disease.
    Inflamm Bowel Dis. 2018 May 17. pii: 4999007. doi: 10.1093.
    PubMed     Abstract available


  812. GORREPATI VS, Stuart A, Deiling S, Koltun W, et al
    Smoking and the Risk of Pouchitis in Ulcerative Colitis Patients With Ileal Pouch-Anal Anastomosis.
    Inflamm Bowel Dis. 2018 May 17. pii: 4999006. doi: 10.1093.
    PubMed     Abstract available


  813. DAI C, Jiang M, Sun MJ
    Prediagnostic Serum Vitamin D Levels and the Risk of Crohn's Disease and Ulcerative Colitis.
    Inflamm Bowel Dis. 2018 May 17. pii: 4999019. doi: 10.1093.
    PubMed    


  814. MOTTA JP, Allain T, Green-Harrison LE, Groves RA, et al
    Iron Sequestration in Microbiota Biofilms As A Novel Strategy for Treating Inflammatory Bowel Disease.
    Inflamm Bowel Dis. 2018 May 17. pii: 4997020. doi: 10.1093.
    PubMed     Abstract available


  815. MADSEN KG, Pottegard A, Hallas J, Kjeldsen J, et al
    Treatment Failure of TNF-alpha Inhibitors in Obese Patients With Inflammatory Bowel Disease-A Cohort Study.
    Inflamm Bowel Dis. 2018 May 17. pii: 4998912. doi: 10.1093.
    PubMed     Abstract available


  816. COLOMBEL JF
    Herpes Zoster in Patients Receiving JAK Inhibitors For Ulcerative Colitis: Mechanism, Epidemiology, Management, and Prevention.
    Inflamm Bowel Dis. 2018 May 17. pii: 4998802. doi: 10.1093.
    PubMed     Abstract available


  817. LIGHTNER AL
    A Cell-Based Approach to the Treatment of Inflammatory Bowel Disease-Entering an Era of Regenerative Medicine.
    Inflamm Bowel Dis. 2018 May 17. pii: 4999009. doi: 10.1093.
    PubMed     Abstract available


  818. JIAN L, Anqi H, Gang L, Litian W, et al
    Food Exclusion Based on IgG Antibodies Alleviates Symptoms in Ulcerative Colitis: A Prospective Study.
    Inflamm Bowel Dis. 2018 May 16. pii: 4996921. doi: 10.1093.
    PubMed     Abstract available


  819. ROBERTS RL, Wallace MC, Seinen ML, van Bodegraven AA, et al
    Nonsynonymous Polymorphism in Guanine Monophosphate Synthetase Is a Risk Factor for Unfavorable Thiopurine Metabolite Ratios in Patients With Inflammatory Bowel Disease.
    Inflamm Bowel Dis. 2018 May 16. pii: 4996867. doi: 10.1093.
    PubMed     Abstract available


  820. LI L, Huang S, Wang H, Chao K, et al
    Cytokine IL9 Triggers the Pathogenesis of Inflammatory Bowel Disease Through the miR21-CLDN8 Pathway.
    Inflamm Bowel Dis. 2018 May 16. pii: 4996911. doi: 10.1093.
    PubMed     Abstract available


  821. WEIMERS P, Halfvarson J, Sachs MC, Saunders-Pullman R, et al
    Inflammatory Bowel Disease and Parkinson's Disease: A Nationwide Swedish Cohort Study.
    Inflamm Bowel Dis. 2018 May 16. pii: 4996912. doi: 10.1093.
    PubMed     Abstract available


  822. BEGGS AD, James J, Caldwell G, Prout T, et al
    Discovery and Validation of Methylation Biomarkers for Ulcerative Colitis Associated Neoplasia.
    Inflamm Bowel Dis. 2018 May 14. pii: 4995684. doi: 10.1093.
    PubMed     Abstract available


  823. BIANCARDI AL, Zaltman C, Troncoso LL, Luiz RR, et al
    The Role of Clinical-Demographic Characteristics in Ophthalmic Manifestations of Inflammatory Bowel Disease.
    Inflamm Bowel Dis. 2018 May 11. pii: 4995039. doi: 10.1093.
    PubMed    


  824. MOON CM, Kim SW, Ahn JB, Ma HW, et al
    Deep Resequencing of Ulcerative Colitis-Associated Genes Identifies Novel Variants in Candidate Genes in the Korean Population.
    Inflamm Bowel Dis. 2018 May 4. pii: 4992873. doi: 10.1093.
    PubMed     Abstract available


  825. ROBLIN X, Riviere P, Flamant M, Veyrard P, et al
    Proactive Therapeutic Drug Monitoring of TNF Antagonists in Inflammatory Bowel Disease.
    Inflamm Bowel Dis. 2018 May 3. pii: 4992140. doi: 10.1093.
    PubMed     Abstract available


  826. WENG MT, Park SH, Matsuoka K, Tung CC, et al
    Incidence and Risk Factor Analysis of Thromboembolic Events in East Asian Patients With Inflammatory Bowel Disease, a Multinational Collaborative Study.
    Inflamm Bowel Dis. 2018 May 3. pii: 4991928. doi: 10.1093.
    PubMed     Abstract available


  827. BARBER GE, Hendler S, Okafor P, Limsui D, et al
    Rising Incidence of Intestinal Infections in Inflammatory Bowel Disease: A Nationwide Analysis.
    Inflamm Bowel Dis. 2018 May 2. pii: 4990922. doi: 10.1093.
    PubMed     Abstract available


    April 2018
  828. OKABAYASHI S, Kobayashi T, Nakano M, Toyonaga T, et al
    A Simple 1-Day Colon Capsule Endoscopy Procedure Demonstrated to be a Highly Acceptable Monitoring Tool for Ulcerative Colitis.
    Inflamm Bowel Dis. 2018 Apr 30. pii: 4990576. doi: 10.1093.
    PubMed     Abstract available


  829. SPENCER EA, Davis SM, Mack DR, Boyle BM, et al
    Serologic Reactivity Reflects Clinical Expression of Ulcerative Colitis in Children.
    Inflamm Bowel Dis. 2018 Apr 30. pii: 4990334. doi: 10.1093.
    PubMed     Abstract available


  830. THEODORAKI E, Orfanoudaki E, Foteinogiannopoulou K, Koutroubakis IE, et al
    Asymptomatic hyperCKemia During Infliximab Therapy in Patients With Inflammatory Bowel Disease.
    Inflamm Bowel Dis. 2018 Apr 30. pii: 4990625. doi: 10.1093.
    PubMed     Abstract available


  831. LEWIS JD
    Inflammatory Bowel Disease Care: What to Do When There Is a Breach of Contract between the Patient and Physician?
    Inflamm Bowel Dis. 2018 Apr 30. pii: 4990352. doi: 10.1093.
    PubMed     Abstract available


  832. BURKE KE, Khalili H, Garber JJ, Haritunians T, et al
    Genetic Markers Predict Primary Nonresponse and Durable Response to Anti-Tumor Necrosis Factor Therapy in Ulcerative Colitis.
    Inflamm Bowel Dis. 2018 Apr 30. pii: 4990575. doi: 10.1093.
    PubMed     Abstract available


  833. PATIL SA, Cross RK
    Current Landscape of Telemedicine Practice in Inflammatory Bowel Disease.
    Inflamm Bowel Dis. 2018 Apr 28. pii: 4989997. doi: 10.1093.
    PubMed     Abstract available


  834. WU B, Wang Z, Zhang Q
    Cost-Effectiveness of Different Strategies for the Treatment of Moderate-to-Severe Ulcerative Colitis.
    Inflamm Bowel Dis. 2018 Apr 27. pii: 4989472. doi: 10.1093.
    PubMed     Abstract available


  835. CHI LY, Zitomersky NL, Liu E, Tollefson S, et al
    The Impact of Combination Therapy on Infliximab Levels and Antibodies in Children and Young Adults With Inflammatory Bowel Disease.
    Inflamm Bowel Dis. 2018 Apr 26. pii: 4987131. doi: 10.1093.
    PubMed     Abstract available


  836. KATSANOS KH, Kyriakidi K, Skamnelos A, Christodoulou DK, et al
    Asymptomatic hyperCKemia During Infliximab Therapy in Patients With Inflammatory Bowel Disease.
    Inflamm Bowel Dis. 2018 Apr 26. pii: 4990626. doi: 10.1093.
    PubMed    


  837. RAMOS GP, Stroh G, Al-Bawardy B, Faubion WA, et al
    Outcomes of Treatment for Latent Tuberculosis Infection in Patients With Inflammatory Bowel Disease Receiving Biologic Therapy.
    Inflamm Bowel Dis. 2018 Apr 26. pii: 4987150. doi: 10.1093.
    PubMed     Abstract available


  838. DIEDEREN K, Krom H, Koole JCD, Benninga MA, et al
    Diet and Anthropometrics of Children With Inflammatory Bowel Disease: A Comparison With the General Population.
    Inflamm Bowel Dis. 2018 Apr 25. pii: 4985538. doi: 10.1093.
    PubMed     Abstract available


  839. GREENER T, Kabakchiev B, Hillary Steinhart A, Silverberg MS, et al
    Higher Infliximab Levels Are Not Associated With an Increase in Adverse Events in Inflammatory Bowel Disease.
    Inflamm Bowel Dis. 2018 Apr 25. pii: 4985513. doi: 10.1093.
    PubMed     Abstract available


  840. KHAN N, Trivedi C, Shah Y, Cole E, et al
    The Natural History of Newly Diagnosed Ulcerative Colitis in Patients with Concomitant Primary Sclerosing Cholangitis.
    Inflamm Bowel Dis. 2018 Apr 25. pii: 4985719. doi: 10.1093.
    PubMed     Abstract available


  841. DANESE S, D'Amico F, Bonovas S, Peyrin-Biroulet L, et al
    Positioning Tofacitinib in the Treatment Algorithm of Moderate to Severe Ulcerative Colitis.
    Inflamm Bowel Dis. 2018 Apr 25. pii: 4985510. doi: 10.1093.
    PubMed     Abstract available


  842. LEGA S, Dubinsky MC
    What Are the Targets of Inflammatory Bowel Disease Management.
    Inflamm Bowel Dis. 2018 Apr 25. pii: 4985529. doi: 10.1093.
    PubMed     Abstract available


  843. BERINSTEIN JA, Waljee AK, Stidham RW, Higgins PDR, et al
    The IBD SGI Diagnostic Test Is Frequently Used by Non-gastroenterologists to Screen for Inflammatory Bowel Disease.
    Inflamm Bowel Dis. 2018;24:e18.
    PubMed    


  844. CHIBA M, Sugawara T, Komatsu M, Tozawa H, et al
    Onset of Ulcerative Colitis in the Second Trimester after Emesis Gravidarum: Treatment with Plant-based Diet.
    Inflamm Bowel Dis. 2018;24:e8-e9.
    PubMed    


  845. ROLLI V, Macquin C, Kokten T, Hablot J, et al
    Zinc-Alpha-2-Glycoprotein in Inflammatory Bowel Disease.
    Inflamm Bowel Dis. 2018;24:e10.
    PubMed    


  846. KOCHHAR G, Steele S, Sanaka M, Gorgun E, et al
    Endoscopic Submucosal Dissection for Flat Colonic Polyps in Patients With Inflammatory Bowel Disease, A Single-Center Experience.
    Inflamm Bowel Dis. 2018;24:e14-e15.
    PubMed    


  847. SHERMAN HOREV H, Rabinowitz KM, Elad H, Barkan R, et al
    Increase in Processing Factors Is Involved in Skewed MicroRNA Expression in Patients with Ulcerative Colitis Who Develop Small Intestine Inflammation after Pouch Surgery.
    Inflamm Bowel Dis. 2018;24:1045-1054.
    PubMed     Abstract available


  848. SULLIVAN SN
    Bullous Pyoderma Gangrenosum and Inflammatory Bowel Disease.
    Inflamm Bowel Dis. 2018;24:e16-e17.
    PubMed    


  849. GAMWELL KL, Baudino MN, Bakula DM, Sharkey CM, et al
    Perceived Illness Stigma, Thwarted Belongingness, and Depressive Symptoms in Youth With Inflammatory Bowel Disease (IBD).
    Inflamm Bowel Dis. 2018;24:960-965.
    PubMed     Abstract available


  850. YE L, Jiang Z, Liu J, Zhou W, et al
    Is There a New Classification of Inflammatory Bowel Disease (IBD)-Adult-Onset Mixed IBD.
    Inflamm Bowel Dis. 2018;24:e19-e20.
    PubMed    


  851. KNOWLES SR, Keefer L, Wilding H, Hewitt C, et al
    Quality of Life in Inflammatory Bowel Disease: A Systematic Review and Meta-analyses-Part II.
    Inflamm Bowel Dis. 2018;24:966-976.
    PubMed     Abstract available


  852. BETTNER W, Rizzo A, Brant S, Dudley-Brown S, et al
    Low Incidence of Dysplasia and Colorectal Cancer Observed among Inflammatory Bowel Disease Patients with Prolonged Colonic Diversion.
    Inflamm Bowel Dis. 2018;24:1092-1098.
    PubMed     Abstract available


  853. MARIABEATRICE P, Andrea I, Giuseppe L, Michela M, et al
    Nonalcoholic Fatty Liver Disease in Inflammatory Bowel Disease: Prevalence and Risk Factors.
    Inflamm Bowel Dis. 2018 Apr 23. pii: 4982709. doi: 10.1093.
    PubMed     Abstract available


  854. ADHATAMSOONTRA P, Silverman AL, Doria NA, Alsulami N, et al
    A Clouded Picture: Online Resources in IBD Lack Patient-Centered Language.
    Inflamm Bowel Dis. 2018;24:e1.
    PubMed    


  855. SEVERS M, Spekhorst LM, Mangen MJ, Dijkstra G, et al
    Sex-Related Differences in Patients With Inflammatory Bowel Disease: Results of 2 Prospective Cohort Studies.
    Inflamm Bowel Dis. 2018 Apr 21. pii: 4980986. doi: 10.1093.
    PubMed     Abstract available


  856. AKHUEMONKHAN E, Parian A, Carson KA, Hutfless S, et al
    Adverse Reactions After Intravenous Iron Infusion Among Inflammatory Bowel Disease Patients in the United States, 2010-2014.
    Inflamm Bowel Dis. 2018 Apr 13. pii: 4969822. doi: 10.1093.
    PubMed     Abstract available


  857. MEIJER B, Mulder CJJ, Bouma G, Ponsioen CY, et al
    Methotrexate and Thioguanine Rescue Therapy for Conventional Thiopurine Failing Ulcerative Colitis Patients: A Multi-center Database Study on Tolerability and Effectiveness.
    Inflamm Bowel Dis. 2018 Apr 13. pii: 4969999. doi: 10.1093.
    PubMed     Abstract available


  858. AUTH MK, Bunn SK, Protheroe AL, Williams LJ, et al
    Improved Medical Treatment and Surgical Surveillance of Children and Adolescents with Ulcerative Colitis in the United Kingdom.
    Inflamm Bowel Dis. 2018 Apr 13. pii: 4969914. doi: 10.1093.
    PubMed     Abstract available


  859. GULATI S, Emmanuel A, Burt M, Dubois P, et al
    Outcomes of Endoscopic Resections of Large Laterally Spreading Colorectal Lesions in Inflammatory Bowel Disease: a Single United Kingdom Center Experience.
    Inflamm Bowel Dis. 2018 Apr 13. pii: 4969983. doi: 10.1093.
    PubMed     Abstract available


  860. SHUTKEVER O, Gracie DJ, Young C, Wood HM, et al
    No Significant Association Between the Fecal Microbiome and the Presence of Irritable Bowel Syndrome-type Symptoms in Patients with Quiescent Inflammatory Bowel Disease.
    Inflamm Bowel Dis. 2018 Apr 13. pii: 4970060. doi: 10.1093.
    PubMed     Abstract available


  861. CARD T, Xu J, Liang H, Bhayat F, et al
    What Is the Risk of Progressive Multifocal Leukoencephalopathy in Patients With Ulcerative Colitis or Crohn's Disease Treated With Vedolizumab?
    Inflamm Bowel Dis. 2018 Apr 13. pii: 4969878. doi: 10.1093.
    PubMed     Abstract available


  862. HOSOMI S, Watanabe K, Nishida Y, Yamagami H, et al
    Combined Infection of Human Herpes Viruses: A Risk Factor for Subsequent Colectomy in Ulcerative Colitis.
    Inflamm Bowel Dis. 2018 Apr 13. pii: 4969863. doi: 10.1093.
    PubMed     Abstract available


  863. VAN DE VONDEL S, Baert F, Reenaers C, Vanden Branden S, et al
    Incidence and Predictors of Success of Adalimumab Dose Escalation and De-escalation in Ulcerative Colitis: a Real-World Belgian Cohort Study.
    Inflamm Bowel Dis. 2018 Apr 13. pii: 4969974. doi: 10.1093.
    PubMed     Abstract available


  864. FLYNN AD, Valentine JF
    Chromoendoscopy for Dysplasia Surveillance in Inflammatory Bowel Disease.
    Inflamm Bowel Dis. 2018 Apr 13. pii: 4969996. doi: 10.1093.
    PubMed     Abstract available


  865. WENTWORTH BJ, Buerlein RCD, Tuskey AG, Overby MA, et al
    Nonadherence to Biologic Therapies in Inflammatory Bowel Disease.
    Inflamm Bowel Dis. 2018 Apr 13. pii: 4969742. doi: 10.1093.
    PubMed     Abstract available


  866. DUBINSKY MC, Cross RK, Sandborn WJ, Long M, et al
    Extraintestinal Manifestations in Vedolizumab and Anti-TNF-Treated Patients With Inflammatory Bowel Disease.
    Inflamm Bowel Dis. 2018 Apr 13. pii: 4969986. doi: 10.1093.
    PubMed     Abstract available


  867. BERNSTEIN CN, Zhang L, Lix LM, Graff LA, et al
    The Validity and Reliability of Screening Measures for Depression and Anxiety Disorders in Inflammatory Bowel Disease.
    Inflamm Bowel Dis. 2018 Apr 13. pii: 4969741. doi: 10.1093.
    PubMed     Abstract available


  868. MARK-CHRISTENSEN A, Laurberg S, Haboubi N
    Dysplasia in Inflammatory Bowel Disease: Historical Review, Critical Histopathological Analysis, and Clinical Implications.
    Inflamm Bowel Dis. 2018 Apr 13. pii: 4969836. doi: 10.1093.
    PubMed     Abstract available


  869. BUER LCT, Hoivik ML, Warren DJ, Medhus AW, et al
    Combining Anti-TNF-alpha and Vedolizumab in the Treatment of Inflammatory Bowel Disease: A Case Series.
    Inflamm Bowel Dis. 2018 Apr 12. pii: 4969708. doi: 10.1093.
    PubMed     Abstract available


    March 2018
  870. GU P, Kuenzig ME, Kaplan GG, Pimentel M, et al
    Fecal Incontinence in Inflammatory Bowel Disease: A Systematic Review and Meta-Analysis.
    Inflamm Bowel Dis. 2018 Mar 30. pii: 4916092. doi: 10.1093.
    PubMed     Abstract available


  871. DE SOUZA HSP, Fiocchi C
    Network Medicine: A Mandatory Next Step for Inflammatory Bowel Disease.
    Inflamm Bowel Dis. 2018;24:671-679.
    PubMed     Abstract available


  872. KNOWLES SR, Graff LA, Wilding H, Hewitt C, et al
    Quality of Life in Inflammatory Bowel Disease: A Systematic Review and Meta-analyses-Part I.
    Inflamm Bowel Dis. 2018;24:742-751.
    PubMed     Abstract available


  873. VENKATESWARAN S, Prince J, Cutler DJ, Marigorta UM, et al
    Enhanced Contribution of HLA in Pediatric Onset Ulcerative Colitis.
    Inflamm Bowel Dis. 2018;24:829-838.
    PubMed     Abstract available


  874. LEE WJ, Lee TA, Calip GS, Suda KJ, et al
    Risk of Serious Bacterial Infection Associated With Tumor Necrosis Factor-Alpha Inhibitors in Children and Young Adults With Inflammatory Bowel Disease.
    Inflamm Bowel Dis. 2018;24:883-891.
    PubMed     Abstract available


  875. CHRISTENSEN B, Colman RJ, Micic D, Gibson PR, et al
    Vedolizumab as Induction and Maintenance for Inflammatory Bowel Disease: 12-month Effectiveness and Safety.
    Inflamm Bowel Dis. 2018;24:849-860.
    PubMed     Abstract available


  876. VORTIA E, Uko VE, Yen-Lieberman B, Frawley J, et al
    Low Indeterminate Rates Associated With Use of the QuantiFERON-TB Gold In-Tube Test in Children With Inflammatory Bowel Disease on Long-term Infliximab.
    Inflamm Bowel Dis. 2018;24:877-882.
    PubMed     Abstract available


  877. STEINHART AH
    Exit Strategies for Biologic Therapy in IBD: Is It Too Soon to Stop?
    Inflamm Bowel Dis. 2018;24:669-670.
    PubMed    


  878. IRVING PM, Iqbal T, Nwokolo C, Subramanian S, et al
    A Randomized, Double-blind, Placebo-controlled, Parallel-group, Pilot Study of Cannabidiol-rich Botanical Extract in the Symptomatic Treatment of Ulcerative Colitis.
    Inflamm Bowel Dis. 2018 Mar 10. pii: 4925788. doi: 10.1093.
    PubMed     Abstract available


  879. SHIRAI S, Hara M, Sakata Y, Tsuruoka N, et al
    Immunogenicity of Quadrivalent Influenza Vaccine for Patients with Inflammatory Bowel Disease Undergoing Immunosuppressive Therapy.
    Inflamm Bowel Dis. 2018 Mar 9. pii: 4925593. doi: 10.1093.
    PubMed     Abstract available


  880. MOUCHLI MA, Singh S, Boardman L, Bruining DH, et al
    Natural History of Established and De Novo Inflammatory Bowel Disease After Liver Transplantation for Primary Sclerosing Cholangitis.
    Inflamm Bowel Dis. 2018 Mar 7. pii: 4924363. doi: 10.1093.
    PubMed     Abstract available


  881. AARDOOM MA, Linda Joosse ME, de Vries ACH, Levine A, et al
    Malignancy and Mortality in Pediatric-onset Inflammatory Bowel Disease: A Systematic Review.
    Inflamm Bowel Dis. 2018 Mar 7. pii: 4924482. doi: 10.1093.
    PubMed     Abstract available


  882. MARQUES DA COSTA P, Correia L, Correia LA
    The Complexity of Renal Involvment in IBD-C3 Glomerulopathy in Ulcerative Colitis.
    Inflamm Bowel Dis. 2018 Mar 7. pii: 4924366. doi: 10.1093.
    PubMed    


  883. LITSTER B, Bernstein CN, Graff LA, Walker JR, et al
    Validation of the PHQ-9 for Suicidal Ideation in Persons with Inflammatory Bowel Disease.
    Inflamm Bowel Dis. 2018 Mar 7. pii: 4924383. doi: 10.1093.
    PubMed     Abstract available


  884. KHAN N, Trivedi C, Shah Y, Patel D, et al
    The Severity of Herpes Zoster in Inflammatory Bowel Disease Patients Treated With Anti-TNF Agents.
    Inflamm Bowel Dis. 2018 Mar 7. pii: 4924495. doi: 10.1093.
    PubMed     Abstract available


  885. LIGHTNER AL, Mathis KL, Tse CS, Pemberton JH, et al
    Postoperative Outcomes in Vedolizumab-Treated Patients Undergoing Major Abdominal Operations for Inflammatory Bowel Disease: Retrospective Multicenter Cohort Study.
    Inflamm Bowel Dis. 2018 Mar 2. pii: 4917693. doi: 10.1093.
    PubMed     Abstract available


  886. DANION P, Buisson A, Roblin X, Mathieu N, et al
    IBD-INFO Questionnaire: A Multicenter French Up-to-Date Survey of Patient Knowledge in Inflammatory Bowel Disease.
    Inflamm Bowel Dis. 2018 Mar 1. pii: 4916100. doi: 10.1093.
    PubMed     Abstract available


  887. PATEL P, Yarur A, Dalal S, Sakuraba A, et al
    Clinical Response and Complications are not Associated with Drug Levels in Patients with Severe Ulcerative Colitis on IV Cyclosporine Induction Therapy.
    Inflamm Bowel Dis. 2018 Mar 1. pii: 4916098. doi: 10.1093.
    PubMed     Abstract available


    February 2018
  888. KAMMERLANDER H, Nielsen J, Kjeldsen J, Knudsen T, et al
    Fecal Calprotectin During Pregnancy in Women With Moderate-Severe Inflammatory Bowel Disease.
    Inflamm Bowel Dis. 2018 Feb 28. pii: 4913664. doi: 10.1093.
    PubMed     Abstract available


  889. DA SILVA S, Keita AV, Mohlin S, Pahlman S, et al
    A Novel Topical PPARgamma Agonist Induces PPARgamma Activity in Ulcerative Colitis Mucosa and Prevents and Reverses Inflammation in Induced Colitis Models.
    Inflamm Bowel Dis. 2018 Feb 24. pii: 4909417. doi: 10.1093.
    PubMed     Abstract available


  890. REZAIE A, Gu P, Kaplan GG, Pimentel M, et al
    Dyssynergic Defecation in Inflammatory Bowel Disease: A Systematic Review and Meta-Analysis.
    Inflamm Bowel Dis. 2018 Feb 24. pii: 4909412. doi: 10.1093.
    PubMed     Abstract available


  891. ZAMORA C, Canto E, Nieto JC, Garcia-Planella E, et al
    Inverse Association Between Circulating Monocyte-Platelet Complexes and Inflammation in Ulcerative Colitis Patients.
    Inflamm Bowel Dis. 2018 Feb 23. pii: 4908015. doi: 10.1093.
    PubMed     Abstract available


  892. KATSANOS KH, Papamichael K, Cheifetz AS, Christodoulou DK, et al
    Full Interchangeability in Regards to Immunogenicity Between the Infliximab Reference Biologic and Biosimilars CT-P13 and SB2 in Inflammatory Bowel Disease.
    Inflamm Bowel Dis. 2018;24:465-466.
    PubMed    


  893. UHLIG HH
    Mendelian Diseases and Inflammatory Bowel Disease-Data Mining for Genetic Risk and Disease-Associated Confounders.
    Inflamm Bowel Dis. 2018;24:467-470.
    PubMed    


  894. HAN L, Maciejewski M, Brockel C, Afzelius L, et al
    Mendelian Disease Associations Reveal Novel Insights into Inflammatory Bowel Disease.
    Inflamm Bowel Dis. 2018;24:471-481.
    PubMed     Abstract available


  895. FIORINO G, Ruiz-Arguello MB, Maguregui A, Nagore D, et al
    Full Interchangeability in Regard to Immunogenicity Between the Infliximab Reference Biologic and Biosimilars CT-P13 and SB2 in Inflammatory Bowel Disease.
    Inflamm Bowel Dis. 2018;24:601-606.
    PubMed     Abstract available


  896. EWELUKWA O, Perez R, Carter LE, Fernandez A, et al
    Incorporation of Scribes Into the Inflammatory Bowel Disease Clinic Improves Quality of Care and Physician Productivity.
    Inflamm Bowel Dis. 2018;24:552-557.
    PubMed     Abstract available


  897. DE ANGELIS PM, Schjolberg AR, Hughes JB, Huitfeldt HS, et al
    Nondysplastic Ulcerative Colitis Has High Levels of the Homologous Recombination Repair Protein NUCKS1 and Low Levels of the DNA Damage Marker Gamma-H2AX.
    Inflamm Bowel Dis. 2018;24:593-600.
    PubMed     Abstract available


  898. BHANDARI S, Saeian K, Stein D
    Increased Rate of Venous Thromboembolism in Hospitalized Inflammatory Bowel Disease Patients With Clostridium difficile Infection.
    Inflamm Bowel Dis. 2018;24:661.
    PubMed    


  899. DAI C, Cao Q, Sun MJ
    Venous Thromboembolism in Hospitalized Inflammatory Bowel Disease Patients with Clostridium difficile Infection.
    Inflamm Bowel Dis. 2018;24:662.
    PubMed    


  900. ZHOU F, Hamza T, Fleur AS, Zhang Y, et al
    Mice with Inflammatory Bowel Disease are Susceptible to Clostridium difficile Infection With Severe Disease Outcomes.
    Inflamm Bowel Dis. 2018;24:573-582.
    PubMed     Abstract available


  901. SAUER CG, Loop MS, Venkateswaran S, Tangpricha V, et al
    Free and Bioavailable 25-Hydroxyvitamin D Concentrations are Associated With Disease Activity in Pediatric Patients With Newly Diagnosed Treatment Naive Ulcerative Colitis.
    Inflamm Bowel Dis. 2018;24:641-650.
    PubMed     Abstract available


  902. OPSTELTEN JL, Chan SSM, Hart AR, van Schaik FDM, et al
    Prediagnostic Serum Vitamin D Levels and the Risk of Crohn's Disease and Ulcerative Colitis in European Populations: A Nested Case-Control Study.
    Inflamm Bowel Dis. 2018;24:633-640.
    PubMed     Abstract available


  903. NORDENVALL C, Olen O, Johan Nilsson P, Ekbom A, et al
    Restorative Surgery in Patients With Primary Sclerosing Cholangitis and Ulcerative Colitis Following a Colectomy.
    Inflamm Bowel Dis. 2018;24:624-632.
    PubMed     Abstract available


  904. SHAH SC, Naymagon S, Panchal HJ, Sands BE, et al
    Accelerated Infliximab Dosing Increases 30-Day Colectomy in Hospitalized Ulcerative Colitis Patients: A Propensity Score Analysis.
    Inflamm Bowel Dis. 2018;24:651-659.
    PubMed     Abstract available


  905. GONCALVES P, Araujo JR, Di Santo JP
    A Cross-Talk Between Microbiota-Derived Short-Chain Fatty Acids and the Host Mucosal Immune System Regulates Intestinal Homeostasis and Inflammatory Bowel Disease.
    Inflamm Bowel Dis. 2018;24:558-572.
    PubMed     Abstract available


  906. KANE S
    Letter to the Editor: Missed Meals While Hospitalized for UC.
    Inflamm Bowel Dis. 2018;24:660.
    PubMed    


  907. FUHLER GM, van der Giessen J, van der Woude CJ, Peppelenbosch MP, et al
    Correlating Fecal Calprotectin With Hemoglobin Levels Within 1 Sample.
    Inflamm Bowel Dis. 2018;24:663.
    PubMed    


    January 2018
  908. KANG B, Lee Y, Lee K, Choi YO, et al
    Long-term Outcomes After Switching to CT-P13 in Pediatric-Onset Inflammatory Bowel Disease: A Single-Center Prospective Observational Study.
    Inflamm Bowel Dis. 2018 Jan 30. pii: 4829375. doi: 10.1093.
    PubMed     Abstract available


  909. MOSHER CA, Brown GR, Weideman RA, Crook TW, et al
    Incidence of Colorectal Cancer and Extracolonic Cancers in Veteran Patients With Inflammatory Bowel Disease.
    Inflamm Bowel Dis. 2018 Jan 30. pii: 4829349. doi: 10.1093.
    PubMed     Abstract available


  910. RAO BB, Lashner B, Kowdley KV
    Reviewing the Risk of Colorectal Cancer in Inflammatory Bowel Disease After Liver Trasnplantation for Primary Sclerosing Cholangitis.
    Inflamm Bowel Dis. 2018;24:269-276.
    PubMed     Abstract available


  911. O'TOOLE A, de Silva PS, Marc LG, Ulysse CA, et al
    Sexual Dysfunction in Men With Inflammatory Bowel Disease: A New IBD-Specific Scale.
    Inflamm Bowel Dis. 2018;24:310-316.
    PubMed     Abstract available


  912. HUGUET M, Pereira B, Goutte M, Goutorbe F, et al
    Systematic Review With Meta-Analysis: Anti-TNF Therapy in Refractory Pouchitis and Crohn's Disease-Like Complications of the Pouch After Ileal Pouch-Anal Anastomosis Following Colectomy for Ulcerative Colitis.
    Inflamm Bowel Dis. 2018;24:261-268.
    PubMed     Abstract available


  913. SCOTT FI, Shah Y, Lasch K, Luo M, et al
    Assessing the Optimal Position for Vedolizumab in the Treatment of Ulcerative Colitis: A Simulation Model.
    Inflamm Bowel Dis. 2018;24:286-295.
    PubMed     Abstract available


  914. YARLAS A, D'Haens G, Willian MK, Teynor M, et al
    Health-Related Quality of Life and Work-Related Outcomes for Patients With Mild-to-Moderate Ulcerative Colitis and Remission Status Following Short-Term and Long-Term Treatment With Multimatrix Mesalamine: A Prospective, Open-Label Study.
    Inflamm Bowel Dis. 2018;24:450-463.
    PubMed     Abstract available


  915. LARSEN L, Drewes AM, Broberg MCH, Fallingborg J, et al
    Changing Infliximab Prescription Patterns in Inflammatory Bowel Disease: A Population-Based Cohort Study, 1999-2014.
    Inflamm Bowel Dis. 2018;24:433-439.
    PubMed     Abstract available


  916. PIESTER T, Frymoyer A, Christofferson M, Yu H, et al
    A Mobile Infliximab Dosing Calculator for Therapy Optimization in Inflammatory Bowel Disease.
    Inflamm Bowel Dis. 2018;24:227-234.
    PubMed     Abstract available


  917. GOYAL A, Yeh A, Bush BR, Firek BA, et al
    Safety, Clinical Response, and Microbiome Findings Following Fecal Microbiota Transplant in Children With Inflammatory Bowel Disease.
    Inflamm Bowel Dis. 2018;24:410-421.
    PubMed     Abstract available


  918. HABERMAN Y, BenShoshan M, Di Segni A, Dexheimer PJ, et al
    Long ncRNA Landscape in the Ileum of Treatment-Naive Early-Onset Crohn Disease.
    Inflamm Bowel Dis. 2018;24:346-360.
    PubMed     Abstract available


  919. MACALUSO FS, Sapienza C, Ventimiglia M, Renna S, et al
    The Addition of an Immunosuppressant After Loss of Response to Anti-TNFalpha Monotherapy in Inflammatory Bowel Disease: A 2-Year Study.
    Inflamm Bowel Dis. 2018;24:394-401.
    PubMed     Abstract available


  920. ROLSTON VS, Boroujerdi L, Long MD, McGovern DPB, et al
    The Influence of Hormonal Fluctuation on Inflammatory Bowel Disease Symptom Severity-A Cross-Sectional Cohort Study.
    Inflamm Bowel Dis. 2018;24:387-393.
    PubMed     Abstract available


  921. PRATT PK JR, David N, Weber HC, Little FF, et al
    Antibody Response to Hepatitis B Virus Vaccine is Impaired in Patients With Inflammatory Bowel Disease on Infliximab Therapy.
    Inflamm Bowel Dis. 2018;24:380-386.
    PubMed     Abstract available


    December 2017
  922. BAKER DM, Lee MJ, Jones GL, Brown SR, et al
    The Informational Needs and Preferences of Patients Considering Surgery for Ulcerative Colitis: Results of a Qualitative Study.
    Inflamm Bowel Dis. 2017;24:179-190.
    PubMed     Abstract available


  923. VAN GENNEP S, de Boer NK, D'Haens GR, Lowenberg M, et al
    Thiopurine Treatment in Ulcerative Colitis: A Critical Review of the Evidence for Current Clinical Practice.
    Inflamm Bowel Dis. 2017;24:67-77.
    PubMed     Abstract available


  924. GROSSBERG LB, Papamichael K, Feuerstein JD, Siegel CA, et al
    A Survey Study of Gastroenterologists' Attitudes and Barriers Toward Therapeutic Drug Monitoring of Anti-TNF Therapy in Inflammatory Bowel Disease.
    Inflamm Bowel Dis. 2017;24:191-197.
    PubMed     Abstract available


  925. KELSO M, Weideman RA, Cipher DJ, Feagins LA, et al
    Factors Associated With Length of Stay in Veterans With Inflammatory Bowel Disease Hospitalized for an Acute Flare.
    Inflamm Bowel Dis. 2017;24:5-11.
    PubMed     Abstract available


  926. VAJRAVELU RK, Osterman MT, Aberra FN, Roy JA, et al
    Indeterminate QuantiFERON-TB Gold Increases Likelihood of Inflammatory Bowel Disease Treatment Delay and Hospitalization.
    Inflamm Bowel Dis. 2017;24:217-226.
    PubMed     Abstract available


  927. AFZALI A, Ciorba MA, Schwartz DA, Sharaf M, et al
    Challenges in Using Real-world Clinical Practice Records for Validation of Clinical Trial Data in Inflammatory Bowel Disease: Lessons Learned.
    Inflamm Bowel Dis. 2017;24:2-4.
    PubMed     Abstract available


  928. HUNDORFEAN G, Chiriac MT, Mihai S, Hartmann A, et al
    Development and Validation of a Confocal Laser Endomicroscopy-Based Score for In Vivo Assessment of Mucosal Healing in Ulcerative Colitis Patients.
    Inflamm Bowel Dis. 2017;24:35-44.
    PubMed     Abstract available


  929. DI RUSCIO M, Vernia F, Ciccone A, Frieri G, et al
    Surrogate Fecal Biomarkers in Inflammatory Bowel Disease: Rivals or Complementary Tools of Fecal Calprotectin?
    Inflamm Bowel Dis. 2017;24:78-92.
    PubMed     Abstract available


  930. NETZ U, Carter J, Eichenberger MR, Feagins K, et al
    Plasma microRNA Profile Differentiates Crohn's Colitis From Ulcerative Colitis.
    Inflamm Bowel Dis. 2017;24:159-165.
    PubMed     Abstract available


  931. MYKLEBUST-HANSEN T, Aamodt G, Haugen M, Brantsaeter AL, et al
    Dietary Patterns in women with Inflammatory Bowel Disease and Risk of Adverse Pregnancy Outcomes: Results from The Norwegian Mother and Child Cohort Study (MoBa).
    Inflamm Bowel Dis. 2017;24:12-24.
    PubMed     Abstract available


  932. MARCHIONI BEERY RM, Barnes EL, Nadkarni A, Korzenik JR, et al
    Suicidal Behavior Among Hospitalized Adults With Inflammatory Bowel Disease: A United States Nationwide Analysis.
    Inflamm Bowel Dis. 2017;24:25-34.
    PubMed     Abstract available


  933. WALJEE AK, Lipson R, Wiitala WL, Zhang Y, et al
    Predicting Hospitalization and Outpatient Corticosteroid Use in Inflammatory Bowel Disease Patients Using Machine Learning.
    Inflamm Bowel Dis. 2017;24:45-53.
    PubMed     Abstract available


  934. HYAMS JS, Chan D, Adedokun OJ, Padgett L, et al
    Subcutaneous Golimumab in Pediatric Ulcerative Colitis: Pharmacokinetics and Clinical Benefit.
    Inflamm Bowel Dis. 2017;23:2227-2237.
    PubMed     Abstract available


  935. BARNES EL, Kochar B, Long MD, Martin CF, et al
    Minority Pediatric Patients with Inflammatory Bowel Disease Demonstrate an Increased Length of Stay.
    Inflamm Bowel Dis. 2017;23:2189-2196.
    PubMed     Abstract available


  936. YE Z, Zhou Y, Huang Y, Wang Y, et al
    Phenotype and Management of Infantile-onset Inflammatory Bowel Disease: Experience from a Tertiary Care Center in China.
    Inflamm Bowel Dis. 2017;23:2154-2164.
    PubMed     Abstract available


  937. EL-MATARY W, Dykes DMH, Bauman L, Elkadri A, et al
    Rapid Infliximab Infusion in Children with Inflammatory Bowel Disease: A Multicenter North American Experience.
    Inflamm Bowel Dis. 2017;23:2104-2108.
    PubMed     Abstract available


  938. SELINGER CP, Lenti MV, Clark T, Rafferty H, et al
    Infliximab Therapeutic Drug Monitoring Changes Clinical Decisions in a Virtual Biologics Clinic for Inflammatory Bowel Disease.
    Inflamm Bowel Dis. 2017;23:2083-2088.
    PubMed     Abstract available


  939. ARSENEAU KKO, Cominelli F
    Improving the Reproducibility and Quality of Reporting for Animal Studies in Inflammatory Bowel Disease.
    Inflamm Bowel Dis. 2017;23:2069-2071.
    PubMed    


    November 2017
  940. SHIBATA W, Sohara M, Wu R, Kobayashi K, et al
    Incidence and Outcomes of Central Venous Catheter-related Blood Stream Infection in Patients with Inflammatory Bowel Disease in Routine Clinical Practice Setting.
    Inflamm Bowel Dis. 2017;23:2042-2047.
    PubMed     Abstract available


  941. HOPKINS CWP
    Inflammatory Bowel Disease, the Hospital Anxiety and Depression Scale and Criterion Contamination.
    Inflamm Bowel Dis. 2017;23:E54.
    PubMed    


    October 2017
  942. ANDERSON A, Click B, Ramos-Rivers C, Cheng D, et al
    Lasting Impact of Clostridium difficile Infection in Inflammatory Bowel Disease: A Propensity Score Matched Analysis.
    Inflamm Bowel Dis. 2017 Oct 27. doi: 10.1097/MIB.0000000000001251.
    PubMed     Abstract available


  943. GAWRONSKA A, Banasiuk M, Lachowicz D, Pituch H, et al
    Metronidazole or Rifaximin for Treatment of Clostridium difficile in Pediatric Patients with Inflammatory Bowel Disease: A Randomized Clinical Trial.
    Inflamm Bowel Dis. 2017 Oct 27. doi: 10.1097/MIB.0000000000001249.
    PubMed     Abstract available


  944. ZHANG W, Teng G, Wu T, Tian Y, et al
    Expression and Clinical Significance of Elafin in Inflammatory Bowel Disease.
    Inflamm Bowel Dis. 2017 Oct 27. doi: 10.1097/MIB.0000000000001252.
    PubMed     Abstract available


  945. SIGURDSSON GV, Schmidt S, Mellstrom D, Ohlsson C, et al
    Bone Mass Development from Childhood into Young Adulthood in Patients with Childhood-onset Inflammatory Bowel Disease.
    Inflamm Bowel Dis. 2017 Oct 20. doi: 10.1097/MIB.0000000000001277.
    PubMed     Abstract available


  946. CONRAD MA, Dawany N, Sullivan KE, Devoto M, et al
    Novel ZBTB24 Mutation Associated with Immunodeficiency, Centromere Instability, and Facial Anomalies Type-2 Syndrome Identified in a Patient with Very Early Onset Inflammatory Bowel Disease.
    Inflamm Bowel Dis. 2017 Oct 11. doi: 10.1097/MIB.0000000000001280.
    PubMed     Abstract available


  947. PONTE A, Pinho R, Fernandes S, Rodrigues A, et al
    Impact of Histological and Endoscopic Remissions on Clinical Recurrence and Recurrence-free Time in Ulcerative Colitis.
    Inflamm Bowel Dis. 2017 Oct 6. doi: 10.1097/MIB.0000000000001275.
    PubMed     Abstract available


  948. ANANTHAKRISHNAN AN, Khalili H, Song M, Higuchi LM, et al
    Genetic Polymorphisms in Fatty Acid Metabolism Modify the Association Between Dietary n3: n6 Intake and Risk of Ulcerative Colitis: A Prospective Cohort Study.
    Inflamm Bowel Dis. 2017 Oct 6. doi: 10.1097/MIB.0000000000001236.
    PubMed     Abstract available


  949. SO J, Tang W, Leung WK, Li M, et al
    Cancer Risk in 2621 Chinese Patients with Inflammatory Bowel Disease: A Population-based Cohort Study.
    Inflamm Bowel Dis. 2017 Oct 6. doi: 10.1097/MIB.0000000000001240.
    PubMed     Abstract available


  950. RIVIERE P, Poullenot F, Zerbib F, Laharie D, et al
    Quality of Sex Life in Patients with Inflammatory Bowel Disease: The Gastroenterologists' Perspective.
    Inflamm Bowel Dis. 2017;23:E51-E52.
    PubMed    


  951. CALDERA F, Wasan SK, Farraye FA, Hayney MS, et al
    Caution When Assessing Immunity to Varicella Through Antibody Testing in Patients with Inflammatory Bowel Disease.
    Inflamm Bowel Dis. 2017;23:E50-E51.
    PubMed    


  952. GALLINGER ZR, Rumman A, Pivovarov K, Fortinsky KJ, et al
    Frequency and Variables Associated with Fasting Orders in Inpatients with Ulcerative Colitis: The Audit of Diet Orders-Ulcerative Colitis (ADORE-UC) Study.
    Inflamm Bowel Dis. 2017;23:1790-1795.
    PubMed     Abstract available


  953. NARULA N, Kassam Z, Yuan Y, Colombel JF, et al
    Systematic Review and Meta-analysis: Fecal Microbiota Transplantation for Treatment of Active Ulcerative Colitis.
    Inflamm Bowel Dis. 2017;23:1702-1709.
    PubMed     Abstract available


  954. CROSS RK
    Safety Considerations with the Use of Corticosteroids and Biologic Therapies in Mild-to-Moderate Ulcerative Colitis.
    Inflamm Bowel Dis. 2017;23:1689-1701.
    PubMed     Abstract available


  955. LIU X, Yu R, Zhu L, Hou X, et al
    Bidirectional Regulation of Circadian Disturbance and Inflammation in Inflammatory Bowel Disease.
    Inflamm Bowel Dis. 2017;23:1741-1751.
    PubMed     Abstract available


    September 2017
  956. KRAWIEC P, Mroczkowska-Juchkiewicz A, Pac-Kozuchowska E
    Serum Hepcidin in Children with Inflammatory Bowel Disease.
    Inflamm Bowel Dis. 2017 Sep 22. doi: 10.1097/MIB.0000000000001245.
    PubMed     Abstract available


  957. ROBLIN X, Boschetti G, Duru G, Williet N, et al
    Distinct Thresholds of Infliximab Trough Level Are Associated with Different Therapeutic Outcomes in Patients with Inflammatory Bowel Disease: A Prospective Observational Study.
    Inflamm Bowel Dis. 2017 Sep 22. doi: 10.1097/MIB.0000000000001223.
    PubMed     Abstract available


  958. PETERSEN BS, August D, Abt R, Alddafari M, et al
    Targeted Gene Panel Sequencing for Early-onset Inflammatory Bowel Disease and Chronic Diarrhea.
    Inflamm Bowel Dis. 2017 Sep 19. doi: 10.1097/MIB.0000000000001235.
    PubMed     Abstract available


  959. NGUYEN VQ, Jiang D, Hoffman SN, Guntaka S, et al
    Impact of Diagnostic Delay and Associated Factors on Clinical Outcomes in a U.S. Inflammatory Bowel Disease Cohort.
    Inflamm Bowel Dis. 2017 Sep 6. doi: 10.1097/MIB.0000000000001257.
    PubMed     Abstract available


  960. VANCAMELBEKE M, Vanuytsel T, Farre R, Verstockt S, et al
    Genetic and Transcriptomic Bases of Intestinal Epithelial Barrier Dysfunction in Inflammatory Bowel Disease.
    Inflamm Bowel Dis. 2017 Sep 6. doi: 10.1097/MIB.0000000000001246.
    PubMed     Abstract available


  961. PARK KT, Heida A, van Rheenen PF
    Standardizing Fecal Calprotectin Monitoring in Asymptomatic Patients with Inflammatory Bowel Disease.
    Inflamm Bowel Dis. 2017;23:E47.
    PubMed    


  962. DAI C, Cao Q, Jiang M
    Clinical Utility of Fecal Calprotectin Monitoring in Asymptomatic Patients with Inflammatory Bowel Disease.
    Inflamm Bowel Dis. 2017;23:E46-E47.
    PubMed    


  963. PAPAMICHAEL K, Casteele NV, Ferrante M, Gils A, et al
    Therapeutic Drug Monitoring During Induction of Anti-Tumor Necrosis Factor Therapy in Inflammatory Bowel Disease: Defining a Therapeutic Drug Window.
    Inflamm Bowel Dis. 2017;23:1510-1515.
    PubMed     Abstract available


  964. TANG MS, Bowcutt R, Leung JM, Wolff MJ, et al
    Integrated Analysis of Biopsies from Inflammatory Bowel Disease Patients Identifies SAA1 as a Link Between Mucosal Microbes with TH17 and TH22 Cells.
    Inflamm Bowel Dis. 2017;23:1544-1554.
    PubMed     Abstract available


    August 2017
  965. ALLEGRETTI J, Eysenbach LM, El-Nachef N, Fischer M, et al
    The Current Landscape and Lessons from Fecal Microbiota Transplantation for Inflammatory Bowel Disease: Past, Present, and Future.
    Inflamm Bowel Dis. 2017 Aug 29. doi: 10.1097/MIB.0000000000001247.
    PubMed     Abstract available


  966. LIGHTNER AL, McKenna NP, Moncrief S, Pemberton JH, et al
    Surgical Outcomes in Vedolizumab-Treated Patients with Ulcerative Colitis.
    Inflamm Bowel Dis. 2017 Aug 29. doi: 10.1097/MIB.0000000000001248.
    PubMed     Abstract available


  967. KONIJETI GG, Kim N, Lewis JD, Groven S, et al
    Efficacy of the Autoimmune Protocol Diet for Inflammatory Bowel Disease.
    Inflamm Bowel Dis. 2017 Aug 29. doi: 10.1097/MIB.0000000000001221.
    PubMed     Abstract available


  968. KAMMERLANDER H, Nielsen J, Knudsen T, Kjeldsen J, et al
    Anti-TNF-alpha Use During the Third Trimester of Pregnancy in Women with Moderate-severe Inflammatory Bowel Disease and the Risk of Preterm Birth and Low Birth Weight.
    Inflamm Bowel Dis. 2017 Aug 29. doi: 10.1097/MIB.0000000000001234.
    PubMed     Abstract available


  969. MUDIREDDY P, Scott F, Feathers A, Lichtenstein GR, et al
    Inflammatory Bowel Disease: Predictors and Causes of Early and Late Hospital Readmissions.
    Inflamm Bowel Dis. 2017 Aug 29. doi: 10.1097/MIB.0000000000001242.
    PubMed     Abstract available


  970. CALDERA F, Wasan SK, Farraye FA, Hayney MS, et al
    Caution When Assessing Immunity to Varicella Through Antibody Testing in Patients with Inflammatory Bowel Disease.
    Inflamm Bowel Dis. 2017 Aug 23. doi: 10.1097/MIB.0000000000001239.
    PubMed    


  971. NARULA N, Kassam Z, Yuan Y, Colombel JF, et al
    Systematic Review and Meta-analysis: Fecal Microbiota Transplantation for Treatment of Active Ulcerative Colitis.
    Inflamm Bowel Dis. 2017 Aug 23. doi: 10.1097/MIB.0000000000001228.
    PubMed     Abstract available


  972. HYAMS JS, Kugathasan S, Dubinsky MC
    Combination Therapy in Pediatric Inflammatory Bowel Disease: Yes, No, Maybe.
    Inflamm Bowel Dis. 2017 Aug 22. doi: 10.1097/MIB.0000000000001206.
    PubMed    


  973. CHRISTIAN KE, Jambaulikar GD, Hagan MN, Syed AM, et al
    Predictors of Early Readmission in Hospitalized Patients with Inflammatory Bowel Disease.
    Inflamm Bowel Dis. 2017 Aug 22. doi: 10.1097/MIB.0000000000001213.
    PubMed     Abstract available


  974. GOLD SL, Cohen-Mekelburg S, Schneider Y, Shen N, et al
    Premedication Use in Preventing Acute Infliximab Infusion Reactions in Patients with Inflammatory Bowel Disease: A Single Center Cohort Study.
    Inflamm Bowel Dis. 2017 Aug 22. doi: 10.1097/MIB.0000000000001189.
    PubMed     Abstract available


  975. BHANDARI S, Mohammed Abdul MK, Dhakal B, Kreuziger LB, et al
    Increased Rate of Venous Thromboembolism in Hospitalized Inflammatory Bowel Disease Patients with Clostridium Difficile Infection.
    Inflamm Bowel Dis. 2017 Aug 22. doi: 10.1097/MIB.0000000000001218.
    PubMed     Abstract available


  976. CHENG J, Hamilton Z, Smyth M, Barker C, et al
    Concomitant Therapy with Immunomodulator Enhances Infliximab Durability in Pediatric Inflammatory Bowel Disease.
    Inflamm Bowel Dis. 2017 Aug 22. doi: 10.1097/MIB.0000000000001212.
    PubMed     Abstract available


  977. LU Y, Zamora-Ros R, Chan S, Cross AJ, et al
    Dietary Polyphenols in the Aetiology of Crohn's Disease and Ulcerative Colitis-A Multicenter European Prospective Cohort Study (EPIC).
    Inflamm Bowel Dis. 2017 Aug 22. doi: 10.1097/MIB.0000000000001108.
    PubMed     Abstract available


  978. LI SX, Thompson KD, Peterson T, Huneven S, et al
    Delivering High Value Inflammatory Bowel Disease Care Through Telemedicine Visits.
    Inflamm Bowel Dis. 2017 Aug 16. doi: 10.1097/MIB.0000000000001210.
    PubMed     Abstract available


  979. BRAMUZZO M, Stocco G, Montico M, Arrigo S, et al
    Risk Factors and Outcomes of Thalidomide-induced Peripheral Neuropathy in a Pediatric Inflammatory Bowel Disease Cohort.
    Inflamm Bowel Dis. 2017 Aug 16. doi: 10.1097/MIB.0000000000001195.
    PubMed     Abstract available


  980. KLAG T, Mazurak N, Fantasia L, Schwille-Kiuntke J, et al
    High Demand for Psychotherapy in Patients with Inflammatory Bowel Disease.
    Inflamm Bowel Dis. 2017 Aug 16. doi: 10.1097/MIB.0000000000001216.
    PubMed     Abstract available


  981. PARK KT, Heida A, van Rheenen PF
    Standardizing Fecal Calprotectin Monitoring in Asymptomatic Patients with Inflammatory Bowel Disease.
    Inflamm Bowel Dis. 2017 Aug 14. doi: 10.1097/MIB.0000000000001229.
    PubMed    


  982. DAI C, Cao Q, Jiang M
    Clinical Utility of Fecal Calprotectin Monitoring in Asymptomatic Patients with Inflammatory Bowel Disease.
    Inflamm Bowel Dis. 2017 Aug 14. doi: 10.1097/MIB.0000000000001225.
    PubMed    


  983. PAPAMICHAEL K, Casteele NV, Ferrante M, Gils A, et al
    Therapeutic Drug Monitoring During Induction of Anti-Tumor Necrosis Factor Therapy in Inflammatory Bowel Disease: Defining a Therapeutic Drug Window.
    Inflamm Bowel Dis. 2017 Aug 14. doi: 10.1097/MIB.0000000000001231.
    PubMed     Abstract available


  984. ISAKOV O, Dotan I, Ben-Shachar S
    Machine Learning-Based Gene Prioritization Identifies Novel Candidate Risk Genes for Inflammatory Bowel Disease.
    Inflamm Bowel Dis. 2017 Aug 8. doi: 10.1097/MIB.0000000000001222.
    PubMed     Abstract available


  985. MARIN-JIMENEZ I, Gobbo Montoya M, Panadero A, Canas M, et al
    Management of the Psychological Impact of Inflammatory Bowel Disease: Perspective of Doctors and Patients-The ENMENTE Project.
    Inflamm Bowel Dis. 2017 Aug 3. doi: 10.1097/MIB.0000000000001205.
    PubMed     Abstract available


  986. PEPE J, Zawadynski S, Herrmann FR, Juillerat P, et al
    Structural Basis of Bone Fragility in Young Subjects with Inflammatory Bowel Disease: A High-resolution pQCT Study of the SWISS IBD Cohort (SIBDC).
    Inflamm Bowel Dis. 2017;23:1410-1417.
    PubMed     Abstract available


  987. JOLVING LR, Nielsen J, Beck-Nielsen SS, Nielsen RG, et al
    The Association Between Maternal Chronic Inflammatory Bowel Disease and Long-term Health Outcomes in Children-A Nationwide Cohort Study.
    Inflamm Bowel Dis. 2017;23:1440-1446.
    PubMed     Abstract available


  988. SUN C, Zhao Y, Gao X, Yuan Y, et al
    Cideb Deficiency Aggravates Dextran Sulfate Sodium-induced Ulcerative Colitis in Mice by Exacerbating the Oxidative Burden in Colonic Mucosa.
    Inflamm Bowel Dis. 2017;23:1338-1347.
    PubMed     Abstract available


  989. AL-DARMAKI A, Hubbard J, Seow CH, Leung Y, et al
    Clinical Predictors of the Risk of Early Colectomy in Ulcerative Colitis: A Population-based Study.
    Inflamm Bowel Dis. 2017;23:1272-1277.
    PubMed     Abstract available


  990. TIAO DK, Chan W, Jeganathan J, Chan JT, et al
    Inflammatory Bowel Disease Pharmacist Adherence Counseling Improves Medication Adherence in Crohn's Disease and Ulcerative Colitis.
    Inflamm Bowel Dis. 2017;23:1257-1261.
    PubMed     Abstract available


    July 2017
  991. BAKER DM, Marshall JH, Lee MJ, Jones GL, et al
    A Systematic Review of Internet Decision-Making Resources for Patients Considering Surgery for Ulcerative Colitis.
    Inflamm Bowel Dis. 2017 Jul 12. doi: 10.1097/MIB.0000000000001198.
    PubMed     Abstract available


  992. COHN HM, Dave M, Loftus EV Jr
    Understanding the Cautions and Contraindications of Immunomodulator and Biologic Therapies for Use in Inflammatory Bowel Disease.
    Inflamm Bowel Dis. 2017 Jul 12. doi: 10.1097/MIB.0000000000001199.
    PubMed     Abstract available


  993. AGUAS PERIS M, Boso V, Navarro B, Marques-Minana MR, et al
    Serum Adalimumab Levels Predict Successful Remission and Safe Deintensification in Inflammatory Bowel Disease Patients in Clinical Practice.
    Inflamm Bowel Dis. 2017 Jul 12. doi: 10.1097/MIB.0000000000001182.
    PubMed     Abstract available


  994. MARTIN T, Smukalla SM, Kane S, Hudesman DP, et al
    Receptive Anal Intercourse in Patients with Inflammatory Bowel Disease: A Clinical Review.
    Inflamm Bowel Dis. 2017 Jul 12. doi: 10.1097/MIB.0000000000001186.
    PubMed     Abstract available


  995. VOSKENS CJ, Fischer A, Roessner S, Lorenz C, et al
    Characterization and Expansion of Autologous GMP-ready Regulatory T Cells for TREG-based Cell Therapy in Patients with Ulcerative Colitis.
    Inflamm Bowel Dis. 2017 Jul 12. doi: 10.1097/MIB.0000000000001192.
    PubMed     Abstract available


  996. SYED S, Michalski ES, Tangpricha V, Chesdachai S, et al
    Vitamin D Status Is Associated with Hepcidin and Hemoglobin Concentrations in Children with Inflammatory Bowel Disease.
    Inflamm Bowel Dis. 2017 Jul 11. doi: 10.1097/MIB.0000000000001178.
    PubMed     Abstract available


  997. SEVERS M, Mangen MJ, Fidder HH, van der Valk ME, et al
    Clinical Predictors of Future Nonadherence in Inflammatory Bowel Disease.
    Inflamm Bowel Dis. 2017 Jul 11. doi: 10.1097/MIB.0000000000001201.
    PubMed     Abstract available


  998. MATSUNO H, Kayama H, Nishimura J, Sekido Y, et al
    CD103+ Dendritic Cell Function Is Altered in the Colons of Patients with Ulcerative Colitis.
    Inflamm Bowel Dis. 2017 Jul 11. doi: 10.1097/MIB.0000000000001204.
    PubMed     Abstract available


  999. STARK CM, Gorman GH, Nylund CM
    Association of Inflammatory Bowel Disease and Urolithiasis in Hospitalized Pediatric Patients.
    Inflamm Bowel Dis. 2017 Jul 10. doi: 10.1097/MIB.0000000000001188.
    PubMed     Abstract available


  1000. ROBER N, Noss L, Goihl A, Reinhold D, et al
    Autoantibodies Against Glycoprotein 2 Isoforms in Pediatric Patients with Inflammatory Bowel Disease.
    Inflamm Bowel Dis. 2017 Jul 6. doi: 10.1097/MIB.0000000000001159.
    PubMed     Abstract available


  1001. JANMOHAMED N, Steinhart AH
    Measuring Severity of Anxiety and Depression in Patients with Inflammatory Bowel Disease: Low Concordance Between Patients and Male Gastroenterologists.
    Inflamm Bowel Dis. 2017;23:1168-1173.
    PubMed     Abstract available


  1002. KHALILI H, de Silva PS, Ananthakrishnan AN, Lochhead P, et al
    Dietary Iron and Heme Iron Consumption, Genetic Susceptibility, and Risk of Crohn's Disease and Ulcerative Colitis.
    Inflamm Bowel Dis. 2017;23:1088-1095.
    PubMed     Abstract available


    June 2017
  1003. TAXONERA C, Rodriguez C, Bertoletti F, Menchen L, et al
    Clinical Outcomes of Golimumab as First, Second or Third Anti-TNF Agent in Patients with Moderate-to-Severe Ulcerative Colitis.
    Inflamm Bowel Dis. 2017 Jun 30. doi: 10.1097/MIB.0000000000001144.
    PubMed     Abstract available


  1004. MA C, Lumb R, Walker EV, Foshaug RR, et al
    Noninvasive Fecal Immunochemical Testing and Fecal Calprotectin Predict Mucosal Healing in Inflammatory Bowel Disease: A Prospective Cohort Study.
    Inflamm Bowel Dis. 2017 Jun 20. doi: 10.1097/MIB.0000000000001173.
    PubMed     Abstract available


  1005. CARLSEN K, Houen G, Jakobsen C, Kallemose T, et al
    Individualized Infliximab Treatment Guided by Patient-managed eHealth in Children and Adolescents with Inflammatory Bowel Disease.
    Inflamm Bowel Dis. 2017 Jun 14. doi: 10.1097/MIB.0000000000001170.
    PubMed     Abstract available


  1006. MEIJER B, Seinen ML, van Egmond R, Bouma G, et al
    Optimizing Thiopurine Therapy in Inflammatory Bowel Disease Among 2 Real-life Intercept Cohorts: Effect of Allopurinol Comedication?
    Inflamm Bowel Dis. 2017 Jun 14. doi: 10.1097/MIB.0000000000001168.
    PubMed     Abstract available


  1007. EPPINGA H, Poortinga S, Thio HB, Nijsten TEC, et al
    Prevalence and Phenotype of Concurrent Psoriasis and Inflammatory Bowel Disease.
    Inflamm Bowel Dis. 2017 Jun 14. doi: 10.1097/MIB.0000000000001169.
    PubMed     Abstract available


  1008. PEDERSEN M, Cromwell J, Nau P
    Sarcopenia is a Predictor of Surgical Morbidity in Inflammatory Bowel Disease.
    Inflamm Bowel Dis. 2017 Jun 9. doi: 10.1097/MIB.0000000000001166.
    PubMed     Abstract available


  1009. PEKOW J, Hutchison AL, Meckel K, Harrington K, et al
    miR-4728-3p Functions as a Tumor Suppressor in Ulcerative Colitis-associated Colorectal Neoplasia Through Regulation of Focal Adhesion Signaling.
    Inflamm Bowel Dis. 2017 Jun 7. doi: 10.1097/MIB.0000000000001104.
    PubMed     Abstract available


  1010. KOPYLOV U, Papamichael K, Katsanos K, Waterman M, et al
    Impact of Infliximab and Cyclosporine on the Risk of Colectomy in Hospitalized Patients with Ulcerative Colitis Complicated by Cytomegalovirus-A Multicenter Retrospective Study.
    Inflamm Bowel Dis. 2017 Jun 5. doi: 10.1097/MIB.0000000000001160.
    PubMed     Abstract available


  1011. PATEL A, Panchal H, Dubinsky MC
    Fecal Calprotectin Levels Predict Histological Healing in Ulcerative Colitis.
    Inflamm Bowel Dis. 2017 Jun 5. doi: 10.1097/MIB.0000000000001157.
    PubMed     Abstract available


  1012. AXELRAD JE, Joelson A, Nobel YR, Lawlor G, et al
    Enteric Infection in Relapse of Inflammatory Bowel Disease: The Utility of Stool Microbial PCR Testing.
    Inflamm Bowel Dis. 2017;23:1034-1039.
    PubMed     Abstract available


  1013. GLASSNER K, Malaty HM, Abraham BP
    Epidemiology and Risk Factors of Nonalcoholic Fatty Liver Disease Among Patients with Inflammatory Bowel Disease.
    Inflamm Bowel Dis. 2017;23:998-1003.
    PubMed     Abstract available


  1014. HEIDA A, Park KT, van Rheenen PF
    Clinical Utility of Fecal Calprotectin Monitoring in Asymptomatic Patients with Inflammatory Bowel Disease: A Systematic Review and Practical Guide.
    Inflamm Bowel Dis. 2017;23:894-902.
    PubMed     Abstract available


  1015. NGUYEN GC, Boland K, Afif W, Bressler B, et al
    Modified Delphi Process for the Development of Choosing Wisely for Inflammatory Bowel Disease.
    Inflamm Bowel Dis. 2017;23:858-865.
    PubMed     Abstract available


  1016. YADAV A, Foromera J, Feuerstein I, Falchuk KR, et al
    Variations in Health Insurance Policies Regarding Biologic Therapy Use in Inflammatory Bowel Disease.
    Inflamm Bowel Dis. 2017;23:853-857.
    PubMed     Abstract available


  1017. BERRY AC, Dholaria K, Czul-Gurdian F, Forster E, et al
    Relationship Between Patient Knowledge and Medication Adherence in Inflammatory Bowel Disease.
    Inflamm Bowel Dis. 2017;23:E39-E40.
    PubMed    


  1018. HOPKINS CWP, Butt HS, Moulton CD
    Beyond Efficacy: The Acceptability of Antidepressant Treatment to Patients with Inflammatory Bowel Disease.
    Inflamm Bowel Dis. 2017;23:E38.
    PubMed    


    May 2017
  1019. DAN A, Boutros M, Nedjar H, Kopylov U, et al
    Cost of Ulcerative Colitis in Quebec, Canada: A Retrospective Cohort Study.
    Inflamm Bowel Dis. 2017 May 29. doi: 10.1097/MIB.0000000000001147.
    PubMed     Abstract available


  1020. BUISSON A, Gonzalez F, Poullenot F, Nancey S, et al
    Comparative Acceptability and Perceived Clinical Utility of Monitoring Tools: A Nationwide Survey of Patients with Inflammatory Bowel Disease.
    Inflamm Bowel Dis. 2017 May 24. doi: 10.1097/MIB.0000000000001140.
    PubMed     Abstract available


  1021. LOPEZ RN, Evans HM, Appleton L, Bishop J, et al
    Point Prevalence of Pediatric Inflammatory Bowel Disease in New Zealand in 2015: Initial Results from the PINZ Study.
    Inflamm Bowel Dis. 2017 May 24. doi: 10.1097/MIB.0000000000001138.
    PubMed     Abstract available


  1022. FEAGINS LA, Waljee A, Hou JK, Gu P, et al
    Incidence of and Predictors for Early Discontinuation of Biological Therapies in Veteran Patients with Inflammatory Bowel Disease.
    Inflamm Bowel Dis. 2017 May 24. doi: 10.1097/MIB.0000000000001145.
    PubMed     Abstract available


  1023. CHAO K, Wang X, Cao Q, Qian J, et al
    Combined Detection of NUDT15 Variants Could Highly Predict Thiopurine-induced Leukopenia in Chinese Patients with Inflammatory Bowel Disease: A Multicenter Analysis.
    Inflamm Bowel Dis. 2017 May 24. doi: 10.1097/MIB.0000000000001148.
    PubMed     Abstract available


  1024. BORREN NZ, Conway G, Tan W, Andrews E, et al
    Distance to Specialist Care and Disease Outcomes in Inflammatory Bowel Disease.
    Inflamm Bowel Dis. 2017 May 16. doi: 10.1097/MIB.0000000000001133.
    PubMed     Abstract available


  1025. VALER P, Algaba A, Santos D, Fuentes ME, et al
    Evaluation of the Quality of Semen and Sexual Function in Men with Inflammatory Bowel Disease.
    Inflamm Bowel Dis. 2017 May 16. doi: 10.1097/MIB.0000000000001081.
    PubMed     Abstract available


  1026. FATTAHI MR, Malek-Hosseini SA, Sivandzadeh GR, Safarpour AR, et al
    Clinical Course of Ulcerative Colitis After Liver Transplantation in Patients with Concomitant Primary Sclerosing Cholangitis and Ulcerative Colitis.
    Inflamm Bowel Dis. 2017 May 16. doi: 10.1097/MIB.0000000000001105.
    PubMed     Abstract available


  1027. NGUYEN GC, Boland K, Afif W, Bressler B, et al
    Modified Delphi Process for the Development of Choosing Wisely for Inflammatory Bowel Disease.
    Inflamm Bowel Dis. 2017 May 15. doi: 10.1097/MIB.0000000000001152.
    PubMed     Abstract available


  1028. YADAV A, Foromera J, Feuerstein I, Falchuk KR, et al
    Variations in Health Insurance Policies Regarding Biologic Therapy Use in Inflammatory Bowel Disease.
    Inflamm Bowel Dis. 2017 May 15. doi: 10.1097/MIB.0000000000001153.
    PubMed     Abstract available


  1029. JULSGAARD M, Hvas CL, Gearry RB, Vestergaard T, et al
    Fecal Calprotectin Is Not Affected by Pregnancy: Clinical Implications for the Management of Pregnant Patients with Inflammatory Bowel Disease.
    Inflamm Bowel Dis. 2017 May 11. doi: 10.1097/MIB.0000000000001136.
    PubMed     Abstract available


  1030. RESTALL GJ, Simms AM, Walker JR, Haviva C, et al
    Coping with Inflammatory Bowel Disease: Engaging with Information to Inform Health-Related Decision Making in Daily Life.
    Inflamm Bowel Dis. 2017 May 11. doi: 10.1097/MIB.0000000000001141.
    PubMed     Abstract available


  1031. KELLY OB, Donnell SO, Stempak JM, Steinhart AH, et al
    Therapeutic Drug Monitoring to Guide Infliximab Dose Adjustment is Associated with Better Endoscopic Outcomes than Clinical Decision Making Alone in Active Inflammatory Bowel Disease.
    Inflamm Bowel Dis. 2017 May 11. doi: 10.1097/MIB.0000000000001126.
    PubMed     Abstract available


  1032. JEGANATHAN J, Lee CH, Rahme A, Tiao DK, et al
    Pediatric-to-adult Transition and Medication Adherence in Patients with Inflammatory Bowel Disease.
    Inflamm Bowel Dis. 2017 May 11. doi: 10.1097/MIB.0000000000001114.
    PubMed     Abstract available


  1033. GUNALTAY S, Repsilber D, Helenius G, Nyhlin N, et al
    Oligoclonal T-cell Receptor Repertoire in Colonic Biopsies of Patients with Microscopic Colitis and Ulcerative Colitis.
    Inflamm Bowel Dis. 2017 May 11. doi: 10.1097/MIB.0000000000001127.
    PubMed     Abstract available


  1034. YANG H, Zhou W, Lv H, Wu D, et al
    The Association Between CMV Viremia or Endoscopic Features and Histopathological Characteristics of CMV Colitis in Patients with Underlying Ulcerative Colitis.
    Inflamm Bowel Dis. 2017;23:814-821.
    PubMed     Abstract available


  1035. THORLACIUS-USSING G, Schnack Nielsen B, Andersen V, Holmstrom K, et al
    Expression and Localization of miR-21 and miR-126 in Mucosal Tissue from Patients with Inflammatory Bowel Disease.
    Inflamm Bowel Dis. 2017;23:739-752.
    PubMed     Abstract available


  1036. BURKE KE, Haviland MJ, Hacker MR, Shainker SA, et al
    Indications for Mode of Delivery in Pregnant Women with Inflammatory Bowel Disease.
    Inflamm Bowel Dis. 2017;23:721-726.
    PubMed     Abstract available


  1037. FOULON A, Dupas JL, Sabbagh C, Chevreau J, et al
    Defining the Most Appropriate Delivery Mode in Women with Inflammatory Bowel Disease: A Systematic Review.
    Inflamm Bowel Dis. 2017;23:712-720.
    PubMed     Abstract available


  1038. NGUYEN GC, Murthy SK, Bressler B, Lam MCW, et al
    Quality of Care and Outcomes Among Hospitalized Inflammatory Bowel Disease Patients: A Multicenter Retrospective Study.
    Inflamm Bowel Dis. 2017;23:695-701.
    PubMed     Abstract available


  1039. ASSA A, Bronsky J, Kolho KL, Zarubova K, et al
    Anti-TNFalpha Treatment After Surgical Resection for Crohn's Disease Is Effective Despite Previous Pharmacodynamic Failure.
    Inflamm Bowel Dis. 2017;23:791-797.
    PubMed     Abstract available


  1040. DOTSON JL, Cho M, Bricker J, Kappelman MD, et al
    Race Differences in Initial Presentation, Early Treatment, and 1-year Outcomes of Pediatric Crohn's Disease: Results from the ImproveCareNow Network.
    Inflamm Bowel Dis. 2017;23:767-774.
    PubMed     Abstract available


  1041. BROCHARD C, Siproudhis L, Leveque J, Grouin A, et al
    Factors Associated with Fecal Incontinence in Women of Childbearing Age with Crohn's Disease.
    Inflamm Bowel Dis. 2017;23:775-780.
    PubMed     Abstract available


  1042. MA C, Fedorak RN, Kaplan GG, Dieleman LA, et al
    Long-term Maintenance of Clinical, Endoscopic, and Radiographic Response to Ustekinumab in Moderate-to-Severe Crohn's Disease: Real-world Experience from a Multicenter Cohort Study.
    Inflamm Bowel Dis. 2017;23:833-839.
    PubMed     Abstract available


  1043. WILSON A, Tirona RG, Kim RB
    CYP3A4 Activity is Markedly Lower in Patients with Crohn's Disease.
    Inflamm Bowel Dis. 2017;23:804-813.
    PubMed     Abstract available


    April 2017
  1044. VAVRICKA SR, Gubler M, Gantenbein C, Spoerri M, et al
    Anti-TNF Treatment for Extraintestinal Manifestations of Inflammatory Bowel Disease in the Swiss IBD Cohort Study.
    Inflamm Bowel Dis. 2017 Apr 27. doi: 10.1097/MIB.0000000000001109.
    PubMed     Abstract available


  1045. MAGNUSSON MK, Strid H, Isaksson S, Simren M, et al
    The Mucosal Antibacterial Response Profile and Fecal Microbiota Composition Are Linked to the Disease Course in Patients with Newly Diagnosed Ulcerative Colitis.
    Inflamm Bowel Dis. 2017 Apr 25. doi: 10.1097/MIB.0000000000001130.
    PubMed     Abstract available


  1046. JACOB V, Crawford C, Cohen-Mekelburg S, Viladomiu M, et al
    Single Delivery of High-Diversity Fecal Microbiota Preparation by Colonoscopy Is Safe and Effective in Increasing Microbial Diversity in Active Ulcerative Colitis.
    Inflamm Bowel Dis. 2017 Apr 25. doi: 10.1097/MIB.0000000000001132.
    PubMed     Abstract available


  1047. BUHL S, Steenholdt C, Rasmussen M, Borghede MK, et al
    Outcomes After Primary Infliximab Treatment Failure in Inflammatory Bowel Disease.
    Inflamm Bowel Dis. 2017 Apr 25. doi: 10.1097/MIB.0000000000001117.
    PubMed     Abstract available


  1048. BARNES EL, Kochar B, Long MD, Kappelman MD, et al
    Modifiable Risk Factors for Hospital Readmission Among Patients with Inflammatory Bowel Disease in a Nationwide Database.
    Inflamm Bowel Dis. 2017 Apr 19. doi: 10.1097/MIB.0000000000001121.
    PubMed     Abstract available


  1049. LIGHTNER AL, Tse CS, Quinn K, Bergquist JR, et al
    Preoperative Clostridium difficile Infection Does Not Affect Pouch Outcomes in Patients with Ulcerative Colitis Who Undergo Ileal Pouch-anal Anastomosis.
    Inflamm Bowel Dis. 2017 Apr 13. doi: 10.1097/MIB.0000000000001122.
    PubMed     Abstract available


  1050. MARTINEZ B, Dailey F, Almario CV, Keller MS, et al
    Patient Understanding of the Risks and Benefits of Biologic Therapies in Inflammatory Bowel Disease: Insights from a Large-scale Analysis of Social Media Platforms.
    Inflamm Bowel Dis. 2017 Apr 13. doi: 10.1097/MIB.0000000000001110.
    PubMed     Abstract available


  1051. ADAMS DW, Gurwara S, Silver HJ, Horst SN, et al
    Sarcopenia Is Common in Overweight Patients with Inflammatory Bowel Disease and May Predict Need for Surgery.
    Inflamm Bowel Dis. 2017 Apr 13. doi: 10.1097/MIB.0000000000001128.
    PubMed     Abstract available


  1052. KOCHAR B, Long MD, Galanko J, Raffals LE, et al
    Inflammatory Bowel Disease is Similar in Patients with Older Onset and Younger Onset.
    Inflamm Bowel Dis. 2017 Apr 13. doi: 10.1097/MIB.0000000000001115.
    PubMed     Abstract available


  1053. VARNI JW, Shulman RJ, Self MM, Saeed SA, et al
    Patient Health Communication Mediating Effects Between Gastrointestinal Symptoms and Gastrointestinal Worry in Pediatric Inflammatory Bowel Disease.
    Inflamm Bowel Dis. 2017 Apr 6. doi: 10.1097/MIB.0000000000001077.
    PubMed     Abstract available


  1054. BANASZKIEWICZ A, Gawronska A, Klincewicz B, Kofla-Dlubacz A, et al
    Immunogenicity of Pertussis Booster Vaccination in Children and Adolescents with Inflammatory Bowel Disease: A Controlled Study.
    Inflamm Bowel Dis. 2017 Apr 6. doi: 10.1097/MIB.0000000000001076.
    PubMed     Abstract available


  1055. NAVANEETHAN U, Edminister T, Zhu X, Kommaraju K, et al
    Vedolizumab Is Safe and Effective in Elderly Patients with Inflammatory Bowel Disease.
    Inflamm Bowel Dis. 2017;23:E17.
    PubMed    


  1056. KHAN A, Chandler M, Borum ML
    Patients with Inflammatory Bowel Disease May Use Electronic Communication with Their Physicians More Frequently Than Those Without Inflammatory Bowel Disease.
    Inflamm Bowel Dis. 2017;23:E16.
    PubMed    


  1057. STOCCO G, Martelossi S, Arrigo S, Barabino A, et al
    Multicentric Case-Control Study on Azathioprine Dose and Pharmacokinetics in Early-onset Pediatric Inflammatory Bowel Disease.
    Inflamm Bowel Dis. 2017;23:628-634.
    PubMed     Abstract available


  1058. TANDON P, James P, Cordeiro E, Mallick R, et al
    Diagnostic Accuracy of Blood-Based Tests and Histopathology for Cytomegalovirus Reactivation in Inflammatory Bowel Disease: A Systematic Review and Meta-Analysis.
    Inflamm Bowel Dis. 2017;23:551-560.
    PubMed     Abstract available


  1059. LAN N, Shen B
    Endoscopic Stricturotomy with Needle Knife in the Treatment of Strictures from Inflammatory Bowel Disease.
    Inflamm Bowel Dis. 2017;23:502-513.
    PubMed     Abstract available


  1060. RUBIN DT, Dubinsky MC, Martino S, Hewett KA, et al
    Communication Between Physicians and Patients with Ulcerative Colitis: Reflections and Insights from a Qualitative Study of In-Office Patient-Physician Visits.
    Inflamm Bowel Dis. 2017;23:494-501.
    PubMed     Abstract available


  1061. KISTANGARI G, Lopez R, Shen B
    Frequency and Risk Factors of Clostridium difficile Infection in Hospitalized Patients With Pouchitis: A Population-based Study.
    Inflamm Bowel Dis. 2017;23:661-671.
    PubMed     Abstract available


  1062. ZUNDLER S, Neurath MF
    Novel Insights into the Mechanisms of Gut Homing and Antiadhesion Therapies in Inflammatory Bowel Diseases.
    Inflamm Bowel Dis. 2017;23:617-627.
    PubMed     Abstract available


  1063. SHIYING W, Boyun S, Jianye Y, Wanjun Z, et al
    The Different Effects of VEGFA121 and VEGFA165 on Regulating Angiogenesis Depend on Phosphorylation Sites of VEGFR2.
    Inflamm Bowel Dis. 2017;23:603-616.
    PubMed     Abstract available


  1064. SAEED MA, Ng GZ, Dabritz J, Wagner J, et al
    Protease-activated Receptor 1 Plays a Proinflammatory Role in Colitis by Promoting Th17-related Immunity.
    Inflamm Bowel Dis. 2017;23:593-602.
    PubMed     Abstract available


  1065. GROSEN A, Kelsen J, Hvas CL, Bellaguarda E, et al
    The Influence of Methotrexate Treatment on Male Fertility and Pregnancy Outcome After Paternal Exposure.
    Inflamm Bowel Dis. 2017;23:561-569.
    PubMed     Abstract available


  1066. DE JONG M, van der Meulen-de Jong A, Romberg-Camps M, Degens J, et al
    Development and Feasibility Study of a Telemedicine Tool for All Patients with IBD: MyIBDcoach.
    Inflamm Bowel Dis. 2017;23:485-493.
    PubMed     Abstract available


  1067. HRADSKY O, Soucek O, Maratova K, Matyskova J, et al
    Supplementation with 2000 IU of Cholecalciferol Is Associated with Improvement of Trabecular Bone Mineral Density and Muscle Power in Pediatric Patients with IBD.
    Inflamm Bowel Dis. 2017;23:514-523.
    PubMed     Abstract available


  1068. CHAUDHRY NA, Riverso M, Grajo JR, Moser PP, et al
    A Fixed Stricture on Routine Cross-sectional Imaging Predicts Disease-Related Complications and Adverse Outcomes in Patients with Crohn's Disease.
    Inflamm Bowel Dis. 2017;23:641-649.
    PubMed     Abstract available


  1069. SHAH ED, Farida JP, Siegel CA, Chong K, et al
    Risk for Overall Infection with Anti-TNF and Anti-integrin Agents Used in IBD: A Systematic Review and Meta-analysis.
    Inflamm Bowel Dis. 2017;23:570-577.
    PubMed     Abstract available


  1070. BERNSTEIN CN, Burchill C, Targownik LE, Singh H, et al
    Maternal Infections That Would Warrant Antibiotic Use Antepartum or Peripartum Are Not a Risk Factor for the Development of IBD: A Population-Based Analysis.
    Inflamm Bowel Dis. 2017;23:635-640.
    PubMed     Abstract available


    March 2017
  1071. NARULA N, Borges L, Steinhart AH, Colombel JF, et al
    Trends in Narcotic and Corticosteroid Prescriptions in Patients with Inflammatory Bowel Disease in the United States Ambulatory Care Setting from 2003 to 2011.
    Inflamm Bowel Dis. 2017 Mar 31. doi: 10.1097/MIB.0000000000001084.
    PubMed     Abstract available


  1072. SUZUKI Y, Iida M, Ito H, Nishino H, et al
    2.4 g Mesalamine (Asacol 400 mg tablet) Once Daily is as Effective as Three Times Daily in Maintenance of Remission in Ulcerative Colitis: A Randomized, Noninferiority, Multi-center Trial.
    Inflamm Bowel Dis. 2017 Mar 31. doi: 10.1097/MIB.0000000000001065.
    PubMed     Abstract available


  1073. ANANTHAKRISHNAN AN, Donaldson T, Lasch K, Yajnik V, et al
    Management of Inflammatory Bowel Disease in the Elderly Patient: Challenges and Opportunities.
    Inflamm Bowel Dis. 2017 Mar 27. doi: 10.1097/MIB.0000000000001099.
    PubMed     Abstract available


  1074. KAMMERLANDER H, Nielsen J, Kjeldsen J, Knudsen T, et al
    The Effect of Disease Activity on Birth Outcomes in a Nationwide Cohort of Women with Moderate to Severe Inflammatory Bowel Disease.
    Inflamm Bowel Dis. 2017 Mar 24. doi: 10.1097/MIB.0000000000001102.
    PubMed     Abstract available


  1075. HATA K, Ishii H, Anzai H, Ishihara S, et al
    Preoperative Extraintestinal Manifestations Associated with Chronic Pouchitis in Japanese Patients with Ulcerative Colitis After Ileal Pouch-anal Anastomosis: A Retrospective Study.
    Inflamm Bowel Dis. 2017 Mar 24. doi: 10.1097/MIB.0000000000001094.
    PubMed     Abstract available


  1076. ZULLOW S, Fazelat A, Farraye FA
    Central Serous Chorioretinopathy in a Patient with Ulcerative Colitis with Pouchitis on Budesonide-EC.
    Inflamm Bowel Dis. 2017 Mar 21. doi: 10.1097/MIB.0000000000001091.
    PubMed    


  1077. EL-MATARY W
    Indicators of Quality of Care in Inflammatory Bowel Disease: Seeking the Right Path for Patients.
    Inflamm Bowel Dis. 2017 Mar 21. doi: 10.1097/MIB.0000000000001069.
    PubMed    


  1078. KHAN N, Patel D, Shah Y, Lichtenstein G, et al
    A Novel User-Friendly Model to Predict Corticosteroid Utilization in Newly Diagnosed Patients with Ulcerative Colitis.
    Inflamm Bowel Dis. 2017 Mar 21. doi: 10.1097/MIB.0000000000001080.
    PubMed     Abstract available


  1079. NGUYEN GC, Murthy SK, Bressler B, Lam MC, et al
    Quality of Care and Outcomes Among Hospitalized Inflammatory Bowel Disease Patients: A Multicenter Retrospective Study.
    Inflamm Bowel Dis. 2017 Mar 21. doi: 10.1097/MIB.0000000000001068.
    PubMed     Abstract available


  1080. NAVIGLIO S, Parentin F, Nider S, Rassu N, et al
    Ocular Involvement in Children with Inflammatory Bowel Disease.
    Inflamm Bowel Dis. 2017 Mar 21. doi: 10.1097/MIB.0000000000001079.
    PubMed     Abstract available


  1081. ISHAK WW, Pan D, Steiner AJ, Feldman E, et al
    Patient-Reported Outcomes of Quality of Life, Functioning, and GI/Psychiatric Symptom Severity in Patients with Inflammatory Bowel Disease (IBD).
    Inflamm Bowel Dis. 2017 Mar 15. doi: 10.1097/MIB.0000000000001060.
    PubMed     Abstract available


  1082. ARORA Z, Mukewar S, Lopez R, Camino D, et al
    Etiopathogenesis of Nephrolithiasis in Ulcerative Colitis Patients with the Ileal Pouch Anal Anastomosis.
    Inflamm Bowel Dis. 2017 Mar 15. doi: 10.1097/MIB.0000000000001070.
    PubMed     Abstract available


  1083. LIGHTNER AL, Mathis KL, Dozois EJ, Hahnsloser D, et al
    Results at Up to 30 Years After Ileal Pouch-Anal Anastomosis for Chronic Ulcerative Colitis.
    Inflamm Bowel Dis. 2017 Mar 15. doi: 10.1097/MIB.0000000000001061.
    PubMed     Abstract available


  1084. KELSEN JR, Dawany N, Conrad M, Devoto M, et al
    Commentary on Mutations in Interleukin-10 Receptor and Clinical Phenotypes in Patients with Very Early-onset Inflammatory Bowel Disease: A Chinese VEO-IBD Collaboration Group Survey.
    Inflamm Bowel Dis. 2017 Mar 6. doi: 10.1097/MIB.0000000000001028.
    PubMed    


  1085. MACER BJ, Prady SL, Mikocka-Walus A
    Antidepressants in Inflammatory Bowel Disease: A Systematic Review.
    Inflamm Bowel Dis. 2017 Mar 6. doi: 10.1097/MIB.0000000000001059.
    PubMed     Abstract available


  1086. HUANG Z, Peng K, Li X, Zhao R, et al
    Mutations in Interleukin-10 Receptor and Clinical Phenotypes in Patients with Very Early Onset Inflammatory Bowel Disease: A Chinese VEO-IBD Collaboration Group Survey.
    Inflamm Bowel Dis. 2017 Mar 6. doi: 10.1097/MIB.0000000000001058.
    PubMed     Abstract available


  1087. SEXTON KA, Walker JR, Graff LA, Bernstein MT, et al
    Evidence of Bidirectional Associations Between Perceived Stress and Symptom Activity: A Prospective Longitudinal Investigation in Inflammatory Bowel Disease.
    Inflamm Bowel Dis. 2017;23:473-483.
    PubMed     Abstract available


  1088. HUANG Y, Dalal S, Antonopoulos D, Hubert N, et al
    Early Transcriptomic Changes in the Ileal Pouch Provide Insight into the Molecular Pathogenesis of Pouchitis and Ulcerative Colitis.
    Inflamm Bowel Dis. 2017;23:366-378.
    PubMed     Abstract available


  1089. CARLSEN K, Jakobsen C, Houen G, Kallemose T, et al
    Self-managed eHealth Disease Monitoring in Children and Adolescents with Inflammatory Bowel Disease: A Randomized Controlled Trial.
    Inflamm Bowel Dis. 2017;23:357-365.
    PubMed     Abstract available


  1090. POOJARY P, Saha A, Chauhan K, Simoes P, et al
    Predictors of Hospital Readmissions for Ulcerative Colitis in the United States: A National Database Study.
    Inflamm Bowel Dis. 2017;23:347-356.
    PubMed     Abstract available


  1091. TARGOWNIK LE, Tennakoon A, Leung S, Lix LM, et al
    Factors Associated with Discontinuation of Anti-TNF Inhibitors Among Persons with IBD: A Population-Based Analysis.
    Inflamm Bowel Dis. 2017;23:409-420.
    PubMed     Abstract available


  1092. ZUNDLER S, Fischer A, Schillinger D, Binder MT, et al
    The alpha4beta1 Homing Pathway Is Essential for Ileal Homing of Crohn's Disease Effector T Cells In Vivo.
    Inflamm Bowel Dis. 2017;23:379-391.
    PubMed     Abstract available


  1093. CARLSEN K, Haddad N, Gordon J, Phan BL, et al
    Self-efficacy and Resilience Are Useful Predictors of Transition Readiness Scores in Adolescents with Inflammatory Bowel Diseases.
    Inflamm Bowel Dis. 2017;23:341-346.
    PubMed     Abstract available


  1094. SEINEN ML, van Asseldonk DP, de Boer NK, Bouma G, et al
    Nodular Regenerative Hyperplasia of the Liver in Patients with IBD Treated with Allopurinol-Thiopurine Combination Therapy.
    Inflamm Bowel Dis. 2017;23:448-452.
    PubMed     Abstract available


  1095. LOPETUSO LR, Jia R, Wang XM, Jia LG, et al
    Epithelial-specific Toll-like Receptor (TLR)5 Activation Mediates Barrier Dysfunction in Experimental Ileitis.
    Inflamm Bowel Dis. 2017;23:392-403.
    PubMed     Abstract available


  1096. COWARD S, Kuenzig ME, Hazlewood G, Clement F, et al
    Comparative Effectiveness of Mesalamine, Sulfasalazine, Corticosteroids, and Budesonide for the Induction of Remission in Crohn's Disease: A Bayesian Network Meta-analysis.
    Inflamm Bowel Dis. 2017;23:461-472.
    PubMed     Abstract available


  1097. GHOSH S, Louis E, Beaugerie L, Bossuyt P, et al
    Development of the IBD Disk: A Visual Self-administered Tool for Assessing Disability in Inflammatory Bowel Diseases.
    Inflamm Bowel Dis. 2017;23:333-340.
    PubMed     Abstract available


  1098. LU C, Gui X, Chen W, Fung T, et al
    Ultrasound Shear Wave Elastography and Contrast Enhancement: Effective Biomarkers in Crohn's Disease Strictures.
    Inflamm Bowel Dis. 2017;23:421-430.
    PubMed     Abstract available


  1099. FAUBION WA, Dubinsky M, Ruemmele FM, Escher J, et al
    Long-term Efficacy and Safety of Adalimumab in Pediatric Patients with Crohn's Disease.
    Inflamm Bowel Dis. 2017;23:453-460.
    PubMed     Abstract available


  1100. HUANG Z, Chao K, Li M, Zhi M, et al
    Methotrexate for Refractory Crohn's Disease Compared with Thiopurines: A Retrospective Non-head-to-head Controlled Study.
    Inflamm Bowel Dis. 2017;23:440-447.
    PubMed     Abstract available


    February 2017
  1101. CARLSEN K, Jakobsen C, Houen G, Kallemose T, et al
    Self-managed eHealth Disease Monitoring in Children and Adolescents with Inflammatory Bowel Disease: A Randomized Controlled Trial.
    Inflamm Bowel Dis. 2017 Feb 13. doi: 10.1097/MIB.0000000000001026.
    PubMed     Abstract available


  1102. POOJARY P, Saha A, Chauhan K, Simoes P, et al
    Predictors of Hospital Readmissions for Ulcerative Colitis in the United States: A National Database Study.
    Inflamm Bowel Dis. 2017 Feb 13. doi: 10.1097/MIB.0000000000001041.
    PubMed     Abstract available


  1103. HUANG Y, Dalal S, Antonopoulos D, Hubert N, et al
    Early Transcriptomic Changes in the Ileal Pouch Provide Insight into the Molecular Pathogenesis of Pouchitis and Ulcerative Colitis.
    Inflamm Bowel Dis. 2017 Feb 13. doi: 10.1097/MIB.0000000000001027.
    PubMed     Abstract available


  1104. BRANDSE JF, Mould D, Smeekes O, Ashruf Y, et al
    A Real-life Population Pharmacokinetic Study Reveals Factors Associated with Clearance and Immunogenicity of Infliximab in Inflammatory Bowel Disease.
    Inflamm Bowel Dis. 2017 Feb 10. doi: 10.1097/MIB.0000000000001043.
    PubMed     Abstract available


  1105. KOPYLOV U, Ron Y, Avni-Biron I, Koslowsky B, et al
    Efficacy and Safety of Vedolizumab for Induction of Remission in Inflammatory Bowel Disease-the Israeli Real-World Experience.
    Inflamm Bowel Dis. 2017 Feb 7. doi: 10.1097/MIB.0000000000001039.
    PubMed     Abstract available


  1106. RODRIGUEZ-PALACIOS A, Corridoni D, Di Stefano G, Di Martino L, et al
    O-014 Bacterial Sensor NOD2 Deletion Causes Th2-Inflammatory Bowel Disease Improvement Without Inducing Acute Metatranscriptomic Dysbiosis in Mice.
    Inflamm Bowel Dis. 2017;23 Suppl 1:S5.
    PubMed     Abstract available


  1107. HABERMAN Y, Ben-Shoshan M, Di-Segni A, Dexheimer P, et al
    O-009 Long ncRNA Landscape in the Ileum of Treatment Naive Early Onset Crohn Disease.
    Inflamm Bowel Dis. 2017;23 Suppl 1:S3-S4.
    PubMed     Abstract available


  1108. KIM ES, Jang BI, Kim KO, Kim EY, et al
    O-007 Impact of Education on School Nurses' Knowledge of Inflammatory Bowel Disease.
    Inflamm Bowel Dis. 2017;23 Suppl 1:S3.
    PubMed     Abstract available


  1109. EL-MATARY W, Samson C, Crim A, Ali S, et al
    O-006 Rapid Infliximab Infusion in Children with Inflammatory Bowel Disease: A Multi-Center North American Experience.
    Inflamm Bowel Dis. 2017;23 Suppl 1:S2-S3.
    PubMed     Abstract available


  1110. SHAKHNOVICH V, Van Haandel L, Becker M, Funk R, et al
    O-005 Combination Therapy with Methotrexate Does Not Change Infliximab Pharmacokinetics in Children with Inflammatory Bowel Disease.
    Inflamm Bowel Dis. 2017;23 Suppl 1:S2.
    PubMed     Abstract available


  1111. DUPONT-LUCAS C, Grandjean-Blanchet C, Leduc B, Tripcovici M, et al
    Prevalence and Risk Factors for Symptoms of Methotrexate Intolerance in Pediatric Inflammatory Bowel Disease.
    Inflamm Bowel Dis. 2017;23:298-303.
    PubMed     Abstract available


  1112. ALEXAKIS C, Saxena S, Chhaya V, Cecil E, et al
    Do Thiopurines Reduce the Risk of Surgery in Elderly Onset Inflammatory Bowel Disease? A 20-Year National Population-Based Cohort Study.
    Inflamm Bowel Dis. 2017 Feb 1. doi: 10.1097/MIB.0000000000001031.
    PubMed     Abstract available


  1113. MAGRO F, Dias CC, Coelho R, Santos PM, et al
    Impact of Early Surgery and Immunosuppression on Crohn's Disease Disabling Outcomes.
    Inflamm Bowel Dis. 2017;23:289-297.
    PubMed     Abstract available


  1114. ZAYYANI NR, Malaty HM, Graham DY
    Increasing Incidence of Crohn's Disease with Familial Clustering in the Kingdom of Bahrain: A 25-Year Population-based Study.
    Inflamm Bowel Dis. 2017;23:304-309.
    PubMed     Abstract available


  1115. DIEDEREN K, de Ridder L, van Rheenen P, Wolters VM, et al
    Complications and Disease Recurrence After Primary Ileocecal Resection in Pediatric Crohn's Disease: A Multicenter Cohort Analysis.
    Inflamm Bowel Dis. 2017;23:272-282.
    PubMed     Abstract available


  1116. VELONIAS G, Conway G, Andrews E, Garber JJ, et al
    Older Age- and Health-related Quality of Life in Inflammatory Bowel Diseases.
    Inflamm Bowel Dis. 2017;23:283-288.
    PubMed     Abstract available


  1117. LI XH, Sun CH, Mao R, Huang SY, et al
    Diffusion-weighted MRI Enables to Accurately Grade Inflammatory Activity in Patients of Ileocolonic Crohn's Disease: Results from an Observational Study.
    Inflamm Bowel Dis. 2017;23:244-253.
    PubMed     Abstract available


    January 2017
  1118. RUAN J, Chen Y, Zhou Y
    Development and Validation of a Questionnaire to Assess the Quality of Life in Patients with Inflammatory Bowel Disease in Mainland China.
    Inflamm Bowel Dis. 2017 Jan 26. doi: 10.1097/MIB.0000000000001024.
    PubMed     Abstract available


  1119. FIORINO G, Manetti N, Armuzzi A, Orlando A, et al
    The PROSIT-BIO Cohort: A Prospective Observational Study of Patients with Inflammatory Bowel Disease Treated with Infliximab Biosimilar.
    Inflamm Bowel Dis. 2017 Jan 12. doi: 10.1097/MIB.0000000000000995.
    PubMed     Abstract available


  1120. KUCHARZIK T, Lemmnitz G, Abels C, Maaser C, et al
    Tripeptide K(D)PT Is Well Tolerated in Mild-to-moderate Ulcerative Colitis: Results from a Randomized Multicenter Study.
    Inflamm Bowel Dis. 2017 Jan 12. doi: 10.1097/MIB.0000000000001000.
    PubMed     Abstract available


  1121. ABDALLA MI, Sandler RS, Kappelman MD, Martin CF, et al
    Prevalence and Impact of Inflammatory Bowel Disease-Irritable Bowel Syndrome on Patient-reported Outcomes in CCFA Partners.
    Inflamm Bowel Dis. 2017 Jan 12. doi: 10.1097/MIB.0000000000001017.
    PubMed     Abstract available


  1122. QIN X
    Damage of the Mucus Layer: The Possible Shared Critical Common Cause for Both Inflammatory Bowel Disease (IBD) and Irritable Bowel Syndrome (IBS).
    Inflamm Bowel Dis. 2017 Jan 10. doi: 10.1097/MIB.0000000000001010.
    PubMed    


  1123. KORELITZ BI, Shamah S
    The Ileitis of Ulcerative Colitis. Why Is It Not Crohn's Disease?
    Inflamm Bowel Dis. 2017 Jan 10. doi: 10.1097/MIB.0000000000001006.
    PubMed    


  1124. SCHREINER P, Biedermann L, Rossel JB, Rogler G, et al
    Prevalence and Determinants of Job Stress in Patients with Inflammatory Bowel Disease.
    Inflamm Bowel Dis. 2017 Jan 10. doi: 10.1097/MIB.0000000000001012.
    PubMed     Abstract available


  1125. COENEN S, Weyts E, Jorissen C, De Munter P, et al
    Effects of Education and Information on Vaccination Behavior in Patients with Inflammatory Bowel Disease.
    Inflamm Bowel Dis. 2017 Jan 10. doi: 10.1097/MIB.0000000000001013.
    PubMed     Abstract available


  1126. CHEN Y, Furuya-Kanamori L, Doi SA, Ananthakrishnan AN, et al
    Clostridium difficile Infection and Risk of Colectomy in Patients with Inflammatory Bowel Disease: A Bias-adjusted Meta-analysis.
    Inflamm Bowel Dis. 2017 Jan 10. doi: 10.1097/MIB.0000000000000998.
    PubMed     Abstract available


  1127. LEWIS JD, Albenberg L, Lee D, Kratz M, et al
    The Importance and Challenges of Dietary Intervention Trials for Inflammatory Bowel Disease.
    Inflamm Bowel Dis. 2017 Jan 10. doi: 10.1097/MIB.0000000000001009.
    PubMed     Abstract available


  1128. PICORARO J, Winberry G, Siegel CA, El-Matary W, et al
    Premedication Use Before Infliximab Administration: A Cross-sectional Analysis.
    Inflamm Bowel Dis. 2017;23:174-180.
    PubMed     Abstract available


  1129. BETTENWORTH D, Gustavsson A, Atreja A, Lopez R, et al
    A Pooled Analysis of Efficacy, Safety, and Long-term Outcome of Endoscopic Balloon Dilation Therapy for Patients with Stricturing Crohn's Disease.
    Inflamm Bowel Dis. 2017;23:133-142.
    PubMed     Abstract available


  1130. ROBLIN X, Duru G, Williet N, Del Tedesco E, et al
    Development and Internal Validation of a Model Using Fecal Calprotectin in Combination with Infliximab Trough Levels to Predict Clinical Relapse in Crohn's Disease.
    Inflamm Bowel Dis. 2017;23:126-132.
    PubMed     Abstract available


  1131. GUMIDYALA AP, Plevinsky JM, Poulopoulos N, Kahn SA, et al
    What Teens Do Not Know Can Hurt Them: An Assessment of Disease Knowledge in Adolescents and Young Adults with IBD.
    Inflamm Bowel Dis. 2017;23:89-96.
    PubMed     Abstract available


  1132. LIE MR, Kreijne JE, van der Woude CJ
    Sex Is Associated with Adalimumab Side Effects and Drug Survival in Patients with Crohn's Disease.
    Inflamm Bowel Dis. 2017;23:75-81.
    PubMed     Abstract available


  1133. COELHO R, Ribeiro H, Maconi G
    Bowel Thickening in Crohn's Disease: Fibrosis or Inflammation? Diagnostic Ultrasound Imaging Tools.
    Inflamm Bowel Dis. 2017;23:23-34.
    PubMed     Abstract available


  1134. YARUR AJ, Quintero MA, Jain A, Czul F, et al
    Serum Amyloid A as a Surrogate Marker for Mucosal and Histologic Inflammation in Patients with Crohn's Disease.
    Inflamm Bowel Dis. 2017;23:158-164.
    PubMed     Abstract available


  1135. SANDS BE, Sandborn WJ, Van Assche G, Lukas M, et al
    Vedolizumab as Induction and Maintenance Therapy for Crohn's Disease in Patients Naive to or Who Have Failed Tumor Necrosis Factor Antagonist Therapy.
    Inflamm Bowel Dis. 2017;23:97-106.
    PubMed     Abstract available


  1136. RISPO A, Imperatore N, Testa A, Mainenti P, et al
    Bowel Damage in Crohn's Disease: Direct Comparison of Ultrasonography-based and Magnetic Resonance-based Lemann Index.
    Inflamm Bowel Dis. 2017;23:143-151.
    PubMed     Abstract available


  1137. SAKURAI T, Kashida H, Komeda Y, Nagai T, et al
    Stress Response Protein RBM3 Promotes the Development of Colitis-associated Cancer.
    Inflamm Bowel Dis. 2017;23:57-65.
    PubMed     Abstract available


  1138. RAO BB, Click BH, Koutroubakis IE, Ramos Rivers C, et al
    The Cost of Crohn's Disease: Varied Health Care Expenditure Patterns Across Distinct Disease Trajectories.
    Inflamm Bowel Dis. 2017;23:107-115.
    PubMed     Abstract available


  1139. VAN DER SLOOT KW, Joshi AD, Bellavance DR, Gilpin KK, et al
    Visceral Adiposity, Genetic Susceptibility, and Risk of Complications Among Individuals with Crohn's Disease.
    Inflamm Bowel Dis. 2017;23:82-88.
    PubMed     Abstract available


  1140. HOU JK, Gasche C, Drazin NZ, Weaver SA, et al
    Assessment of Gaps in Care and the Development of a Care Pathway for Anemia in Patients with Inflammatory Bowel Diseases.
    Inflamm Bowel Dis. 2017;23:35-43.
    PubMed     Abstract available


  1141. HERFARTH HH, Jackson S, Schliebe BG, Martin C, et al
    Investigator-Initiated IBD Trials in the United States: Facts, Obstacles, and Answers.
    Inflamm Bowel Dis. 2017;23:14-22.
    PubMed     Abstract available


    December 2016
  1142. NGUYEN GC, Bernstein CN, Benchimol EI
    Risk of Surgery and Mortality in Elderly-onset Inflammatory Bowel Disease: A Population-based Cohort Study.
    Inflamm Bowel Dis. 2016 Dec 16. doi: 10.1097/MIB.0000000000000993.
    PubMed     Abstract available


  1143. RUBIN DT, Feld LD, Goeppinger SR, Margolese J, et al
    The Crohn's and Colitis Foundation of America Survey of Inflammatory Bowel Disease Patient Health Care Access.
    Inflamm Bowel Dis. 2016 Dec 16. doi: 10.1097/MIB.0000000000000994.
    PubMed     Abstract available


  1144. HOU JK, Kramer JR, Richardson P, Sansgiry S, et al
    Tuberculosis Screening and Reactivation Among a National Cohort of Patients with Inflammatory Bowel Disease Treated with Tumor Necrosis Factor Alpha Antagonists.
    Inflamm Bowel Dis. 2016 Dec 16. doi: 10.1097/MIB.0000000000001003.
    PubMed     Abstract available


  1145. FRIEDMAN S, Larsen PV, Fedder J, Norgard BM, et al
    The Efficacy of Assisted Reproduction in Women with Inflammatory Bowel Disease and the Impact of Surgery-A Nationwide Cohort Study.
    Inflamm Bowel Dis. 2016 Dec 16. doi: 10.1097/MIB.0000000000000996.
    PubMed     Abstract available


  1146. SIVA S, Rubin DT, Gulotta G, Wroblewski K, et al
    Zinc Deficiency is Associated with Poor Clinical Outcomes in Patients with Inflammatory Bowel Disease.
    Inflamm Bowel Dis. 2016.
    PubMed     Abstract available


  1147. TAHARA T, Hirata I, Nakano N, Nagasaka M, et al
    Comprehensive DNA Methylation Profiling of Inflammatory Mucosa in Ulcerative Colitis.
    Inflamm Bowel Dis. 2016.
    PubMed     Abstract available


  1148. GRACIE DJ, Ford AC
    Ongoing Symptoms in Ulcerative Colitis Patients in Remission: Irritable Bowel Syndrome or Gastrointestinal Symptoms in the Absence of Inflammation?
    Inflamm Bowel Dis. 2016.
    PubMed    


  1149. HUANG C, De Ravin SS, Paul AR, Heller T, et al
    Genetic Risk for Inflammatory Bowel Disease Is a Determinant of Crohn's Disease Development in Chronic Granulomatous Disease.
    Inflamm Bowel Dis. 2016;22:2794-2801.
    PubMed     Abstract available


    November 2016
  1150. CUI DJ, Yang XL, Hu M, Yang LC, et al
    Effects of Preoperative Methotrexate on Complications After Surgery for Inflammatory Bowel Disease.
    Inflamm Bowel Dis. 2016.
    PubMed    


  1151. ISHIKAWA D, Sasaki T, Osada T, Kuwahara-Arai K, et al
    Changes in Intestinal Microbiota Following Combination Therapy with Fecal Microbial Transplantation and Antibiotics for Ulcerative Colitis.
    Inflamm Bowel Dis. 2016.
    PubMed     Abstract available


  1152. ROBINSON AM, Gondalia SV, Karpe AV, Eri R, et al
    Fecal Microbiota and Metabolome in a Mouse Model of Spontaneous Chronic Colitis: Relevance to Human Inflammatory Bowel Disease.
    Inflamm Bowel Dis. 2016.
    PubMed     Abstract available


  1153. HUANG C, De Ravin SS, Paul AR, Heller T, et al
    Genetic Risk for Inflammatory Bowel Disease Is a Determinant of Crohn's Disease Development in Chronic Granulomatous Disease.
    Inflamm Bowel Dis. 2016.
    PubMed     Abstract available


  1154. TAKESHITA K, Mizuno S, Mikami Y, Sujino T, et al
    A Single Species of Clostridium Subcluster XIVa Decreased in Ulcerative Colitis Patients.
    Inflamm Bowel Dis. 2016.
    PubMed     Abstract available


  1155. CALDERA F, Hayney MS
    Barriers to Administration of Herpes Zoster Immunization in Patients with Inflammatory Bowel Disease.
    Inflamm Bowel Dis. 2016;22:E44.
    PubMed    


  1156. MOTTET C, Schoepfer AM, Juillerat P, Cosnes J, et al
    Experts Opinion on the Practical Use of Azathioprine and 6-Mercaptopurine in Inflammatory Bowel Disease.
    Inflamm Bowel Dis. 2016;22:2733-2747.
    PubMed     Abstract available


  1157. HASHASH JG, Sigal R, Wein-Levy P, Szigethy EM, et al
    Inflammatory Bowel Disease (IBD) Connect: A Novel Volunteer Program for Hospitalized Patients with IBD and Their Families.
    Inflamm Bowel Dis. 2016;22:2748-2753.
    PubMed     Abstract available


  1158. GIANOTTI RJ, Moss AC
    The Use and Efficacy of Fecal Microbiota Transplantation for Refractory Clostridium difficile in Patients with Inflammatory Bowel Disease.
    Inflamm Bowel Dis. 2016;22:2704-2710.
    PubMed     Abstract available


  1159. REICH J, Guo L, Hall J, Tran A, et al
    A Survey of Social Media Use and Preferences in Patients with Inflammatory Bowel Disease.
    Inflamm Bowel Dis. 2016;22:2678-2687.
    PubMed     Abstract available


  1160. COLLIJ V, Festen EA, Alberts R, Weersma RK, et al
    Drug Repositioning in Inflammatory Bowel Disease Based on Genetic Information.
    Inflamm Bowel Dis. 2016;22:2562-2570.
    PubMed     Abstract available


  1161. TEW GA, Jones K, Mikocka-Walus A
    Physical Activity Habits, Limitations, and Predictors in People with Inflammatory Bowel Disease: A Large Cross-sectional Online Survey.
    Inflamm Bowel Dis. 2016.
    PubMed     Abstract available


    October 2016
  1162. CHOY MC, Visvanathan K, De Cruz P
    An Overview of the Innate and Adaptive Immune System in Inflammatory Bowel Disease.
    Inflamm Bowel Dis. 2016.
    PubMed     Abstract available


  1163. BARNES EL, Burakoff R
    New Biomarkers for Diagnosing Inflammatory Bowel Disease and Assessing Treatment Outcomes.
    Inflamm Bowel Dis. 2016.
    PubMed     Abstract available


  1164. PALONE F, Vitali R, Cucchiara S, Mennini M, et al
    Fecal HMGB1 Reveals Microscopic Inflammation in Adult and Pediatric Patients with Inflammatory Bowel Disease in Clinical and Endoscopic Remission.
    Inflamm Bowel Dis. 2016.
    PubMed     Abstract available


    September 2016
  1165. CHEN SW, Wang PY, Liu YC, Sun L, et al
    Effect of Long Noncoding RNA H19 Overexpression on Intestinal Barrier Function and Its Potential Role in the Pathogenesis of Ulcerative Colitis.
    Inflamm Bowel Dis. 2016.
    PubMed     Abstract available


  1166. CANEPARO V, Pastorelli L, Pisani LF, Bruni B, et al
    Distinct Anti-IFI16 and Anti-GP2 Antibodies in Inflammatory Bowel Disease and Their Variation with Infliximab Therapy.
    Inflamm Bowel Dis. 2016.
    PubMed     Abstract available


  1167. JONEFJALL B, Ohman L, Simren M, Strid H, et al
    IBS-like Symptoms in Patients with Ulcerative Colitis in Deep Remission Are Associated with Increased Levels of Serum Cytokines and Poor Psychological Well-being.
    Inflamm Bowel Dis. 2016.
    PubMed     Abstract available


  1168. QIN X
    Perinuclear Antineutrophil Cytoplasmic Antibody with a Large Portion Being Anti-beta-Glucuronidase, May Have Played a Causative Role in the Pathogenesis of Inflammatory Bowel Disease.
    Inflamm Bowel Dis. 2016.
    PubMed    


    May 2016
  1169. DEGRUTTOLA AK, Low D, Mizoguchi A, Mizoguchi E, et al
    Current Understanding of Dysbiosis in Disease in Human and Animal Models.
    Inflamm Bowel Dis. 2016;22:1137-50.
    PubMed     Abstract available


  1170. DONEGAN A, Boyle B, Crandall W, Dotson JL, et al
    Connecting Families: A Pediatric IBD Center's Development and Implementation of a Volunteer Parent Mentor Program.
    Inflamm Bowel Dis. 2016;22:1151-6.
    PubMed     Abstract available


  1171. GREENUP AJ, Bressler B, Rosenfeld G
    Medical Imaging in Small Bowel Crohn's Disease-Computer Tomography Enterography, Magnetic Resonance Enterography, and Ultrasound: "Which One Is the Best for What?".
    Inflamm Bowel Dis. 2016;22:1246-61.
    PubMed     Abstract available


  1172. GANZ ML, Sugarman R, Wang R, Hansen BB, et al
    The Economic and Health-related Impact of Crohn's Disease in the United States: Evidence from a Nationally Representative Survey.
    Inflamm Bowel Dis. 2016;22:1032-41.
    PubMed     Abstract available


  1173. CALABRESE E, Maaser C, Zorzi F, Kannengiesser K, et al
    Bowel Ultrasonography in the Management of Crohn's Disease. A Review with Recommendations of an International Panel of Experts.
    Inflamm Bowel Dis. 2016;22:1168-83.
    PubMed     Abstract available


  1174. SEHGAL P, Colombel JF, Narula N
    Adverse Events During Anti-TNFalpha Therapies in IBD (Excluding Infections and Malignancies): When to Stop, Continue, or Switch Therapies.
    Inflamm Bowel Dis. 2016;22:1239-45.
    PubMed     Abstract available


  1175. SAAD AM, Czul F, Sakuraba A, Rubin DT, et al
    Age of Diagnosis is Associated with Disease Presentation and Therapeutic Complications in Patients with Crohn's Disease.
    Inflamm Bowel Dis. 2016;22:1027-31.
    PubMed     Abstract available


  1176. FLASAR MH, Chao J, Ozbay AB, Skup M, et al
    Biological and Immunomodulator Use in Crohn's Disease in a Medicaid Population.
    Inflamm Bowel Dis. 2016;22:1056-64.
    PubMed     Abstract available


  1177. CHACHU KA, Osterman MT
    How to Diagnose and Treat IBD Mimics in the Refractory IBD Patient Who Does Not Have IBD.
    Inflamm Bowel Dis. 2016;22:1262-74.
    PubMed     Abstract available


  1178. HAYASHI R, Tsuchiya K, Fukushima K, Horita N, et al
    Reduced Human alpha-defensin 6 in Noninflamed Jejunal Tissue of Patients with Crohn's Disease.
    Inflamm Bowel Dis. 2016;22:1119-28.
    PubMed     Abstract available


  1179. INOKUCHI T, Kato J, Hiraoka S, Takashima S, et al
    Fecal Immunochemical Test Versus Fecal Calprotectin for Prediction of Mucosal Healing in Crohn's Disease.
    Inflamm Bowel Dis. 2016;22:1078-85.
    PubMed     Abstract available


  1180. CHEN ML, Sundrud MS
    Cytokine Networks and T-Cell Subsets in Inflammatory Bowel Diseases.
    Inflamm Bowel Dis. 2016;22:1157-67.
    PubMed     Abstract available


  1181. GALE G, Sigurdsson GV, Ostman S, Malmborg P, et al
    Does Crohn's Disease with Concomitant Orofacial Granulomatosis Represent a Distinctive Disease Subtype?
    Inflamm Bowel Dis. 2016;22:1071-7.
    PubMed     Abstract available


  1182. LIMKETKAI BN, Parian AM, Shah ND, Colombel JF, et al
    Short Bowel Syndrome and Intestinal Failure in Crohn's Disease.
    Inflamm Bowel Dis. 2016;22:1209-18.
    PubMed     Abstract available


  1183. MURAWSKA N, Fabisiak A, Fichna J
    Anemia of Chronic Disease and Iron Deficiency Anemia in Inflammatory Bowel Diseases: Pathophysiology, Diagnosis, and Treatment.
    Inflamm Bowel Dis. 2016;22:1198-208.
    PubMed     Abstract available


  1184. WRIGHT EK, Kamm MA, De Cruz P, Hamilton AL, et al
    Comparison of Fecal Inflammatory Markers in Crohn's Disease.
    Inflamm Bowel Dis. 2016;22:1086-94.
    PubMed     Abstract available


    April 2016
  1185. BUCHNER AM, Lichtenstein GR
    How to Assess and Document Endoscopies in IBD Patients by Including Standard Scoring Systems.
    Inflamm Bowel Dis. 2016;22:1010-9.
    PubMed     Abstract available


  1186. GILS A, Van Stappen T, Dreesen E, Storme R, et al
    Harmonization of Infliximab and Anti-Infliximab Assays Facilitates the Comparison Between Originators and Biosimilars in Clinical Samples.
    Inflamm Bowel Dis. 2016;22:969-75.
    PubMed     Abstract available


  1187. DUBINSKY MC, Rosh J, Faubion WA Jr, Kierkus J, et al
    Efficacy and Safety of Escalation of Adalimumab Therapy to Weekly Dosing in Pediatric Patients with Crohn's Disease.
    Inflamm Bowel Dis. 2016;22:886-93.
    PubMed     Abstract available


  1188. KAUR M, Panikkath D, Yan X, Liu Z, et al
    Perianal Crohn's Disease is Associated with Distal Colonic Disease, Stricturing Disease Behavior, IBD-Associated Serologies and Genetic Variation in the JAK-STAT Pathway.
    Inflamm Bowel Dis. 2016;22:862-9.
    PubMed     Abstract available


  1189. VERGARA M, Sicilia B, Prieto L, Casellas F, et al
    Development and Validation of the Short Crohn's Disease Work Disability Questionnaire.
    Inflamm Bowel Dis. 2016;22:955-62.
    PubMed     Abstract available


  1190. JUNG ES, Cheon JH, Lee JH, Park SJ, et al
    HLA-C*01 is a Risk Factor for Crohn's Disease.
    Inflamm Bowel Dis. 2016;22:796-806.
    PubMed     Abstract available


  1191. MA C, Beilman CL, Huang VW, Fedorak DK, et al
    Anti-TNF Therapy Within 2 Years of Crohn's Disease Diagnosis Improves Patient Outcomes: A Retrospective Cohort Study.
    Inflamm Bowel Dis. 2016;22:870-9.
    PubMed     Abstract available


    March 2016
  1192. MIKOCKA-WALUS A, Knowles SR, Keefer L, Graff L, et al
    Controversies Revisited: A Systematic Review of the Comorbidity of Depression and Anxiety with Inflammatory Bowel Diseases.
    Inflamm Bowel Dis. 2016;22:752-62.
    PubMed     Abstract available


  1193. WITTEN J, Siles R, Shen B, Yao Q, et al
    Triple Disease Combination: Familial Mediterranean Fever, Crohn's Disease, and Chronic Idiopathic Urticaria with Angioedema.
    Inflamm Bowel Dis. 2016;22:E12-3.
    PubMed    


  1194. KRUGLIAK CLEVELAND N, Colman RJ, Rodriquez D, Hirsch A, et al
    Surveillance of IBD Using High Definition Colonoscopes Does Not Miss Adenocarcinoma in Patients with Low-grade Dysplasia.
    Inflamm Bowel Dis. 2016;22:631-7.
    PubMed     Abstract available


  1195. KJELDSEN J, Nielsen J, Larsen MD, Qvist N, et al
    Postoperative Use of Anti-TNF-alpha Agents in Patients with Crohn's Disease and Risk of Reoperation-A Nationwide Cohort Study.
    Inflamm Bowel Dis. 2016;22:599-606.
    PubMed     Abstract available


  1196. ROY A, Lichtiger S
    Clostridium difficile Infection: A Rarity in Patients Receiving Chronic Antibiotic Treatment for Crohn's Disease.
    Inflamm Bowel Dis. 2016;22:648-53.
    PubMed     Abstract available


  1197. CARRIERE J, Bretin A, Darfeuille-Michaud A, Barnich N, et al
    Exosomes Released from Cells Infected with Crohn's Disease-associated Adherent-Invasive Escherichia coli Activate Host Innate Immune Responses and Enhance Bacterial Intracellular Replication.
    Inflamm Bowel Dis. 2016;22:516-28.
    PubMed     Abstract available


  1198. CLEYNEN I, Konings P, Robberecht C, Laukens D, et al
    Genome-Wide Copy Number Variation Scan Identifies Complement Component C4 as Novel Susceptibility Gene for Crohn's Disease.
    Inflamm Bowel Dis. 2016;22:505-15.
    PubMed     Abstract available


  1199. CHOI SH, Kim KW, Lee JY, Kim KJ, et al
    Diffusion-weighted Magnetic Resonance Enterography for Evaluating Bowel Inflammation in Crohn's Disease: A Systematic Review and Meta-analysis.
    Inflamm Bowel Dis. 2016;22:669-79.
    PubMed     Abstract available


  1200. SAMAAN MA, de Jong D, Sahami S, Morgan S, et al
    Incidence and Severity of Prepouch Ileitis: A Distinct Disease Entity or a Manifestation of Refractory Pouchitis?
    Inflamm Bowel Dis. 2016;22:662-8.
    PubMed     Abstract available


    February 2016
  1201. MONIF GR
    Translation of Hypothesis to Therapy in Crohn's Disease.
    Inflamm Bowel Dis. 2016;22:E8-9.
    PubMed    


  1202. WALTER JG, Kahn SA, Noe JD, Schurman JV, et al
    Feeling Fine: Anxiety and Depressive Symptoms in Youth with Established IBD.
    Inflamm Bowel Dis. 2016;22:402-8.
    PubMed     Abstract available


  1203. MIKOCKA-WALUS A, Andrews JM, Bampton P
    Cognitive Behavioral Therapy for IBD.
    Inflamm Bowel Dis. 2016;22:E5-6.
    PubMed    


  1204. SORRENTINO D
    Preclinical and Undiagnosed Crohn's Disease: The Submerged Iceberg.
    Inflamm Bowel Dis. 2016;22:476-86.
    PubMed     Abstract available


  1205. HARRIS KA, Horst S, Gadani A, Nohl A, et al
    Patients with Refractory Crohn's Disease Successfully Treated with Ustekinumab.
    Inflamm Bowel Dis. 2016;22:397-401.
    PubMed     Abstract available


  1206. GRAY WN, Maddux MH
    Current Transition Practices in Pediatric IBD: Findings from a National Survey of Pediatric Providers.
    Inflamm Bowel Dis. 2016;22:372-9.
    PubMed     Abstract available


  1207. DUCHATELLIER CF, Kumar R, Krupoves A, Braegger C, et al
    Steroid Administration and Growth Impairment in Children with Crohn's Disease.
    Inflamm Bowel Dis. 2016;22:355-63.
    PubMed     Abstract available


  1208. NAFTALI T, Reshef L, Kovacs A, Porat R, et al
    Distinct Microbiotas are Associated with Ileum-Restricted and Colon-Involving Crohn's Disease.
    Inflamm Bowel Dis. 2016;22:293-302.
    PubMed     Abstract available


  1209. OCHOA-CORTES F, Turco F, Linan-Rico A, Soghomonyan S, et al
    Enteric Glial Cells: A New Frontier in Neurogastroenterology and Clinical Target for Inflammatory Bowel Diseases.
    Inflamm Bowel Dis. 2016;22:433-49.
    PubMed     Abstract available


  1210. SUNADA K, Shinozaki S, Nagayama M, Yano T, et al
    Long-term Outcomes in Patients with Small Intestinal Strictures Secondary to Crohn's Disease After Double-balloon Endoscopy-assisted Balloon Dilation.
    Inflamm Bowel Dis. 2016;22:380-6.
    PubMed     Abstract available


  1211. MENYS A, Makanyanga J, Plumb A, Bhatnagar G, et al
    Aberrant Motility in Unaffected Small Bowel is Linked to Inflammatory Burden and Patient Symptoms in Crohn's Disease.
    Inflamm Bowel Dis. 2016;22:424-32.
    PubMed     Abstract available


  1212. GAWRON LM, Sanders J, Steele KP, Flynn AD, et al
    Reproductive Planning and Contraception for Women with Inflammatory Bowel Diseases.
    Inflamm Bowel Dis. 2016;22:459-64.
    PubMed     Abstract available


  1213. GOLAN D, Gross B, Miller A, Klil-Drori S, et al
    Cognitive Function of Patients with Crohn's Disease is Associated with Intestinal Disease Activity.
    Inflamm Bowel Dis. 2016;22:364-71.
    PubMed     Abstract available


    January 2016
  1214. BETTENWORTH D, Rieder F
    Reversibility of Stricturing Crohn's Disease-Fact or Fiction?
    Inflamm Bowel Dis. 2016;22:241-7.
    PubMed     Abstract available


  1215. VAZEILLE E, Chassaing B, Buisson A, Dubois A, et al
    GipA Factor Supports Colonization of Peyer's Patches by Crohn's Disease-associated Escherichia Coli.
    Inflamm Bowel Dis. 2016;22:68-81.
    PubMed     Abstract available


  1216. HERFARTH HH, Kappelman MD, Long MD, Isaacs KL, et al
    Use of Methotrexate in the Treatment of Inflammatory Bowel Diseases.
    Inflamm Bowel Dis. 2016;22:224-33.
    PubMed     Abstract available


  1217. MCCONNELL RA, Mahadevan U
    Use of Immunomodulators and Biologics Before, During, and After Pregnancy.
    Inflamm Bowel Dis. 2016;22:213-23.
    PubMed     Abstract available


  1218. REICH KM, Fedorak RN, Madsen K, Kroeker KI, et al
    Role of Vitamin D in Infliximab-induced Remission in Adult Patients with Crohn's Disease.
    Inflamm Bowel Dis. 2016;22:92-9.
    PubMed     Abstract available


  1219. MANCINA RM, Spagnuolo R, Milano M, Brogneri S, et al
    PNPLA3 148M Carriers with Inflammatory Bowel Diseases Have Higher Susceptibility to Hepatic Steatosis and Higher Liver Enzymes.
    Inflamm Bowel Dis. 2016;22:134-40.
    PubMed     Abstract available


  1220. ZUO L, Li Y, Zhu W, Shen B, et al
    Mesenteric Adipocyte Dysfunction in Crohn's Disease is Associated with Hypoxia.
    Inflamm Bowel Dis. 2016;22:114-26.
    PubMed     Abstract available


    October 2015
  1221. PUTIGNANI L, Del Chierico F, Vernocchi P, Cicala M, et al
    Gut Microbiota Dysbiosis as Risk and Premorbid Factors of IBD and IBS Along the Childhood-Adulthood Transition.
    Inflamm Bowel Dis. 2015.
    PubMed     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Inflammatory Bowel Diseases is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: